REACTOME_INTERLEUKIN_6_SIGNALING 1.76 1.91 1.85 1.65 2.11 2.23 2.23 2.04 2.25 2.32 1.95 2.13 2.18 2.13 2.1 2.19 1.97 1.77 1.97 2.15 1.95 2.13 2.31 2.38 2.01 1.95
REACTOME_APOPTOSIS 2.18 2.22 2.37 2.24 2.35 2.43 2.42 2.34 2.35 2.41 2.28 2.29 2.38 2.36 2.37 2.34 2.23 2.19 2.29 2.4 2.25 2.33 2.41 2.46 2.36 2.25
REACTOME_HEMOSTASIS 2.19 2.26 2.38 2.23 2.48 2.52 2.45 2.4 2.44 2.46 2.32 2.39 2.48 2.51 2.45 2.44 2.32 2.23 2.39 2.48 2.26 2.38 2.51 2.57 2.47 2.37
REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS 2.53 2.56 2.67 2.54 2.63 2.74 2.68 2.68 2.61 2.73 2.58 2.59 2.64 2.64 2.68 2.64 2.57 2.49 2.55 2.7 2.51 2.59 2.68 2.81 2.68 2.53
REACTOME_MAPK3_ERK1_ACTIVATION 2.32 2.58 2.64 2.46 2.68 2.86 2.9 2.78 2.91 2.85 2.65 2.67 2.82 2.74 2.88 2.79 2.38 2.49 2.54 2.8 2.6 2.74 2.96 2.88 2.71 2.6
REACTOME_TRANSLESION_SYNTHESIS_BY_Y_FAMILY_DNA_POLYMERASES_BYPASSES_LESIONS_ON_DNA_TEMPLATE 1.94 1.93 2.04 1.92 2.09 2.05 2.06 2.03 2.02 2.05 1.96 2.02 2.07 2.07 2.01 2.04 2.04 1.98 1.97 1.99 2.12 2.1 2.08 2.14 2.03 2.02
REACTOME_RECOGNITION_OF_DNA_DAMAGE_BY_PCNA_CONTAINING_REPLICATION_COMPLEX 2.16 2.17 2.45 2.24 2.38 2.29 2.34 2.34 2.32 2.37 2.38 2.36 2.34 2.39 2.36 2.39 2.35 2.27 2.26 2.29 2.44 2.43 2.38 2.43 2.33 2.33
REACTOME_TRANSLESION_SYNTHESIS_BY_POLH 2.47 2.53 2.44 2.35 2.63 2.52 2.54 2.54 2.54 2.56 2.51 2.59 2.54 2.55 2.52 2.5 2.63 2.61 2.52 2.46 2.78 2.64 2.6 2.65 2.53 2.52
REACTOME_RECOGNITION_AND_ASSOCIATION_OF_DNA_GLYCOSYLASE_WITH_SITE_CONTAINING_AN_AFFECTED_PURINE 1.63 1.69 1.67 1.43 1.93 1.8 1.79 1.72 1.77 1.7 1.7 1.67 1.73 1.79 1.76 1.76 1.65 1.47 1.7 1.8 1.5 1.71 1.85 1.99 1.77 1.7
REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY 1.29 1.27 1.66 1.58 1.57 1.57 1.62 1.39 1.53 1.55 1.44 1.46 1.59 1.6 1.32 1.41 1.42 1.24 1.45 1.52 1.33 1.33 1.52 1.63 1.47 1.33
REACTOME_ACTIVATION_OF_BAD_AND_TRANSLOCATION_TO_MITOCHONDRIA 2.62 2.6 2.43 2.35 2.62 2.78 2.55 2.51 2.49 2.53 2.46 2.39 2.51 2.5 2.59 2.48 2.49 2.23 2.51 2.53 2.39 2.45 2.53 2.58 2.57 2.37
REACTOME_FORMATION_OF_APOPTOSOME 2.34 2.46 2.65 2.41 2.35 2.57 2.67 2.48 2.51 2.57 2.5 2.46 2.5 2.53 2.58 2.61 2.2 2.37 2.39 2.56 2.46 2.41 2.62 2.7 2.6 2.35
REACTOME_CYTOCHROME_C_MEDIATED_APOPTOTIC_RESPONSE 2.31 2.38 2.54 2.32 2.36 2.5 2.57 2.43 2.47 2.52 2.37 2.42 2.44 2.41 2.48 2.46 2.18 2.36 2.36 2.49 2.38 2.35 2.49 2.6 2.52 2.26
REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS 2.17 2.23 2.41 2.27 2.53 2.54 2.53 2.42 2.46 2.53 2.37 2.44 2.56 2.55 2.48 2.41 2.4 2.25 2.35 2.47 2.33 2.47 2.55 2.53 2.51 2.4
REACTOME_APOPTOTIC_FACTOR_MEDIATED_RESPONSE 2.22 2.28 2.37 2.15 2.26 2.36 2.41 2.35 2.35 2.42 2.26 2.34 2.34 2.3 2.36 2.32 2.14 2.26 2.25 2.39 2.32 2.28 2.4 2.53 2.37 2.19
REACTOME_OPIOID_SIGNALLING 2.33 2.4 2.39 2.16 2.48 2.5 2.48 2.38 2.47 2.36 2.34 2.37 2.46 2.48 2.4 2.46 2.22 2.33 2.47 2.49 2.26 2.34 2.49 2.53 2.36 2.22
REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB 1.97 2.18 2.13 1.94 2.23 2.28 2.13 2.03 2.26 2.1 2.08 2.21 2.26 2.33 2.06 2.17 1.8 2 2.3 2.26 1.72 1.88 2.29 2.3 2.03 1.95
REACTOME_CAMK_IV_MEDIATED_PHOSPHORYLATION_OF_CREB 2.36 2.33 2.43 2.3 2.56 2.59 2.48 2.36 2.43 2.44 2.35 2.48 2.52 2.52 2.3 2.48 2.23 2.35 2.45 2.63 2.32 2.25 2.41 2.48 2.31 2.3
REACTOME_CA_DEPENDENT_EVENTS 2.24 2.36 2.35 2.11 2.4 2.46 2.4 2.27 2.38 2.31 2.29 2.38 2.4 2.46 2.27 2.4 2.04 2.25 2.42 2.46 2.19 2.22 2.44 2.45 2.27 2.1
REACTOME_G_PROTEIN_MEDIATED_EVENTS 2.31 2.41 2.4 2.15 2.47 2.53 2.49 2.37 2.47 2.37 2.34 2.45 2.47 2.52 2.34 2.48 2.18 2.33 2.52 2.52 2.26 2.3 2.51 2.55 2.36 2.2
REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING 1.04 0.98 1.13 0.91 0.9 0.94 0.82 0.91 0.94 0.88 1.29 0.87 0.91 0.89 0.95 1.08 0.95 0.96 1 0.84 1.21 1.17 1 1.02 0.87 1.09
REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE 2.41 2.45 2.34 2.38 2.59 2.64 2.47 2.33 2.52 2.44 2.28 2.37 2.5 2.55 2.5 2.46 2.34 2.44 2.48 2.55 2.33 2.37 2.46 2.56 2.43 2.34
REACTOME_NEUROTRANSMITTER_CLEARANCE 1.94 2.14 2.41 2.21 2.26 2.4 2.37 2.32 2.34 2.36 2.19 2.41 2.46 2.38 2.31 2.37 2.4 2.31 2.31 2.53 2.45 2.51 2.28 2.51 2.5 2.4
REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION 2.36 2.46 2.47 2.22 2.6 2.69 2.57 2.49 2.53 2.52 2.43 2.5 2.6 2.6 2.52 2.53 2.31 2.4 2.55 2.61 2.37 2.48 2.6 2.67 2.52 2.4
REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES 2.36 2.44 2.44 2.26 2.58 2.66 2.53 2.45 2.51 2.49 2.39 2.47 2.56 2.57 2.5 2.51 2.3 2.4 2.53 2.58 2.36 2.45 2.55 2.64 2.49 2.38
REACTOME_NEURONAL_SYSTEM 2.21 2.29 2.29 2.13 2.43 2.51 2.38 2.32 2.37 2.36 2.25 2.34 2.4 2.42 2.35 2.38 2.16 2.25 2.41 2.44 2.21 2.29 2.4 2.49 2.36 2.25
REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX 1.24 1.2 1.29 1.39 1.19 1.25 1.32 1.19 1.3 1.21 1.29 1.16 1.24 1.25 1.12 1.25 1.16 1.1 1.13 1.24 1.2 1.12 1.26 1.23 1.27 1.13
REACTOME_IRS_MEDIATED_SIGNALLING 1.96 1.99 2.06 1.85 2.35 2.41 2.2 2.21 2.34 2.3 2.1 2.29 2.39 2.33 2.17 2.24 2.21 1.96 2.21 2.31 1.95 2.15 2.4 2.48 2.24 2.2
REACTOME_RAF_INDEPENDENT_MAPK1_3_ACTIVATION 2.44 2.51 2.51 2.3 2.61 2.71 2.68 2.63 2.62 2.69 2.6 2.68 2.57 2.56 2.66 2.66 2.43 2.49 2.52 2.6 2.52 2.58 2.67 2.67 2.63 2.53
REACTOME_FORMATION_OF_THE_EARLY_ELONGATION_COMPLEX 1.26 1.29 1.41 1.5 1.23 1.29 1.36 1.37 1.36 1.28 1.38 1.25 1.28 1.31 1.2 1.41 1.25 1.17 1.2 1.32 1.25 1.23 1.34 1.35 1.38 1.21
REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1 2.12 2.14 2.41 2.23 2.28 2.32 2.37 2.2 2.29 2.3 2.4 2.17 2.24 2.29 2.3 2.25 2.03 2.11 2.15 2.19 2.17 2.32 2.4 2.19 2.29 2.12
REACTOME_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION 2.02 2.01 2.58 2.48 2.28 2.36 2.34 2.19 2.39 2.3 2.38 2.14 2.32 2.27 2.38 2.29 2.05 2.02 2.11 2.24 2.13 2.31 2.44 2.32 2.32 2.12
REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS 2.69 2.71 2.79 2.69 2.8 2.9 2.74 2.79 2.67 2.83 2.7 2.69 2.73 2.76 2.81 2.79 2.7 2.52 2.71 2.78 2.57 2.74 2.79 2.88 2.8 2.66
REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS 1.73 1.8 2.06 1.98 1.84 2 1.92 1.92 1.93 1.92 1.85 1.86 1.97 2.04 1.95 2.02 1.75 1.78 1.94 1.92 1.81 1.98 2.07 2.08 1.87 1.8
REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE 2.11 2.19 2.1 2.17 2.36 2.38 2.23 2.1 2.33 2.35 2.14 2.35 2.33 2.38 2.24 2.2 2.22 2.07 2.33 2.32 2.03 2.14 2.38 2.46 2.27 2.14
REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR 1.9 1.92 2.04 1.92 2.02 2.07 2.04 1.99 2.04 1.96 1.94 1.91 2.04 1.95 2.03 2.01 1.86 1.89 1.98 2.06 2.02 2.07 2.03 2.08 1.98 1.94
REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES 1.97 1.96 2.18 2.19 2.02 2.14 2.12 2.06 2.05 2.13 1.98 2.02 2.06 2.11 2.11 2.14 1.96 1.99 2.01 2.07 2 2.06 2.17 2.17 2.08 2.04
REACTOME_PROLACTIN_RECEPTOR_SIGNALING 1.8 1.89 2 1.86 2.23 2.15 1.88 1.94 2.08 2.09 2.08 2.08 2.05 2.11 2.06 2.01 1.91 1.71 2.01 2 1.91 1.95 2.27 2.29 2.03 1.97
REACTOME_SIGNALING_BY_NODAL 1.35 1.76 1.9 1.59 2.02 1.92 1.93 2.01 1.97 1.9 1.59 1.99 1.95 2.01 2.03 1.98 1.88 1.63 1.74 1.97 1.82 1.96 2.03 2.16 2.07 2.01
REACTOME_FERTILIZATION 1.17 1.1 1.36 1.33 1.33 1.25 1.3 1.34 1.35 1.34 1.18 1.24 1.24 1.15 1.26 1.2 1.3 0.85 1.06 1.3 1.25 1.3 1.35 1.37 1.36 1.45
REACTOME_MEIOTIC_SYNAPSIS 1.71 1.71 1.97 1.74 2.16 2.13 2.11 2 2.19 2.19 1.93 2.01 2.1 2.07 2.03 1.97 1.93 1.58 1.81 1.99 1.71 1.93 2.2 2.19 2.11 1.99
REACTOME_ROS_AND_RNS_PRODUCTION_IN_PHAGOCYTES 2.55 2.61 2.92 2.65 2.68 2.84 2.8 2.75 2.7 2.75 2.64 2.6 2.73 2.7 2.72 2.74 2.52 2.51 2.66 2.77 2.54 2.69 2.77 2.88 2.78 2.61
REACTOME_SIGNALING_BY_FGFR_IN_DISEASE 1.79 1.88 2.01 1.83 2.13 2.17 2.05 2.1 2.09 2.12 2 2.14 2.16 2.11 1.99 2.1 2.07 1.81 2.02 2.14 1.87 2.04 2.14 2.28 2.09 2.06
REACTOME_SIGNALING_BY_ERBB2 2.07 2.07 2.19 2.18 2.33 2.3 2.29 2.24 2.29 2.28 2.23 2.21 2.26 2.22 2.19 2.24 2.25 2.1 2.14 2.18 2.16 2.28 2.3 2.29 2.23 2.19
REACTOME_SIGNALING_BY_ERBB2_IN_CANCER 1.89 1.87 2.02 1.99 2.29 2.28 2.27 2.11 2.3 2.2 2.08 2.11 2.24 2.19 2.09 2.13 2 1.86 2.03 2.06 1.9 2.14 2.22 2.23 2.1 1.99
REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR 1.57 1.58 1.62 1.5 1.99 2.05 1.99 1.91 1.84 1.9 1.62 1.86 2.14 2.12 1.96 1.94 1.82 1.85 1.92 2.13 1.82 1.98 2.08 2.18 2.08 1.85
REACTOME_CELLULAR_RESPONSE_TO_HYPOXIA 1.79 1.78 1.99 1.84 1.93 1.96 1.99 1.91 1.93 1.87 1.83 1.86 1.96 1.88 1.93 1.93 1.79 1.82 1.87 2.02 2 2.04 1.99 2.01 1.94 1.89
REACTOME_CONSTITUTIVE_SIGNALING_BY_LIGAND_RESPONSIVE_EGFR_CANCER_VARIANTS 2.34 2.3 2.42 2.31 2.44 2.4 2.48 2.54 2.38 2.44 2.4 2.43 2.32 2.32 2.38 2.46 2.42 2.36 2.4 2.31 2.47 2.54 2.37 2.36 2.4 2.4
REACTOME_SIGNALING_BY_ERBB4 2.27 2.3 2.51 2.43 2.58 2.68 2.61 2.43 2.56 2.6 2.47 2.52 2.58 2.55 2.5 2.48 2.43 2.4 2.43 2.52 2.41 2.58 2.57 2.63 2.48 2.44
REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION 1.96 2.06 2.31 2.16 2.22 2.29 2.36 2.24 2.29 2.26 2.22 2.18 2.32 2.27 2.24 2.19 2.09 2.02 2.11 2.29 2.15 2.29 2.37 2.38 2.23 2.18
REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES 1.67 1.71 1.93 1.79 1.84 1.95 1.95 1.82 1.98 1.85 1.77 1.76 1.94 1.81 1.86 1.83 1.64 1.61 1.77 1.96 1.86 1.93 1.95 1.95 1.8 1.73
REACTOME_ERYTHROCYTES_TAKE_UP_CARBON_DIOXIDE_AND_RELEASE_OXYGEN 2.05 2.06 2.97 2.7 2.48 2.47 2.33 2.61 2.56 2.74 2.56 2.28 2.32 2.24 2.93 2.94 2.84 2.31 2.27 2.72 2.68 3.01 3.03 2.46 2.93 3
REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING 1.49 1.47 1.67 1.69 1.95 2 1.97 1.76 1.94 1.83 1.7 1.74 1.99 1.92 1.74 1.78 1.65 1.58 1.74 1.77 1.58 1.8 1.88 1.94 1.76 1.65
REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING 1.58 1.57 1.82 1.77 2.04 2.11 2.1 1.84 2.09 1.89 1.83 1.8 2.1 1.99 1.88 1.92 1.65 1.58 1.82 1.87 1.59 1.86 2.01 2.06 1.88 1.74
REACTOME_NUCLEAR_SIGNALING_BY_ERBB4 2.08 2.05 2.37 2.24 2.49 2.6 2.48 2.28 2.47 2.51 2.3 2.46 2.54 2.46 2.32 2.32 2.38 2.24 2.2 2.43 2.34 2.49 2.47 2.51 2.42 2.38
REACTOME_INTERLEUKIN_7_SIGNALING 1.95 2.01 2.03 1.97 2.33 2.39 2.28 2.15 2.28 2.32 2.07 2.25 2.35 2.36 2.21 2.21 2.21 1.89 2.23 2.21 1.97 2.2 2.39 2.39 2.27 2.19
REACTOME_DEVELOPMENTAL_BIOLOGY 2.07 2.15 2.26 2.12 2.37 2.43 2.33 2.3 2.3 2.36 2.19 2.29 2.36 2.37 2.32 2.32 2.19 2.13 2.26 2.37 2.13 2.27 2.38 2.46 2.34 2.27
REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT 1.68 1.73 1.86 1.77 1.87 1.89 1.93 1.75 1.91 1.86 1.73 1.78 1.85 1.87 1.78 1.77 1.66 1.63 1.83 1.82 1.68 1.65 1.96 1.91 1.77 1.66
REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM 1.98 2.04 2.26 2.13 2.29 2.36 2.28 2.21 2.28 2.31 2.18 2.21 2.32 2.33 2.27 2.27 2.12 2.05 2.18 2.28 2.09 2.24 2.35 2.42 2.28 2.2
REACTOME_ADAPTIVE_IMMUNE_SYSTEM 2.01 2.08 2.28 2.16 2.31 2.39 2.3 2.22 2.29 2.33 2.2 2.24 2.32 2.34 2.29 2.26 2.11 2.04 2.22 2.3 2.07 2.23 2.37 2.43 2.29 2.19
REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING 2.07 1.98 2.1 2.15 2.05 2.01 1.92 2 1.88 2 2.21 2 1.91 1.86 1.96 2.08 2 2.15 1.95 1.99 2.06 2.1 2.02 2.04 2 2.13
REACTOME_INWARDLY_RECTIFYING_K_CHANNELS 2.5 2.53 2.42 2.25 2.65 2.71 2.58 2.65 2.52 2.54 2.56 2.49 2.64 2.62 2.69 2.61 2.52 2.55 2.61 2.74 2.52 2.66 2.6 2.62 2.6 2.57
REACTOME_POTASSIUM_CHANNELS 2.04 2.08 2.02 1.85 2.24 2.3 2.15 2.19 2.15 2.14 2.07 2.16 2.21 2.22 2.18 2.23 2.02 2.11 2.26 2.31 2.05 2.16 2.2 2.3 2.16 2.1
REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS 1.85 1.89 1.75 1.61 2.06 2.14 1.95 1.93 1.96 1.94 1.78 2.05 1.99 2.05 1.88 2.04 1.68 1.9 2.16 2.11 1.82 1.92 2.01 2.17 1.91 1.84
REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS 1.26 1.01 1.57 1.35 1.48 1.49 1.17 1.26 1.52 1.31 1.49 1.25 1.29 1.34 1.29 1.53 1.1 1.14 1.43 1.48 1.04 1.36 1.46 1.52 1.31 1.2
REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING 2.58 2.63 2.83 2.84 2.67 2.65 2.7 2.67 2.57 2.64 2.77 2.66 2.59 2.65 2.68 2.66 2.69 2.73 2.66 2.61 2.78 2.85 2.74 2.68 2.55 2.6
REACTOME_TRANSCRIPTION_OF_E2F_TARGETS_UNDER_NEGATIVE_CONTROL_BY_DREAM_COMPLEX 1.61 1.59 2.03 1.95 1.88 1.92 1.96 1.78 1.78 1.79 1.76 1.8 1.9 1.94 1.83 1.85 1.79 1.7 1.65 1.82 1.64 1.85 1.86 1.82 1.87 1.74
REACTOME_TRANSCRIPTION_OF_E2F_TARGETS_UNDER_NEGATIVE_CONTROL_BY_P107_RBL1_AND_P130_RBL2_IN_COMPLEX_WITH_HDAC1 1.64 1.58 2.05 1.96 1.89 1.94 1.94 1.8 1.84 1.77 1.74 1.75 1.88 1.95 1.83 1.8 1.72 1.64 1.66 1.87 1.71 1.84 1.87 1.84 1.89 1.8
REACTOME_MITOCHONDRIAL_IRON_SULFUR_CLUSTER_BIOGENESIS 1.62 1.75 1.71 1.34 1.75 1.7 1.68 1.6 1.56 1.63 1.54 1.69 1.58 1.6 1.53 1.59 1.5 1.58 1.72 1.64 1.54 1.49 1.54 1.61 1.7 1.69
REACTOME_RORA_ACTIVATES_GENE_EXPRESSION 1.34 1.42 1.43 1.41 1.44 1.41 1.46 1.28 1.38 1.34 1.29 1.18 1.29 1.31 1.25 1.31 1.07 1.31 1.39 1.35 1.07 1.25 1.35 1.24 1.17 1.04
REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION 1.7 1.74 1.74 1.6 1.9 1.99 1.83 1.74 1.81 1.75 1.56 1.72 1.8 1.9 1.67 1.74 1.57 1.66 1.84 1.93 1.47 1.67 1.77 1.79 1.63 1.64
REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS 1.42 1.53 1.78 1.71 1.87 1.93 1.8 1.77 1.87 1.98 1.61 1.84 1.89 1.95 1.78 1.78 1.69 1.51 1.71 1.79 1.56 1.82 1.92 2.08 1.94 1.98
REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS 1.63 1.66 1.43 1.42 1.84 1.94 1.66 1.73 1.71 1.85 1.33 1.77 1.84 1.89 1.69 1.77 1.76 1.54 1.88 1.86 1.55 1.64 1.92 2 1.74 1.74
REACTOME_CASPASE_ACTIVATION_VIA_DEATH_RECEPTORS_IN_THE_PRESENCE_OF_LIGAND 1.18 1.15 1.69 1.31 1.47 1.42 1.45 1.29 1.2 1.26 1.39 1.19 1.39 1.32 1.11 1.13 1.05 1.06 1.37 1.35 1.22 1.37 1.31 1.36 1.44 1.4
REACTOME_INTRINSIC_PATHWAY_OF_FIBRIN_CLOT_FORMATION 1.85 1.92 2.17 2.05 2.11 2.17 2.2 2.22 2.13 2.02 1.98 1.91 2.2 2.12 2.03 2.18 2.23 1.84 1.98 2.23 2.26 2.3 2.23 2.26 2.35 2.33
REACTOME_COMMON_PATHWAY_OF_FIBRIN_CLOT_FORMATION 1.21 1.13 1.44 1.32 1.32 1.29 1.4 1.39 1.29 1.25 1.33 1.15 1.48 1.48 1.41 1.54 1.4 1.31 1.24 1.33 1.39 1.44 1.37 1.37 1.51 1.41
REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE 1.64 1.67 1.89 1.72 1.88 1.92 1.95 1.91 1.85 1.77 1.79 1.68 1.97 1.93 1.8 1.92 1.98 1.68 1.71 1.93 1.98 2.03 1.93 1.94 2.09 2.04
REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS 2.02 1.95 1.87 1.99 2.22 2.22 1.99 1.96 2 2.1 1.86 2.01 2.01 2.03 1.79 1.9 2.06 1.82 2.06 2 1.86 1.81 2.02 1.94 1.92 1.97
REACTOME_THE_CITRIC_ACID_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT 1.89 1.99 2.08 2.06 1.96 2.02 2 2.05 1.98 1.98 1.99 1.96 2.02 2.03 2.04 2.08 1.98 1.91 1.96 2.04 1.97 2.01 2 2.03 2 2.01
REACTOME_SIGNALING_BY_SCF_KIT 1.77 1.74 1.83 1.74 2.1 2.07 2 1.88 1.97 2.04 1.83 2.01 2.05 2.02 1.94 1.92 1.99 1.78 2.04 1.99 1.74 1.91 2.04 2.09 1.9 1.85
REACTOME_REGULATION_OF_KIT_SIGNALING 1.76 1.74 1.69 1.58 1.95 2 2 1.87 1.85 1.94 1.76 1.9 1.99 1.94 1.9 1.83 1.94 1.77 1.98 1.92 1.69 1.73 1.87 1.86 1.89 1.76
REACTOME_COLLAGEN_DEGRADATION 1.37 1.42 1.47 1.36 1.65 1.62 1.51 1.49 1.54 1.55 1.36 1.48 1.54 1.54 1.47 1.5 1.42 1.27 1.43 1.55 1.41 1.54 1.56 1.61 1.54 1.52
REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE 2.38 2.38 2.34 2.35 2.33 2.45 2.36 2.3 2.33 2.36 2.3 2.27 2.28 2.31 2.37 2.29 2.22 2.19 2.37 2.4 2.25 2.23 2.35 2.43 2.3 2.15
REACTOME_BETA_DEFENSINS 0.9 0.84 0.67 0.75 0.85 0.51 0.36 0.4 0.55 0.51 0.67 0.61 0.48 0.53 0.32 0.44 0.44 0.89 0.66 0.55 0.8 0.74 0.38 0.5 0.64 0.75
REACTOME_DEFENSINS 0.91 0.84 0.77 0.94 0.82 0.61 0.59 0.58 0.67 0.53 0.76 0.61 0.62 0.57 0.65 0.52 0.57 0.81 0.62 0.63 0.79 0.82 0.53 0.54 0.63 0.72
REACTOME_REPRODUCTION 1.57 1.59 1.85 1.71 2 2 1.89 1.8 1.94 2 1.74 1.84 1.91 1.89 1.83 1.82 1.73 1.43 1.68 1.83 1.59 1.8 2.02 2.03 1.94 1.83
REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX 1.75 1.78 1.96 1.86 2.02 2.04 1.94 1.91 1.96 1.95 1.8 1.92 1.98 1.97 1.84 1.88 1.91 1.72 1.78 2 1.85 1.97 1.94 2.04 2.01 1.98
REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION 1.82 1.89 2.02 1.83 2.11 2.15 2.05 1.97 2.07 2.06 1.88 2.03 2.13 2.12 1.97 2.02 2.03 1.86 1.95 2.1 1.98 2.07 2.1 2.18 2.13 2.06
REACTOME_COLLAGEN_FORMATION 1.33 1.36 1.52 1.38 1.64 1.62 1.5 1.45 1.55 1.53 1.4 1.51 1.61 1.61 1.45 1.49 1.56 1.34 1.4 1.57 1.47 1.6 1.56 1.66 1.56 1.54
REACTOME_REVERSIBLE_HYDRATION_OF_CARBON_DIOXIDE 1.99 2.21 2.02 1.69 2.48 2.56 2.12 2.28 2.35 2.31 1.94 2.17 2.4 2.35 2.29 2.35 2.06 1.99 2.14 2.51 2.11 2.35 2.32 2.49 2.14 2.26
REACTOME_ACYL_CHAIN_REMODELLING_OF_PC 1.58 1.76 1.85 1.72 1.87 2.05 1.92 1.8 1.96 2 1.75 1.79 2.08 2.02 1.85 1.9 1.7 1.6 1.81 1.98 1.56 1.74 1.93 2.1 1.92 1.85
REACTOME_ACYL_CHAIN_REMODELLING_OF_PS 1.8 1.93 1.88 1.69 1.91 2.11 2.04 1.91 2 1.92 1.88 1.82 2.06 2.02 2.03 1.95 1.71 1.77 1.94 2.12 1.7 1.78 2.05 2.15 1.95 1.92
REACTOME_ACYL_CHAIN_REMODELLING_OF_PE 1.61 1.78 1.87 1.78 1.84 2.04 1.96 1.81 1.96 1.98 1.81 1.83 2.12 2.07 1.86 1.9 1.76 1.64 1.83 2.03 1.62 1.75 1.93 2.08 1.94 1.9
REACTOME_ACYL_CHAIN_REMODELLING_OF_PI 1.31 1.42 1.5 1.39 1.28 1.42 1.37 1.45 1.44 1.54 1.42 1.28 1.61 1.64 1.49 1.48 1.47 1.44 1.31 1.52 1.38 1.52 1.38 1.46 1.45 1.46
REACTOME_ACYL_CHAIN_REMODELLING_OF_PG 1.71 1.77 1.92 1.6 1.76 1.94 1.8 1.76 1.76 1.74 1.83 1.69 1.86 1.89 1.84 1.87 1.65 1.69 1.84 1.87 1.58 1.79 1.73 1.87 1.77 1.7
REACTOME_SYNTHESIS_OF_PA 1.71 1.81 1.99 1.73 2.06 2.19 2.01 1.89 2.08 2.06 1.87 1.94 2.13 2.08 2.03 2.02 1.88 1.82 1.96 2.02 1.69 1.91 2.05 2.21 1.98 1.87
REACTOME_SYNTHESIS_OF_PC 1.89 1.88 1.9 1.89 2.04 2.1 1.93 1.92 1.96 2.02 1.87 2.11 2.02 1.98 2.01 1.94 1.95 1.83 1.99 2.13 1.91 1.94 2.07 2.06 2.06 1.96
REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS 1.78 1.87 1.98 1.84 2.03 2.13 2 1.97 2.06 2.07 1.91 2 2.12 2.09 2.04 2.04 1.91 1.86 2 2.07 1.84 1.98 2.1 2.2 2.07 1.97
REACTOME_INOSITOL_PHOSPHATE_METABOLISM 1.71 1.67 1.78 1.72 1.87 1.93 1.88 1.76 1.85 1.87 1.75 1.84 1.83 1.88 1.79 1.8 1.72 1.74 1.87 1.92 1.7 1.74 1.97 2.01 1.82 1.72
REACTOME_PI_METABOLISM 1.94 1.89 1.95 1.76 2.13 2.15 2.08 1.92 2.09 2.05 1.88 2.03 2.06 2.06 2 1.94 1.87 1.8 2.02 2.12 1.82 1.95 2.17 2.17 1.99 1.91
REACTOME_PHOSPHOLIPID_METABOLISM 1.86 1.89 1.96 1.82 2.09 2.16 2.05 1.96 2.09 2.08 1.9 2.03 2.1 2.09 2.04 2.02 1.9 1.84 2.03 2.1 1.84 1.98 2.14 2.21 2.05 1.96
REACTOME_DAG_AND_IP3_SIGNALING 2.09 2.18 2.25 2.03 2.2 2.26 2.24 2.13 2.2 2.14 2.13 2.23 2.24 2.3 2.08 2.25 1.93 2.12 2.28 2.3 2.06 2.11 2.25 2.28 2.13 1.99
REACTOME_MEIOSIS 1.61 1.62 1.88 1.73 2.07 2.06 1.97 1.82 2.02 2.06 1.8 1.86 1.97 1.96 1.89 1.86 1.75 1.49 1.73 1.86 1.61 1.83 2.07 2.06 1.98 1.84
REACTOME_CELL_CELL_COMMUNICATION 2.05 2.06 2.12 1.95 2.34 2.39 2.23 2.15 2.25 2.28 2.13 2.24 2.33 2.33 2.18 2.21 2.1 1.99 2.25 2.24 2.08 2.16 2.36 2.4 2.25 2.19
REACTOME_SIGNALING_BY_ACTIVIN 1.22 1.73 1.88 1.63 1.82 1.82 1.86 1.95 1.87 1.71 1.47 1.79 1.89 1.98 1.91 1.81 1.82 1.7 1.69 1.94 1.8 1.92 2 2.11 2.07 1.96
REACTOME_G0_AND_EARLY_G1 1.59 1.55 1.95 1.89 1.89 1.96 1.91 1.77 1.87 1.87 1.75 1.76 1.92 1.95 1.84 1.83 1.74 1.63 1.66 1.84 1.67 1.84 1.91 1.89 1.84 1.75
REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS 1.91 1.97 2.45 2.25 2.22 2.36 2.33 2.18 2.19 2.25 2.13 2.11 2.27 2.31 2.21 2.19 2.09 1.96 2.11 2.27 1.94 2.24 2.28 2.35 2.36 2.23
REACTOME_METHYLATION 2.45 2.36 2.42 2.36 2.43 2.53 2.32 2.26 2.35 2.31 2.12 2.33 2.3 2.33 2.05 2.22 2.34 2.17 2.34 2.5 2.15 2.16 2.31 2.38 2.27 2.22
REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES 1.51 1.63 2.22 2.13 1.72 1.82 2.02 1.75 1.95 2.03 1.85 1.91 1.94 2.03 1.9 1.98 1.67 1.64 1.78 1.88 1.53 1.69 2.04 2.07 2 1.88
REACTOME_GLUCURONIDATION 1.19 1.27 1.99 1.63 1.8 1.9 1.86 1.63 1.95 1.93 1.75 1.74 1.94 2.01 1.98 1.94 1.56 1.46 1.54 1.71 1.46 1.89 2.04 2.09 1.9 1.67
REACTOME_GLUTATHIONE_CONJUGATION 1.87 1.96 2.17 1.95 2.06 2.26 2.15 2.08 1.82 1.92 1.97 1.9 2.09 2.14 1.97 1.89 2.03 1.88 2.03 2.19 1.99 2.26 1.98 2.16 2.16 2.1
REACTOME_ELASTIC_FIBRE_FORMATION 1.59 1.68 1.75 1.52 1.82 1.84 1.77 1.69 1.77 1.76 1.74 1.79 1.9 1.88 1.72 1.88 1.77 1.68 1.79 1.83 1.76 1.89 1.85 1.94 1.88 1.82
REACTOME_POLO_LIKE_KINASE_MEDIATED_EVENTS 1.55 1.66 1.77 1.63 1.8 1.9 1.89 1.76 1.84 1.66 1.56 1.67 1.94 1.84 1.78 1.7 1.62 1.6 1.75 1.92 1.6 1.71 1.75 1.77 1.83 1.69
REACTOME_EUKARYOTIC_TRANSLATION_ELONGATION 2.38 2.34 2.57 2.48 2.37 2.35 2.41 2.46 2.36 2.44 2.42 2.45 2.34 2.39 2.39 2.48 2.57 2.44 2.29 2.42 2.5 2.52 2.49 2.5 2.47 2.43
REACTOME_SIGNALING_BY_NOTCH 1.76 1.83 1.96 1.92 1.96 2.01 1.94 1.91 1.96 1.95 1.88 1.92 1.94 1.91 1.93 1.92 1.82 1.8 1.91 1.96 1.8 1.9 2.03 2.07 1.91 1.82
REACTOME_TELOMERE_MAINTENANCE 1.54 1.6 1.81 1.75 1.73 1.71 1.76 1.7 1.73 1.76 1.73 1.68 1.73 1.76 1.74 1.77 1.69 1.52 1.64 1.74 1.66 1.71 1.8 1.84 1.73 1.69
REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION 2.69 2.83 2.93 2.73 2.89 3 2.91 2.93 2.91 2.98 2.83 2.88 2.92 2.97 2.96 2.94 2.75 2.77 2.89 2.97 2.78 2.82 2.98 3.07 3.01 2.89
REACTOME_METABOLISM_OF_NUCLEOTIDES 1.55 1.62 1.98 1.83 1.73 1.85 1.77 1.71 1.76 1.8 1.72 1.71 1.77 1.76 1.79 1.8 1.63 1.64 1.69 1.76 1.61 1.73 1.87 1.9 1.79 1.65
REACTOME_MITOCHONDRIAL_BIOGENESIS 1.66 1.63 1.82 1.72 1.81 1.85 1.77 1.63 1.79 1.74 1.71 1.73 1.81 1.86 1.73 1.71 1.68 1.6 1.75 1.77 1.63 1.66 1.82 1.78 1.75 1.64
REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA 1.4 1.43 1.55 1.57 1.5 1.57 1.59 1.54 1.46 1.54 1.29 1.43 1.49 1.61 1.53 1.5 1.33 1.44 1.37 1.55 1.35 1.48 1.51 1.56 1.49 1.44
REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS 1.28 1.3 1.42 1.44 1.36 1.43 1.45 1.4 1.33 1.41 1.19 1.31 1.36 1.46 1.4 1.38 1.21 1.32 1.26 1.41 1.26 1.36 1.38 1.42 1.36 1.32
REACTOME_ACTIVATION_OF_MATRIX_METALLOPROTEINASES 1.81 1.81 1.95 1.95 2.08 2.06 1.96 1.99 1.91 1.93 1.8 1.91 1.94 1.93 1.94 1.91 1.97 1.8 1.73 2.01 1.89 2.01 1.91 1.87 2.05 2.06
REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS 2.06 2.09 2.42 1.97 2.56 2.59 2.45 2.35 2.51 2.47 2.24 2.36 2.43 2.4 2.35 2.31 2.24 2.09 2.21 2.32 2 2.21 2.55 2.5 2.32 2.27
REACTOME_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS 0.64 0.9 1.1 0.85 1.08 1.11 1 1.16 1.05 1.09 0.84 1.02 1.02 1.05 1.17 1.26 1.02 0.88 1.12 1.12 1.11 1.29 1.01 1.1 1.11 1.48
REACTOME_ZBP1_DAI_MEDIATED_INDUCTION_OF_TYPE_I_IFNS 1.48 1.51 1.51 1.48 1.67 1.66 1.56 1.66 1.52 1.59 1.47 1.52 1.65 1.6 1.51 1.54 1.6 1.42 1.57 1.65 1.34 1.56 1.61 1.64 1.7 1.67
REACTOME_DEGRADATION_OF_CYSTEINE_AND_HOMOCYSTEINE 1.29 1.55 1.73 1.47 1.57 1.57 1.55 1.46 1.59 1.47 1.46 1.31 1.45 1.42 1.58 1.59 1.28 1.25 1.31 1.55 1.32 1.64 1.75 1.72 1.62 1.47
REACTOME_SULFUR_AMINO_ACID_METABOLISM 1.6 1.74 2.05 1.74 1.96 1.99 1.89 1.76 1.97 1.93 1.81 1.79 1.92 1.86 1.84 1.88 1.65 1.52 1.84 1.92 1.53 1.79 2 2.01 1.85 1.73
REACTOME_HIV_LIFE_CYCLE 1.69 1.75 1.88 1.84 1.78 1.84 1.8 1.76 1.82 1.83 1.77 1.81 1.79 1.82 1.81 1.84 1.75 1.76 1.77 1.83 1.75 1.77 1.82 1.86 1.86 1.8
REACTOME_BUDDING_AND_MATURATION_OF_HIV_VIRION 2.36 2.42 2.38 2.18 2.37 2.42 2.3 2.27 2.45 2.4 2.25 2.39 2.33 2.29 2.35 2.4 2.45 2.45 2.45 2.36 2.39 2.28 2.35 2.4 2.38 2.33
REACTOME_EARLY_PHASE_OF_HIV_LIFE_CYCLE 1.7 1.77 1.6 1.69 1.9 1.9 1.74 1.51 1.87 1.87 1.85 1.88 1.9 1.98 1.84 1.79 1.65 1.83 1.83 1.79 1.67 1.74 1.91 1.88 1.97 1.71
REACTOME_GOLGI_CISTERNAE_PERICENTRIOLAR_STACK_REORGANIZATION 2.63 2.68 2.84 2.73 2.92 2.98 2.92 2.66 2.98 2.94 2.89 2.65 2.97 2.9 2.84 2.76 2.58 2.54 2.67 2.88 2.64 2.74 3.05 2.89 2.88 2.61
REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI 1.5 1.55 1.69 1.62 1.62 1.64 1.64 1.48 1.58 1.62 1.6 1.43 1.71 1.64 1.53 1.7 1.47 1.62 1.5 1.54 1.56 1.66 1.54 1.5 1.65 1.61
REACTOME_HIV_INFECTION 1.79 1.84 1.96 1.89 1.9 1.96 1.94 1.86 1.94 1.93 1.82 1.89 1.89 1.91 1.9 1.91 1.8 1.81 1.87 1.96 1.84 1.89 1.95 1.99 1.93 1.86
REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS 1.93 2 2.09 2.01 2.08 2.15 2.13 2.05 2.11 2.1 1.94 2.04 2.06 2.07 2.07 2.06 1.92 1.96 2.04 2.16 2.04 2.09 2.15 2.19 2.07 2.01
REACTOME_GLYCOSAMINOGLYCAN_METABOLISM 1.58 1.66 1.8 1.66 1.76 1.86 1.78 1.8 1.75 1.75 1.66 1.75 1.85 1.89 1.82 1.8 1.72 1.7 1.79 1.84 1.72 1.8 1.84 1.89 1.84 1.77
REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS 1.75 1.83 2.16 2.07 2.01 2.14 2.11 2.05 2.03 2.07 1.98 1.99 2.07 2.1 2.06 2.01 1.85 1.83 1.97 2.13 1.84 1.97 2.04 2.14 2.03 1.96
REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS 1.85 1.97 2.09 2.08 1.88 1.93 1.93 2.01 1.96 1.93 2.01 1.88 1.97 1.96 1.99 2.01 1.93 1.86 1.88 1.99 1.94 1.97 1.94 1.92 1.95 1.97
REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION 2.35 2.46 2.33 2.12 2.59 2.52 2.51 2.46 2.52 2.38 2.35 2.41 2.55 2.58 2.45 2.54 2.36 2.39 2.57 2.58 2.23 2.36 2.54 2.54 2.45 2.36
REACTOME_TRIGLYCERIDE_CATABOLISM 2.1 2.23 2.59 2.49 2.49 2.57 2.55 2.45 2.53 2.52 2.39 2.34 2.52 2.53 2.48 2.51 2.33 2.25 2.32 2.41 2.18 2.29 2.55 2.45 2.32 2.14
REACTOME_INTEGRATION_OF_ENERGY_METABOLISM 2.17 2.27 2.28 2.12 2.4 2.44 2.35 2.3 2.4 2.31 2.23 2.33 2.39 2.42 2.34 2.34 2.27 2.29 2.41 2.45 2.18 2.32 2.41 2.5 2.37 2.29
REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM 1.6 1.66 1.88 1.76 1.78 1.86 1.78 1.86 1.76 1.73 1.72 1.7 1.91 2.02 1.9 1.89 1.71 1.66 1.74 1.85 1.71 1.81 1.81 1.91 1.97 1.86
REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM 1.57 1.69 1.75 1.57 1.74 1.85 1.72 1.71 1.78 1.72 1.62 1.75 1.84 1.86 1.76 1.73 1.74 1.72 1.79 1.84 1.73 1.79 1.86 1.91 1.79 1.72
REACTOME_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION 1.55 1.71 1.92 1.85 1.79 1.91 1.83 1.84 1.84 1.94 1.71 1.83 1.77 1.79 1.79 1.76 1.58 1.55 1.8 1.9 1.62 1.75 1.89 1.98 1.84 1.83
REACTOME_CELL_CYCLE 1.95 2.01 2.22 2.1 2.22 2.27 2.22 2.13 2.22 2.23 2.1 2.1 2.21 2.22 2.2 2.17 2.05 1.95 2.09 2.18 1.99 2.13 2.25 2.28 2.18 2.07
REACTOME_SIGNALING_BY_EGFR_IN_CANCER 2.58 2.61 2.84 2.65 2.83 2.9 2.96 2.9 2.85 2.87 2.81 2.8 2.87 2.86 2.86 2.91 2.75 2.65 2.68 2.77 2.75 2.94 2.9 2.92 2.88 2.82
REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING 2.07 2.3 2.24 2.01 2.38 2.37 2.27 2.2 2.35 2.25 2.14 2.4 2.38 2.44 2.21 2.33 2.06 2.14 2.41 2.39 1.89 2.03 2.35 2.36 2.23 2.16
REACTOME_NEF_MEDIATES_DOWN_MODULATION_OF_CELL_SURFACE_RECEPTORS_BY_RECRUITING_THEM_TO_CLATHRIN_ADAPTERS 2.24 2.35 2.49 2.23 2.45 2.55 2.52 2.46 2.47 2.53 2.26 2.41 2.45 2.52 2.49 2.51 2.42 2.49 2.43 2.56 2.39 2.45 2.51 2.68 2.58 2.47
REACTOME_THE_ROLE_OF_NEF_IN_HIV_1_REPLICATION_AND_DISEASE_PATHOGENESIS 2.34 2.37 2.38 2.25 2.48 2.55 2.51 2.39 2.48 2.46 2.19 2.42 2.39 2.47 2.4 2.4 2.39 2.37 2.49 2.57 2.34 2.42 2.49 2.67 2.47 2.37
REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES 1.14 1.17 1.38 1.34 1.39 1.36 1.31 1.29 1.4 1.34 1.24 1.36 1.43 1.43 1.25 1.28 1.38 1.23 1.19 1.37 1.24 1.37 1.37 1.49 1.31 1.3
REACTOME_MTOR_SIGNALLING 1.55 1.63 1.66 1.66 1.65 1.71 1.59 1.57 1.67 1.75 1.56 1.66 1.62 1.68 1.71 1.64 1.43 1.56 1.67 1.57 1.43 1.52 1.7 1.77 1.65 1.54
REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF 1.35 1.5 1.5 1.48 1.58 1.64 1.59 1.56 1.58 1.53 1.43 1.51 1.5 1.55 1.5 1.52 1.42 1.38 1.52 1.61 1.43 1.52 1.57 1.55 1.55 1.47
REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE 1.98 1.96 1.98 1.88 2.12 2.19 2.14 1.97 2.16 2.14 1.94 2.13 2.1 2.13 2.05 1.99 1.95 1.86 2.05 2.17 1.89 2.02 2.22 2.21 2.05 1.96
REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE 2.49 2.48 2.61 2.34 2.67 2.7 2.64 2.47 2.54 2.6 2.47 2.49 2.64 2.63 2.55 2.51 2.41 2.42 2.53 2.67 2.43 2.56 2.78 2.68 2.55 2.42
REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE 1.98 1.96 2.02 1.94 2.09 2.1 2.09 1.84 2.06 2.08 1.86 1.93 2.01 2 1.97 1.89 1.92 1.84 2.03 2.07 1.83 1.94 2.11 2.04 2 1.91
REACTOME_SYNTHESIS_OF_PIPS_AT_THE_LATE_ENDOSOME_MEMBRANE 1.52 1.55 1.48 1.51 1.42 1.38 1.41 1.22 1.37 1.4 1.43 1.4 1.34 1.37 1.42 1.41 1.48 1.42 1.41 1.52 1.55 1.37 1.46 1.28 1.3 1.35
REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS 1.71 1.68 1.82 1.81 1.91 1.98 1.88 1.8 1.95 1.86 1.89 1.91 1.9 1.91 1.85 1.81 1.67 1.65 1.83 1.93 1.66 1.78 1.98 2.03 1.88 1.81
REACTOME_GLYCOSPHINGOLIPID_METABOLISM 1.87 1.93 2.06 1.91 2.11 2.1 2.15 2.04 2.13 2.09 1.98 2.1 2.13 2.08 2 2 1.96 1.82 1.96 2.09 1.92 2.01 2.1 2.14 2.15 2.06
REACTOME_MYD88_INDEPENDENT_TLR4_CASCADE 2.11 2.15 2.25 2.12 2.34 2.36 2.31 2.26 2.29 2.34 2.33 2.31 2.29 2.3 2.28 2.23 2.2 2.17 2.19 2.27 2.18 2.24 2.32 2.38 2.23 2.14
REACTOME_MTORC1_MEDIATED_SIGNALLING 1.74 1.91 1.79 1.87 1.88 1.87 1.68 1.7 1.81 1.89 1.69 1.86 1.76 1.84 1.85 1.76 1.55 1.74 1.81 1.72 1.53 1.65 1.75 1.91 1.84 1.75
REACTOME_THE_ACTIVATION_OF_ARYLSULFATASES 1.57 1.69 2.04 2.01 1.65 1.79 1.91 1.8 1.91 1.92 1.84 1.94 1.71 1.69 1.74 1.67 1.38 1.41 1.77 1.82 1.48 1.63 1.82 1.91 1.86 1.74
REACTOME_SIGNALING_BY_NTRKS 1.94 1.96 1.87 1.86 2.07 2.11 2.01 1.96 2.04 2.05 1.98 2.06 2 2.02 1.94 1.94 1.93 1.87 2.03 2.05 1.84 1.88 2.03 2.09 2.01 1.9
REACTOME_COMPLEMENT_CASCADE 2.09 2.17 2.28 2.13 2.38 2.39 2.19 2.11 2.24 2.2 2.08 2.15 2.28 2.27 2.14 2.18 2.23 1.99 2.12 2.25 2.25 2.36 2.27 2.27 2.48 2.45
REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT 1.35 1.47 1.67 1.53 1.64 1.58 1.24 1.29 1.52 1.35 1.01 1.03 1.47 1.48 1.34 1.49 1.44 1.25 1.12 1.4 1.67 1.8 1.44 1.45 1.95 2
REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS 1.32 1.44 1.49 1.5 1.51 1.46 0.99 1.07 1.3 0.94 0.98 0.84 1.32 1.34 1.1 1.23 1.24 1.07 1 1.21 1.45 1.68 1.19 1.26 1.85 1.93
REACTOME_SIGNALLING_TO_RAS 1.15 1.28 1.42 1.23 1.57 1.69 1.59 1.47 1.71 1.67 1.56 1.51 1.69 1.68 1.62 1.65 1.46 1.38 1.57 1.53 1.16 1.53 1.72 1.75 1.52 1.33
REACTOME_HIV_TRANSCRIPTION_INITIATION 1.51 1.56 1.84 1.79 1.6 1.62 1.64 1.69 1.65 1.68 1.72 1.63 1.63 1.66 1.64 1.76 1.59 1.47 1.57 1.66 1.58 1.67 1.65 1.68 1.72 1.67
REACTOME_HIV_TRANSCRIPTION_ELONGATION 1.22 1.27 1.4 1.48 1.23 1.29 1.34 1.33 1.35 1.28 1.36 1.26 1.27 1.3 1.19 1.4 1.22 1.15 1.21 1.32 1.26 1.21 1.34 1.34 1.34 1.22
REACTOME_TRANSCRIPTION_OF_THE_HIV_GENOME 1.43 1.46 1.69 1.67 1.51 1.55 1.57 1.56 1.56 1.56 1.58 1.53 1.54 1.57 1.5 1.63 1.5 1.39 1.48 1.57 1.5 1.55 1.56 1.59 1.61 1.56
REACTOME_ABORTIVE_ELONGATION_OF_HIV_1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT 1.36 1.39 1.5 1.72 1.41 1.45 1.52 1.5 1.51 1.44 1.56 1.42 1.49 1.51 1.36 1.58 1.39 1.28 1.36 1.54 1.37 1.35 1.42 1.48 1.56 1.33
REACTOME_HIV_ELONGATION_ARREST_AND_RECOVERY 1.37 1.35 1.49 1.65 1.41 1.45 1.49 1.41 1.51 1.43 1.51 1.42 1.48 1.49 1.33 1.55 1.35 1.25 1.36 1.51 1.36 1.32 1.41 1.46 1.51 1.31
REACTOME_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR 2.48 2.45 2.77 2.36 2.69 2.8 2.86 2.69 2.62 2.68 2.45 2.62 2.62 2.64 2.68 2.62 2.54 2.34 2.55 2.63 2.36 2.52 2.68 2.66 2.56 2.48
REACTOME_TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE 2.09 2.14 2.22 2.1 2.33 2.35 2.3 2.24 2.26 2.32 2.34 2.31 2.27 2.28 2.25 2.23 2.19 2.16 2.19 2.25 2.16 2.23 2.32 2.35 2.22 2.11
REACTOME_TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE 2.2 2.28 2.4 2.25 2.49 2.55 2.51 2.42 2.44 2.49 2.46 2.45 2.48 2.48 2.43 2.38 2.32 2.26 2.33 2.45 2.27 2.41 2.51 2.57 2.39 2.31
REACTOME_INNATE_IMMUNE_SYSTEM 2.17 2.25 2.42 2.3 2.45 2.52 2.45 2.38 2.43 2.45 2.34 2.37 2.46 2.47 2.42 2.41 2.3 2.21 2.36 2.45 2.24 2.39 2.5 2.55 2.45 2.36
REACTOME_INFLUENZA_INFECTION 2.15 2.13 2.38 2.29 2.26 2.27 2.3 2.28 2.3 2.35 2.22 2.27 2.25 2.3 2.27 2.35 2.28 2.16 2.14 2.28 2.21 2.32 2.35 2.33 2.34 2.25
REACTOME_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS 1.63 1.64 1.7 1.84 1.69 1.8 1.72 1.66 1.67 1.76 1.52 1.57 1.67 1.8 1.77 1.81 1.58 1.67 1.61 1.72 1.59 1.81 1.75 1.66 1.55 1.57
REACTOME_NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS 1.6 1.57 1.8 1.84 1.7 1.84 1.8 1.65 1.74 1.69 1.53 1.6 1.73 1.82 1.66 1.66 1.51 1.57 1.55 1.75 1.49 1.58 1.74 1.76 1.7 1.61
REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS 1.49 1.55 1.75 1.8 1.61 1.65 1.73 1.73 1.66 1.71 1.59 1.6 1.65 1.72 1.68 1.75 1.53 1.54 1.49 1.73 1.53 1.67 1.66 1.74 1.71 1.63
REACTOME_NOD1_2_SIGNALING_PATHWAY 2.14 2.09 2.35 2.28 2.38 2.41 2.26 2.3 2.36 2.34 2.34 2.26 2.36 2.37 2.32 2.34 2.27 2.15 2.23 2.25 2.23 2.36 2.39 2.49 2.33 2.31
REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS 2.28 2.24 2.38 2.27 2.53 2.55 2.42 2.45 2.45 2.46 2.38 2.43 2.5 2.47 2.41 2.42 2.45 2.28 2.36 2.42 2.34 2.41 2.48 2.58 2.51 2.48
REACTOME_TOLL_LIKE_RECEPTOR_CASCADES 2.11 2.17 2.33 2.19 2.39 2.44 2.42 2.32 2.34 2.41 2.33 2.35 2.37 2.39 2.36 2.3 2.22 2.17 2.25 2.37 2.17 2.31 2.44 2.48 2.32 2.23
REACTOME_TICAM1_RIP1_MEDIATED_IKK_COMPLEX_RECRUITMENT 2.73 2.72 2.89 2.79 2.87 2.79 2.79 2.9 2.72 2.75 2.84 2.76 2.75 2.76 2.9 2.88 2.85 2.77 2.69 2.79 2.84 2.89 2.78 2.86 2.78 2.81
REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA 2.32 2.33 2.57 2.52 2.57 2.59 2.57 2.55 2.53 2.58 2.52 2.43 2.56 2.57 2.59 2.56 2.48 2.44 2.4 2.54 2.48 2.6 2.62 2.66 2.58 2.48
REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS 2.05 2.07 2.03 2.06 2.13 2.41 2.24 2.11 2.22 2.3 2.02 2.11 2.2 2.19 2.23 2.14 1.78 1.92 2.36 2.25 1.84 2.14 2.32 2.35 2.16 1.85
REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY 2.15 2.24 2.36 1.77 2.39 2.4 2.33 2.3 2.36 2.25 2.34 2.47 2.39 2.51 2.18 2.42 1.95 2.3 2.42 2.54 2.12 2.16 2.42 2.58 2.24 2.08
REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY 2.02 2.01 2.25 1.74 2.23 2.21 2.23 2.26 2.18 2.11 2.18 2.26 2.22 2.3 2.08 2.25 1.84 2.1 2.23 2.36 2 2.03 2.23 2.35 2.07 2.02
REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN 1.53 1.56 1.62 1.69 1.7 1.77 1.74 1.65 1.63 1.62 1.37 1.57 1.64 1.75 1.62 1.6 1.48 1.53 1.55 1.69 1.36 1.56 1.62 1.74 1.66 1.59
REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX 1.9 1.92 2.03 2.01 2.07 2.1 1.98 1.92 2.02 2.05 1.97 2 2 2.1 1.98 2 1.96 1.91 2.02 2.01 1.87 1.95 2.05 2.1 1.98 1.95
REACTOME_P38MAPK_EVENTS 0.95 1.07 1.28 1.14 1.34 1.41 1.27 1.12 1.49 1.4 1.5 1.36 1.42 1.43 1.24 1.36 1.25 1.08 1.28 1.23 1.04 1.25 1.47 1.51 1.29 1.28
REACTOME_TELOMERE_EXTENSION_BY_TELOMERASE 1.7 1.73 1.67 1.64 1.82 1.81 1.78 1.66 1.78 1.73 1.63 1.63 1.69 1.73 1.73 1.67 1.76 1.53 1.76 1.81 1.62 1.64 1.89 1.91 1.7 1.62
REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B 2.7 2.7 2.7 2.78 2.92 2.92 2.79 2.78 2.76 2.89 2.73 2.81 2.8 2.76 2.69 2.76 2.79 2.71 2.81 2.78 2.75 2.71 2.81 2.79 2.8 2.82
REACTOME_APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS 1.98 2.03 2.21 2.14 2.22 2.3 2.24 2.14 2.22 2.21 2.07 2.09 2.24 2.18 2.14 2.14 2.01 1.93 2.09 2.22 2.09 2.16 2.26 2.25 2.12 2.07
REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1 1.97 2 2.14 2.06 2.15 2.2 2.15 2.08 2.13 2.13 2.01 2.04 2.16 2.09 2.03 2.08 1.96 1.93 2.07 2.14 2.1 2.11 2.14 2.18 2.06 2.03
REACTOME_GLUTATHIONE_SYNTHESIS_AND_RECYCLING 1.2 1.23 1.2 0.88 1.5 1.65 1.44 1.35 1.34 1.39 1.2 1.45 1.43 1.41 1.16 1.15 1.38 1.03 1.25 1.4 1.21 1.33 1.45 1.54 1.48 1.47
REACTOME_POLYMERASE_SWITCHING_ON_THE_C_STRAND_OF_THE_TELOMERE 1.3 1.27 1.49 1.32 1.51 1.44 1.49 1.4 1.43 1.47 1.44 1.33 1.44 1.52 1.37 1.49 1.37 1.18 1.33 1.44 1.31 1.46 1.52 1.47 1.46 1.35
REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_C_STRAND_OF_THE_TELOMERE 1.49 1.43 1.56 1.41 1.63 1.52 1.54 1.45 1.44 1.5 1.53 1.43 1.48 1.55 1.42 1.45 1.59 1.38 1.47 1.5 1.48 1.43 1.56 1.58 1.54 1.4
REACTOME_TELOMERE_C_STRAND_LAGGING_STRAND_SYNTHESIS 1.3 1.26 1.46 1.32 1.47 1.43 1.46 1.35 1.35 1.42 1.4 1.32 1.39 1.46 1.32 1.41 1.35 1.18 1.3 1.38 1.31 1.38 1.47 1.44 1.44 1.3
REACTOME_TELOMERE_C_STRAND_SYNTHESIS_INITIATION 1.65 1.69 1.62 1.5 1.78 1.63 1.74 1.66 1.68 1.7 1.8 1.56 1.54 1.67 1.64 1.72 1.58 1.53 1.69 1.68 1.54 1.69 1.76 1.68 1.74 1.63
REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE 2.13 2.24 2.34 2.17 2.45 2.52 2.39 2.39 2.46 2.42 2.21 2.33 2.49 2.48 2.36 2.36 2.23 2.15 2.35 2.49 2.25 2.35 2.49 2.59 2.48 2.41
REACTOME_ASSEMBLY_OF_THE_HIV_VIRION 2.75 2.73 2.85 2.7 2.73 2.7 2.63 2.59 2.74 2.78 2.74 2.81 2.67 2.53 2.7 2.72 2.86 2.71 2.62 2.59 2.7 2.69 2.76 2.78 2.68 2.67
REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS 1.59 1.69 1.64 1.73 1.72 1.79 1.74 1.58 1.69 1.74 1.47 1.62 1.67 1.77 1.65 1.63 1.42 1.54 1.63 1.74 1.39 1.56 1.75 1.75 1.65 1.54
REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS 1.06 1.14 1.71 1.68 1.35 1.48 1.33 1.29 1.31 1.41 1.39 1.27 1.33 1.41 1.33 1.47 1.25 1.1 1.36 1.39 1.11 1.44 1.44 1.45 1.37 1.37
REACTOME_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE 1.86 1.82 1.74 1.9 2.04 2.04 1.86 1.83 1.78 2 1.75 1.93 1.83 1.86 1.65 1.72 1.88 1.73 1.99 1.87 1.7 1.6 1.85 1.78 1.76 1.86
REACTOME_PHOSPHORYLATION_OF_THE_APC_C 1.93 1.8 1.87 1.99 2.15 2.14 1.91 1.8 1.93 2.09 1.88 1.85 2 1.92 1.68 1.78 1.85 1.67 2.01 1.9 1.64 1.64 2.01 1.84 1.83 1.85
REACTOME_UNWINDING_OF_DNA 0.86 0.67 0.88 0.77 0.97 1.01 0.9 0.91 0.87 1.11 0.98 1.04 0.82 0.95 0.73 0.99 1.14 0.82 0.81 0.85 0.81 0.9 1.07 0.96 0.79 0.94
REACTOME_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS 1.53 1.65 1.75 1.81 1.76 1.83 1.81 1.72 1.7 1.78 1.54 1.7 1.71 1.82 1.74 1.68 1.55 1.64 1.61 1.74 1.52 1.68 1.76 1.79 1.71 1.65
REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING 1.91 1.9 1.85 2.01 1.9 2.08 2.09 2.01 2 2.06 1.77 1.73 2.05 1.98 2.09 1.96 1.86 1.85 1.97 2.08 1.94 2.09 2.17 2.02 2.08 1.82
REACTOME_SIGNALING_BY_EGFR 1.95 1.96 2.16 2.09 2.21 2.23 2.2 2.13 2.17 2.2 2.1 2.11 2.19 2.17 2.13 2.13 2.04 1.94 2.04 2.11 1.97 2.12 2.2 2.24 2.1 2.08
REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM 1.62 1.69 1.83 1.67 1.73 1.85 1.75 1.79 1.76 1.75 1.71 1.81 1.84 1.81 1.83 1.73 1.83 1.79 1.77 1.85 1.86 1.88 1.88 1.89 1.75 1.74
REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A 2.68 2.68 2.64 2.68 2.89 2.9 2.75 2.77 2.69 2.81 2.65 2.79 2.77 2.76 2.63 2.71 2.84 2.65 2.75 2.77 2.75 2.73 2.74 2.78 2.69 2.78
REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE 2.18 2.16 2.45 2.28 2.25 2.25 2.27 2.3 2.26 2.33 2.27 2.28 2.23 2.29 2.23 2.33 2.32 2.19 2.17 2.28 2.22 2.36 2.37 2.34 2.36 2.29
REACTOME_DARPP_32_EVENTS 2.09 2.18 2.17 2.01 2.19 2.26 2.17 2.11 2.24 2.13 2.06 2.14 2.17 2.17 2.19 2.2 1.95 1.98 2.21 2.2 1.94 2.08 2.22 2.22 2.1 2.01
REACTOME_GAB1_SIGNALOSOME 1.87 1.94 1.95 1.78 2.33 2.42 2.31 2.12 2.4 2.34 2.07 2.2 2.45 2.4 2.19 2.15 2.03 1.75 2.08 2.21 1.75 2.1 2.42 2.43 2.19 2.07
REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING 1.66 1.67 2.06 1.81 2.06 2.26 2.3 2.08 2.16 2.1 1.97 1.95 2.35 2.28 2.12 2.14 1.85 1.81 1.91 2.09 1.72 2.11 2.22 2.22 2.13 2.01
REACTOME_NUCLEAR_IMPORT_OF_REV_PROTEIN 1.53 1.6 1.68 1.75 1.73 1.79 1.79 1.68 1.67 1.71 1.49 1.64 1.69 1.78 1.69 1.62 1.47 1.55 1.55 1.7 1.44 1.63 1.7 1.74 1.69 1.6
REACTOME_EXTENSION_OF_TELOMERES 1.41 1.41 1.53 1.43 1.56 1.57 1.58 1.44 1.5 1.52 1.45 1.44 1.5 1.55 1.46 1.49 1.47 1.31 1.46 1.52 1.44 1.47 1.61 1.6 1.51 1.41
REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_ZBP1 1.48 1.52 1.42 1.41 1.64 1.63 1.54 1.65 1.43 1.49 1.37 1.46 1.59 1.53 1.41 1.48 1.58 1.39 1.55 1.64 1.33 1.52 1.49 1.54 1.65 1.63
REACTOME_SEROTONIN_NEUROTRANSMITTER_RELEASE_CYCLE 2.48 2.47 2.26 2.42 2.52 2.55 2.52 2.35 2.46 2.5 2.2 2.35 2.48 2.5 2.42 2.34 2.3 2.36 2.57 2.6 2.06 2.2 2.4 2.45 2.43 2.28
REACTOME_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE 2.83 2.85 2.73 2.84 3.02 3.08 3.03 2.87 2.92 2.98 2.62 2.86 2.94 2.99 2.96 2.86 2.71 2.8 2.98 3.12 2.47 2.7 2.82 2.98 2.91 2.72
REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS 1.31 1.37 1.49 1.36 1.38 1.51 1.69 1.48 1.69 1.66 1.35 1.43 1.57 1.64 1.64 1.51 1.31 1.38 1.44 1.63 1.27 1.31 1.52 1.56 1.51 1.38
REACTOME_EGFR_DOWNREGULATION 2.17 2.25 2.5 2.47 2.46 2.52 2.53 2.47 2.42 2.49 2.37 2.41 2.48 2.48 2.45 2.44 2.36 2.3 2.29 2.45 2.33 2.5 2.5 2.56 2.48 2.46
REACTOME_STING_MEDIATED_INDUCTION_OF_HOST_IMMUNE_RESPONSES 1.96 1.98 2.04 1.96 2.37 2.32 2.12 2.07 2.19 2.26 2.18 2.09 2.3 2.35 2.19 2.23 2.01 1.96 2.13 2.25 1.92 2.19 2.33 2.38 2.34 2.24
REACTOME_CYTOSOLIC_SENSORS_OF_PATHOGEN_ASSOCIATED_DNA 1.97 2.07 2.2 2.19 2.18 2.14 2.16 2.22 2.07 2.13 2.14 2.11 2.14 2.14 2.15 2.23 2.14 2.05 2.06 2.18 2.1 2.21 2.13 2.26 2.21 2.19
REACTOME_SIGNALING_BY_CYTOSOLIC_FGFR1_FUSION_MUTANTS 1.52 1.73 1.56 1.28 1.72 1.79 1.73 1.74 1.7 1.76 1.47 1.86 1.71 1.65 1.56 1.58 1.81 1.6 1.77 1.69 1.56 1.7 1.74 1.84 1.63 1.56
REACTOME_FGFR1_MUTANT_RECEPTOR_ACTIVATION 1.76 1.9 1.89 1.6 2.15 2.21 2.06 2.08 2.09 2.18 1.97 2.22 2.19 2.13 1.97 1.99 2.18 1.87 2.07 2.15 1.87 2.03 2.21 2.31 2.08 2.08
REACTOME_FGFR2_MUTANT_RECEPTOR_ACTIVATION 1.88 1.99 2.36 2.18 2.24 2.3 2.22 2.36 2.26 2.33 2.29 2.32 2.36 2.32 2.23 2.42 2.24 1.94 2.1 2.36 2.08 2.28 2.35 2.54 2.36 2.39
REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE 1.8 1.83 2.07 1.95 2.01 2.04 2.02 1.96 2.03 1.97 1.9 1.91 2 2.02 1.98 1.95 1.88 1.79 1.94 2.01 1.79 1.87 2.02 2.06 1.97 1.86
REACTOME_SYNTHESIS_OF_PYROPHOSPHATES_IN_THE_CYTOSOL 1.78 1.71 1.92 1.68 1.9 1.89 1.95 1.8 1.84 1.89 1.76 1.94 1.84 1.87 1.79 1.89 1.94 1.91 1.8 2.04 1.87 1.76 1.81 1.89 1.78 1.71
REACTOME_SYNTHESIS_OF_IP2_IP_AND_INS_IN_THE_CYTOSOL 1.94 1.83 1.89 1.77 2.06 2.13 2.05 1.8 1.97 2.04 1.79 1.88 1.93 2 1.9 1.88 1.59 1.84 2.05 2.06 1.7 1.92 2.08 2.18 1.96 1.77
REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL 1.67 1.67 1.72 1.75 1.88 1.95 1.9 1.83 1.89 1.84 1.76 1.88 1.84 1.88 1.85 1.84 1.81 1.7 1.87 1.94 1.76 1.75 2.03 2.03 1.91 1.79
REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT 1.78 1.82 1.91 1.96 2.16 2.26 2.04 2.09 1.98 2.13 1.86 2.11 2.18 2.15 2.13 2.07 2.12 2 2.05 2.2 2.04 2.15 2.12 2.23 2.12 2.11
REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION 1.27 1.24 1.14 1.22 1.38 1.43 1.3 1.26 1.35 1.28 1.29 1.29 1.35 1.34 1.22 1.28 1.31 1.2 1.35 1.23 1.04 1.22 1.35 1.36 1.23 1.18
REACTOME_SIGNALING_BY_PDGF 1.64 1.73 1.85 1.83 2 2.1 1.94 1.85 2.04 2.02 1.74 1.9 2.09 2.09 1.88 1.9 1.86 1.69 1.85 2.01 1.6 1.86 1.97 2.16 1.94 1.87
REACTOME_SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21 1.87 1.86 2.09 1.99 1.98 2.04 2.02 2 2 1.99 1.9 1.92 2.01 1.94 2.01 2.01 1.86 1.86 1.92 2.09 2.06 2.11 2.05 2.07 1.96 1.92
REACTOME_SIGNALLING_TO_ERKS 1.8 1.89 1.75 1.69 1.94 2.05 1.93 1.84 1.98 1.97 1.88 1.96 1.91 1.9 1.89 1.86 1.79 1.77 2 1.93 1.67 1.79 2.03 2.05 1.85 1.66
REACTOME_CELLULAR_HEXOSE_TRANSPORT 1.71 1.83 1.89 1.73 1.72 1.94 1.87 1.84 1.93 1.95 1.75 1.7 2.02 2.1 1.9 1.96 1.96 1.8 1.87 1.91 1.95 2.13 1.94 2.06 2.14 2.04
REACTOME_METABOLISM_OF_PORPHYRINS 1.32 1.51 2.02 1.78 1.82 1.82 1.76 1.75 1.78 1.82 1.81 1.71 1.82 1.84 1.77 1.84 1.6 1.45 1.67 1.78 1.64 1.85 1.78 1.96 1.85 1.73
REACTOME_HEME_BIOSYNTHESIS 1.09 1.15 1.74 1.63 1.53 1.47 1.52 1.44 1.51 1.56 1.59 1.6 1.53 1.58 1.64 1.65 1.32 1.27 1.29 1.47 1.45 1.65 1.44 1.7 1.47 1.36
REACTOME_HEME_DEGRADATION 1.45 1.75 2.25 1.82 2.13 2.06 2.05 2 1.99 1.97 1.92 1.67 2.13 2.1 1.85 1.92 1.7 1.41 1.88 1.98 1.9 2.04 2.01 2.17 2.21 2.07
REACTOME_SIGNALING_BY_FGFR 2.17 2.23 2.4 2.27 2.48 2.53 2.42 2.43 2.45 2.45 2.35 2.37 2.51 2.48 2.37 2.47 2.35 2.24 2.39 2.48 2.31 2.4 2.48 2.64 2.44 2.4
REACTOME_FGFR3_LIGAND_BINDING_AND_ACTIVATION 1.95 1.91 2.26 1.76 2.33 2.46 2.22 2.25 2.35 2.43 2.32 2.45 2.51 2.48 2.25 2.45 2.46 2.1 2.28 2.43 2.25 2.47 2.52 2.64 2.31 2.43
REACTOME_FGFR2_LIGAND_BINDING_AND_ACTIVATION 1.72 1.73 1.85 1.7 2.1 2.17 1.94 1.93 2.08 2.07 1.95 2.13 2.18 2.14 1.91 2.03 2.14 1.83 1.95 2.05 1.84 1.99 2.17 2.23 1.97 2.06
REACTOME_FGFR1_LIGAND_BINDING_AND_ACTIVATION 1.66 1.63 1.82 1.56 1.93 2.06 1.86 1.87 2.01 2.02 1.97 2.11 2.1 2.01 1.9 2.04 2.08 1.78 1.89 2.02 1.76 1.95 2.15 2.27 1.96 2.07
REACTOME_FGFR1C_LIGAND_BINDING_AND_ACTIVATION 1.8 1.78 1.96 1.69 2.15 2.27 2 2.06 2.19 2.25 2.19 2.33 2.33 2.26 2.07 2.21 2.31 1.95 2.05 2.16 2.01 2.17 2.36 2.41 2.18 2.34
REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION 1.89 1.91 2.07 1.76 2.32 2.41 2.13 2.19 2.32 2.36 2.21 2.42 2.45 2.41 2.11 2.23 2.43 1.98 2.14 2.3 2.08 2.22 2.47 2.54 2.25 2.42
REACTOME_FGFR2B_LIGAND_BINDING_AND_ACTIVATION 2.28 2.31 2.43 2.26 2.79 2.87 2.59 2.56 2.77 2.75 2.46 2.74 2.88 2.84 2.5 2.72 2.87 2.47 2.61 2.72 2.41 2.56 2.85 2.92 2.58 2.63
REACTOME_GAP_JUNCTION_ASSEMBLY 2.29 2.46 2.65 2.48 2.38 2.54 2.54 2.59 2.56 2.54 2.48 2.56 2.53 2.56 2.55 2.54 2.44 2.5 2.47 2.61 2.51 2.43 2.57 2.69 2.65 2.52
REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE 2.9 3.08 3.3 3.17 2.99 3.14 3.13 3.22 3.23 3.21 3.11 3.28 3.06 3.05 3.13 3.16 2.98 3.02 3.11 3.21 3.08 2.86 3.11 3.32 3.31 3.1
REACTOME_GAP_JUNCTION_DEGRADATION 2.22 2.28 2.35 2.06 2.18 2.18 2.25 2.2 2.3 2.21 2.29 2.1 2.25 2.3 2.36 2.34 2.11 2.15 2.17 2.2 2.13 2.2 2.31 2.33 2.3 2.19
REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI 2.02 2.16 2.05 2.02 2.16 2.17 2.07 2.12 2.19 2.16 2.11 2.14 2.18 2.26 2.13 2.23 2.01 2.02 2.24 2.13 1.93 1.93 2.32 2.34 2.08 1.93
REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING 1.75 1.79 1.75 1.75 1.91 1.92 1.76 1.75 1.82 1.85 1.73 1.86 1.81 1.85 1.79 1.83 1.83 1.78 1.9 1.82 1.64 1.71 1.92 1.93 1.79 1.7
REACTOME_CHOLESTEROL_BIOSYNTHESIS 1.6 1.78 1.76 1.63 1.89 2 1.96 1.84 1.91 1.9 1.67 1.96 1.88 1.89 1.79 1.74 1.66 1.65 1.75 1.93 1.51 1.56 1.94 1.92 1.87 1.74
REACTOME_SNRNP_ASSEMBLY 1.32 1.4 1.42 1.44 1.47 1.52 1.46 1.42 1.39 1.42 1.24 1.34 1.38 1.48 1.41 1.4 1.23 1.3 1.31 1.43 1.19 1.41 1.46 1.47 1.44 1.36
REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS 1.96 2.01 2.09 1.82 2.31 2.35 2.24 2.11 2.25 2.2 2.04 2.14 2.25 2.27 2.15 2.17 2.12 2.04 2.17 2.25 1.98 2.11 2.33 2.36 2.19 2.14
REACTOME_ANDROGEN_BIOSYNTHESIS 1.66 1.66 2.05 1.82 2.05 2.11 1.99 1.83 2.21 2.13 1.83 1.91 2.3 2.24 1.9 1.87 1.87 1.45 1.89 2 1.47 1.65 2.22 2.32 1.92 1.61
REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL 1.87 1.89 2.06 1.81 2.22 2.25 2.16 2.01 2.18 2.1 1.97 2.06 2.18 2.16 2.08 2.12 2.02 1.91 2.09 2.14 1.87 2.07 2.29 2.24 2.12 2.09
REACTOME_P75NTR_SIGNALS_VIA_NF_KB 2.39 2.38 2.64 2.45 2.49 2.52 2.54 2.56 2.42 2.46 2.52 2.48 2.5 2.49 2.53 2.62 2.45 2.5 2.38 2.52 2.64 2.81 2.52 2.62 2.59 2.58
REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK 1.54 1.6 1.68 1.48 1.84 1.86 1.89 1.81 1.82 1.84 1.6 1.86 1.91 1.84 1.84 1.8 1.65 1.59 1.68 1.85 1.72 1.85 1.89 1.91 1.84 1.75
REACTOME_REGULATED_PROTEOLYSIS_OF_P75NTR 1.55 1.51 1.58 1.33 1.76 1.83 1.83 1.67 1.79 1.53 1.43 1.64 1.76 1.62 1.51 1.39 1.58 1.24 1.43 1.79 1.44 1.5 1.59 1.75 1.64 1.61
REACTOME_P75NTR_REGULATES_AXONOGENESIS 2.34 2.26 2.51 2.46 2.66 2.65 2.57 2.27 2.57 2.61 2.48 2.44 2.48 2.48 2.26 2.34 2.42 2.04 2.3 2.5 2.18 2.45 2.54 2.41 2.36 2.33
REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING 1.87 1.92 2.06 1.93 2.1 2.1 2.11 2.06 2.06 2.06 1.93 2.04 2.08 2.02 2.03 1.98 1.96 1.85 1.93 2.07 1.96 2.06 2.08 2.1 2.07 1.99
REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL 1.97 1.78 1.89 1.6 1.99 2.09 2.04 1.94 2.04 1.86 1.75 1.94 1.97 1.93 1.95 1.93 1.87 1.83 1.96 2.08 1.75 1.87 2.16 2.06 1.86 1.8
REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL 2.01 1.96 2.06 1.73 2.32 2.34 2.3 2.1 2.32 2.17 1.97 2.19 2.31 2.25 2.11 2.09 2.16 2.02 2.16 2.24 1.98 2.11 2.41 2.37 2.18 2.16
REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM 1.96 1.98 2.23 1.87 2.35 2.39 2.27 2.15 2.3 2.26 2.1 2.18 2.29 2.28 2.18 2.2 2.12 1.99 2.13 2.23 1.95 2.13 2.4 2.39 2.2 2.14
REACTOME_SIGNALING_BY_VEGF 2.12 2.18 2.2 2.17 2.27 2.33 2.26 2.15 2.25 2.28 2.21 2.27 2.24 2.24 2.22 2.24 2.11 2.14 2.27 2.24 2.09 2.13 2.32 2.35 2.16 2.06
REACTOME_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX 1.87 1.9 2.06 1.93 2.04 2.08 2.06 1.95 2.05 1.98 1.95 1.94 2.03 1.99 1.99 1.96 1.81 1.87 1.96 2.04 1.97 1.99 2.05 2.1 1.95 1.9
REACTOME_RHO_GTPASE_EFFECTORS 2.3 2.4 2.5 2.4 2.59 2.64 2.54 2.45 2.54 2.57 2.44 2.46 2.56 2.56 2.51 2.46 2.4 2.3 2.44 2.53 2.3 2.42 2.62 2.65 2.53 2.39
REACTOME_SIGNALING_BY_WNT 2.04 2.11 2.19 2.07 2.24 2.31 2.23 2.18 2.22 2.19 2.12 2.15 2.25 2.24 2.21 2.18 2.08 2.08 2.22 2.27 2.09 2.2 2.26 2.34 2.2 2.11
REACTOME_METABOLISM_OF_STEROID_HORMONES 1.38 1.39 1.87 1.79 1.68 1.77 1.65 1.57 1.78 1.74 1.62 1.54 1.81 1.79 1.65 1.7 1.56 1.3 1.58 1.6 1.39 1.55 1.83 1.83 1.67 1.54
REACTOME_PREGNENOLONE_BIOSYNTHESIS 1.18 1.4 1.83 1.81 1.59 1.72 1.57 1.53 1.51 1.55 1.66 1.38 1.66 1.67 1.57 1.7 1.57 1.38 1.49 1.32 1.45 1.61 1.69 1.53 1.49 1.67
REACTOME_BETA_CATENIN_PHOSPHORYLATION_CASCADE 1.91 1.96 2.05 1.96 2.07 2.07 2.2 1.93 2.08 2 2.12 1.96 2.02 2.06 1.92 1.96 1.84 1.87 1.99 1.99 1.77 1.72 1.97 1.99 1.87 1.88
REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING 1.59 1.58 1.87 1.86 2.07 2.16 2.14 1.87 2.1 1.95 1.81 1.85 2.16 2.07 1.91 1.97 1.69 1.65 1.87 1.92 1.62 1.92 2.05 2.08 1.91 1.77
REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING 1.93 1.97 1.94 2.02 2.46 2.47 2.33 2.1 2.46 2.33 2.02 2.23 2.42 2.32 2.08 2.12 2.01 1.76 2.12 2.22 1.73 2.01 2.37 2.41 2.12 1.96
REACTOME_COBALAMIN_CBL_VITAMIN_B12_TRANSPORT_AND_METABOLISM 1.99 1.96 1.88 1.85 2.13 2.18 2.03 1.76 2.21 2.15 2.02 1.99 2.15 2.17 1.92 2 1.88 1.85 1.96 1.93 1.84 1.89 2.02 2 2.03 1.95
REACTOME_METABOLISM_OF_FOLATE_AND_PTERINES 0.93 0.79 1.29 1.03 1.19 1.3 1.23 1.24 1.15 1.35 1.29 1.34 1.18 1.27 1.31 1.09 1.18 1.1 1.02 1.28 1.01 0.96 1.27 1.22 1.04 0.89
REACTOME_BIOTIN_TRANSPORT_AND_METABOLISM 0.52 0.54 1.24 1.15 0.97 0.82 0.86 0.83 0.97 0.93 0.83 0.92 0.85 0.88 0.9 0.81 0.71 0.73 0.8 1.07 0.68 0.83 1.02 1.03 0.97 0.81
REACTOME_VITAMIN_D_CALCIFEROL_METABOLISM 2.06 2.17 2.63 2.44 2.24 2.36 2.32 2.53 2.42 2.43 2.19 2.34 2.37 2.38 2.45 2.48 2.07 1.97 2.12 2.34 2.11 2.35 2.46 2.45 2.55 2.42
REACTOME_NICOTINATE_METABOLISM 1.5 1.62 1.61 1.48 1.68 1.88 1.74 1.72 1.71 1.71 1.56 1.75 1.79 1.79 1.71 1.7 1.65 1.56 1.64 1.83 1.53 1.73 1.7 1.83 1.75 1.71
REACTOME_METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS 1.62 1.67 1.8 1.59 1.83 1.94 1.86 1.74 1.87 1.87 1.69 1.8 1.88 1.9 1.8 1.78 1.72 1.63 1.73 1.86 1.65 1.76 1.86 1.94 1.84 1.74
REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS 1.67 1.72 1.86 1.66 1.9 2 1.92 1.79 1.9 1.9 1.75 1.84 1.93 1.95 1.89 1.88 1.79 1.7 1.82 1.92 1.77 1.88 1.93 2.02 1.91 1.8
REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS 1.4 1.5 1.66 1.32 1.6 1.7 1.59 1.51 1.61 1.57 1.41 1.61 1.67 1.64 1.65 1.59 1.68 1.62 1.62 1.72 1.61 1.72 1.76 1.79 1.58 1.59
REACTOME_NICOTINAMIDE_SALVAGING 1.38 1.53 1.6 1.36 1.65 1.81 1.66 1.67 1.68 1.66 1.47 1.68 1.71 1.71 1.58 1.58 1.61 1.3 1.54 1.74 1.35 1.65 1.62 1.81 1.69 1.65
REACTOME_SIGNALING_BY_NOTCH1 1.64 1.69 1.85 1.79 1.82 1.83 1.78 1.78 1.84 1.81 1.78 1.78 1.77 1.74 1.84 1.76 1.69 1.68 1.74 1.79 1.68 1.74 1.84 1.93 1.78 1.71
REACTOME_SIGNALING_BY_NOTCH2 2.15 2.19 2.29 2.27 2.42 2.41 2.28 2.34 2.4 2.38 2.33 2.34 2.29 2.23 2.32 2.29 2.26 2.21 2.23 2.33 2.24 2.22 2.39 2.45 2.23 2.24
REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL 1.6 1.6 1.7 1.73 1.71 1.8 1.82 1.68 1.73 1.92 1.78 1.78 1.71 1.75 1.81 1.82 1.51 1.6 1.66 1.74 1.52 1.53 1.97 1.83 1.62 1.39
REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION 1.98 2.02 1.92 1.84 2.09 2.11 1.99 2.03 1.97 2.05 2.01 2.11 1.99 2.03 1.98 1.93 1.95 1.92 1.99 2.08 1.82 1.82 1.98 2.07 2.03 1.97
REACTOME_ERK_MAPK_TARGETS 2.09 2.14 2.04 1.88 2.08 2.2 2.1 2.09 2 2.18 2.19 2.25 1.93 1.97 2.04 1.98 1.95 2.02 1.99 2.04 1.92 1.94 2.11 2.15 2.14 2.04
REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL 1.47 1.54 1.72 1.58 1.79 1.79 1.75 1.7 1.7 1.73 1.6 1.63 1.77 1.77 1.61 1.66 1.6 1.48 1.54 1.75 1.72 1.83 1.71 1.73 1.92 1.9
REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM 1.89 1.88 2.03 1.77 2.31 2.31 2.22 2.05 2.19 2.22 1.96 2.11 2.26 2.18 2.11 2.05 1.87 1.47 2.01 2.15 1.68 1.93 2.25 2.33 2.07 2.04
REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK 2.04 2.11 2.15 2.02 2.38 2.45 2.31 2.28 2.34 2.33 2.15 2.31 2.39 2.36 2.26 2.24 2.2 2.04 2.23 2.36 2.08 2.23 2.42 2.5 2.31 2.22
REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT 2.04 2.08 2.12 2.09 2.14 2.24 2.17 2.14 2.18 2.19 2.1 2.15 2.15 2.18 2.17 2.16 2.05 2.02 2.13 2.22 2.03 2.09 2.2 2.26 2.15 2.09
REACTOME_MEMBRANE_TRAFFICKING 2.07 2.13 2.21 2.14 2.23 2.3 2.25 2.18 2.25 2.24 2.14 2.17 2.23 2.26 2.23 2.19 2.12 2.09 2.2 2.26 2.07 2.14 2.27 2.31 2.21 2.13
REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING 2.09 2.1 2.06 1.98 2.05 2.1 2.14 2.05 2.15 2.09 1.97 2.03 2.11 2.14 2.04 2.03 1.98 2.03 2.12 2.16 1.95 1.89 2.14 2.13 2.02 1.9
REACTOME_CARNITINE_METABOLISM 1.32 1.4 1.6 1.38 1.41 1.55 1.38 1.32 1.46 1.45 1.43 1.49 1.4 1.46 1.47 1.44 1.27 1.36 1.52 1.49 1.34 1.39 1.46 1.51 1.4 1.39
REACTOME_SIGNALING_BY_BMP 1.78 1.83 1.94 1.89 2.05 2.06 2 1.92 1.98 2 1.99 1.98 1.97 2.11 1.91 1.98 1.95 1.82 1.97 2 1.85 1.89 2.07 2.1 2.01 1.94
REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT 1.87 1.94 2.09 1.99 2.07 2.16 2.08 2.01 2.07 2.05 1.98 2.01 2.1 2.09 2.05 2.04 1.91 1.91 2.04 2.12 1.96 2.07 2.1 2.19 2.06 1.96
REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX 1.4 1.49 1.58 1.59 1.68 1.79 1.66 1.5 1.67 1.63 1.5 1.48 1.69 1.69 1.6 1.49 1.47 1.43 1.57 1.61 1.39 1.53 1.75 1.83 1.61 1.43
REACTOME_G_PROTEIN_ACTIVATION 2.52 2.58 2.37 2.21 2.65 2.61 2.66 2.52 2.66 2.56 2.45 2.45 2.64 2.62 2.66 2.65 2.55 2.63 2.65 2.64 2.44 2.58 2.68 2.69 2.56 2.42
REACTOME_METABOLISM_OF_NITRIC_OXIDE_NOS3_ACTIVATION_AND_REGULATION 2.15 2.11 1.78 1.77 2.24 2.23 2.21 2.09 2.12 2.07 1.87 1.85 2.25 2.06 2.29 2.17 2 2.07 2.07 2.01 1.98 2.15 2.3 2.13 2.08 2
REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES 1.2 1.22 1.29 1.19 1.49 1.49 1.34 1.26 1.31 1.36 1.24 1.31 1.39 1.39 1.32 1.32 1.36 1.15 1.26 1.39 1.34 1.46 1.37 1.41 1.43 1.41
REACTOME_METABOLISM_OF_ANGIOTENSINOGEN_TO_ANGIOTENSINS 2.45 2.29 2.78 2.66 2.85 2.91 2.67 2.66 2.8 2.77 2.53 2.6 2.97 2.91 2.69 2.8 2.59 2.37 2.63 2.83 2.6 2.85 2.75 2.83 3.02 2.8
REACTOME_KERATAN_SULFATE_BIOSYNTHESIS 1.64 1.74 1.89 1.78 1.85 1.91 1.79 1.93 1.8 1.78 1.75 1.76 1.94 2.08 1.98 1.94 1.8 1.74 1.81 1.92 1.74 1.82 1.84 1.96 2 1.91
REACTOME_KERATAN_SULFATE_DEGRADATION 1.68 1.6 2.17 1.92 1.77 1.95 2.01 1.89 1.79 1.68 1.94 1.8 2.03 2.09 1.89 1.89 1.71 1.65 1.68 1.91 1.93 2.03 1.89 1.93 2.16 2.07
REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS 1.59 1.73 1.65 1.71 1.79 1.8 1.69 1.8 1.7 1.65 1.67 1.74 1.8 1.7 1.63 1.63 1.94 1.79 1.68 1.9 1.82 1.81 1.77 1.75 1.7 1.72
REACTOME_DERMATAN_SULFATE_BIOSYNTHESIS 1.58 1.69 1.77 1.45 1.89 1.84 1.71 1.84 1.69 1.7 1.65 1.82 1.79 1.8 1.71 1.62 1.94 1.76 1.73 1.98 1.87 1.7 1.89 1.77 1.59 1.63
REACTOME_HS_GAG_BIOSYNTHESIS 1.58 1.68 1.68 1.54 1.72 1.88 1.72 1.64 1.79 1.72 1.49 1.7 1.8 1.86 1.75 1.77 1.57 1.65 1.83 1.8 1.62 1.75 1.87 1.94 1.77 1.68
REACTOME_TCR_SIGNALING 1.97 1.98 2.23 2.15 2.17 2.27 2.17 2.05 2.12 2.18 2.1 2.12 2.22 2.22 2.17 2.17 2 1.96 2.1 2.17 2.09 2.21 2.3 2.35 2.16 2.09
REACTOME_HS_GAG_DEGRADATION 1.87 1.91 2.1 1.86 1.95 2.14 2.05 1.92 2.06 2 1.92 2.06 2.17 2.19 2.11 1.94 1.96 1.96 2.13 2.16 1.99 2.09 2.15 2.24 2.08 1.95
REACTOME_CS_DS_DEGRADATION 1.67 1.78 2.06 1.83 1.8 1.95 1.9 1.97 1.98 1.95 2.03 1.98 2.06 2.02 2 1.9 1.91 1.93 1.75 1.93 2.15 2.02 2.07 2.14 1.96 1.87
REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES 1.93 1.94 2.16 1.99 2.19 2.26 2.08 1.96 1.86 2.04 1.93 2.01 2.08 2.18 2.08 2.1 2.12 1.99 2.03 2.14 2.15 2.26 2.26 2.33 2.04 2.05
REACTOME_ERKS_ARE_INACTIVATED 2.49 2.49 2.38 2.3 2.39 2.54 2.43 2.51 2.28 2.58 2.57 2.72 2.26 2.3 2.34 2.29 2.24 2.35 2.26 2.37 2.21 2.29 2.43 2.42 2.5 2.47
REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL 1.96 2.04 2.19 2 2.33 2.36 2.29 2.21 2.3 2.26 2.12 2.19 2.36 2.37 2.24 2.25 2.15 2.01 2.18 2.28 2.13 2.24 2.33 2.4 2.32 2.22
REACTOME_SIGNALING_BY_HIPPO 2.15 2.13 1.98 1.87 2.15 2.21 2.13 2.05 2.15 2.01 1.93 1.9 2.04 2.06 1.95 1.93 2.11 2.05 2 2.1 1.92 1.87 1.99 2.07 2.06 1.88
REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS 2.44 2.46 2.39 2.38 2.48 2.55 2.56 2.43 2.5 2.49 2.42 2.48 2.5 2.54 2.47 2.45 2.38 2.37 2.57 2.53 2.35 2.42 2.5 2.56 2.42 2.36
REACTOME_FCGR_ACTIVATION 1.51 1.54 1.56 1.35 1.73 1.88 1.55 1.29 1.58 1.55 1.21 1.45 1.67 1.65 1.47 1.43 1.61 1.36 1.65 1.52 1.45 1.65 1.63 1.74 1.77 1.82
REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS 2.14 2.2 2.17 2.08 2.25 2.41 2.3 2.18 2.36 2.36 2.18 2.46 2.35 2.46 2.25 2.25 2.2 2.15 2.49 2.39 2.24 2.28 2.37 2.5 2.19 2.19
REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION 2.37 2.49 2.49 1.98 2.76 2.76 2.59 2.47 2.59 2.61 2.32 2.62 2.73 2.72 2.37 2.59 2.78 2.62 2.55 2.64 2.48 2.5 2.68 2.67 2.52 2.41
REACTOME_ENOS_ACTIVATION 2.37 2.33 1.93 1.94 2.47 2.44 2.38 2.21 2.3 2.26 2.12 2.06 2.42 2.18 2.41 2.28 2.2 2.28 2.24 2.16 2.19 2.35 2.44 2.33 2.28 2.21
REACTOME_MICRORNA_MIRNA_BIOGENESIS 1.45 1.57 1.71 1.63 1.72 1.71 1.66 1.56 1.75 1.69 1.71 1.6 1.7 1.71 1.62 1.73 1.53 1.49 1.59 1.71 1.64 1.63 1.7 1.73 1.63 1.6
REACTOME_COPII_MEDIATED_VESICLE_TRANSPORT 1.86 1.91 1.99 2.03 1.92 2.05 2.07 2.01 1.99 2.02 1.95 1.95 1.96 2.02 2 1.98 1.89 1.82 1.92 2.08 1.88 1.92 2.03 2.09 1.95 1.9
REACTOME_REGULATION_OF_PYRUVATE_DEHYDROGENASE_PDH_COMPLEX 1.68 1.71 1.75 1.8 1.76 1.94 1.82 1.77 1.77 1.73 1.67 1.79 1.82 1.89 1.97 1.95 1.55 1.62 1.84 1.77 1.79 1.76 1.87 1.98 1.74 1.73
REACTOME_ALPHA_LINOLENIC_OMEGA3_AND_LINOLEIC_OMEGA6_ACID_METABOLISM 1.89 2.02 1.91 1.76 2.33 2.35 2.16 2.03 2.14 2.22 1.82 2.08 2.34 2.28 1.92 2.11 2.27 2.07 2.06 2.25 1.9 2.07 2.09 2.19 2.27 2.31
REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE 1.96 2.01 2.13 1.97 2.19 2.2 2.22 2.18 2.16 2.16 2 2.15 2.2 2.13 2.14 2.09 2.05 1.96 2.03 2.18 2.07 2.15 2.19 2.22 2.17 2.07
REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS 2.5 2.48 2.65 2.52 2.71 2.73 2.74 2.77 2.6 2.62 2.6 2.66 2.68 2.62 2.72 2.66 2.57 2.42 2.48 2.68 2.69 2.81 2.71 2.74 2.55 2.55
REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES 2.68 2.67 2.93 2.74 2.8 2.82 2.82 2.85 2.71 2.77 2.79 2.81 2.82 2.81 2.86 2.97 2.73 2.79 2.67 2.8 2.96 3.12 2.85 2.96 2.87 2.84
REACTOME_NF_KB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL 2.67 2.64 2.96 2.76 2.77 2.85 2.86 2.87 2.73 2.76 2.85 2.78 2.83 2.8 2.82 2.96 2.71 2.76 2.69 2.83 2.94 3.13 2.86 2.95 2.86 2.87
REACTOME_METABOLISM_OF_AMINE_DERIVED_HORMONES 0.56 0.46 0.9 0.68 0.53 0.63 0.65 0.64 0.69 0.64 0.69 0.57 0.68 0.64 0.77 0.79 0.61 0.57 0.52 0.7 0.65 0.9 0.57 0.77 0.77 0.63
REACTOME_PEPTIDE_HORMONE_BIOSYNTHESIS 1 1.15 1.27 1.26 1.46 1.15 1.32 1.15 1.48 1.16 1.2 1.13 1.35 1.48 1.31 1.3 1.11 1.05 1.3 1.38 1.02 1.1 1.54 1.38 1.06 1.2
REACTOME_THYROXINE_BIOSYNTHESIS 0.49 0.34 0.42 0.41 0.35 0.42 0.5 0.37 0.44 0.38 0.4 0.35 0.58 0.44 0.51 0.44 0.35 0.41 0.35 0.46 0.32 0.56 0.46 0.55 0.52 0.45
REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE 2.38 2.41 2.09 2.11 2.58 2.61 2.45 2.13 2.49 2.42 2.12 2.3 2.5 2.47 2.17 2.28 2.27 2.33 2.42 2.51 2.23 2.13 2.36 2.37 2.35 2.23
REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS 1.52 1.37 1.39 1.28 1.81 1.7 1.48 1.58 1.55 1.54 1.24 1.6 1.54 1.59 1.53 1.45 1.54 1.63 1.65 1.6 1.39 1.39 1.53 1.6 1.51 1.58
REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS 1.81 2.01 2.12 2.33 2.23 2.35 2.24 2.27 2.13 2.35 2.14 2.33 2.36 2.33 2.41 2.29 2.33 2.14 2.16 2.36 2.32 2.41 2.37 2.48 2.37 2.3
REACTOME_PECAM1_INTERACTIONS 1.7 1.71 1.67 1.53 2 2.01 1.93 1.78 1.84 1.93 1.74 1.88 1.98 1.94 1.9 1.9 1.69 1.64 1.82 1.8 1.67 1.86 1.86 2 1.99 1.81
REACTOME_BASIGIN_INTERACTIONS 2.05 2.06 2.22 2.01 2.37 2.32 2.22 2.26 2.37 2.23 2.21 2.32 2.38 2.42 2.14 2.22 2.25 2.14 2.17 2.26 2.24 2.28 2.28 2.3 2.38 2.26
REACTOME_TIE2_SIGNALING 1.83 1.9 2.04 1.89 2.24 2.32 2.17 2.01 2.24 2.25 2.02 2.09 2.27 2.27 2.22 2.17 2 1.82 2.18 2.12 1.77 2.06 2.17 2.25 2.04 1.93
REACTOME_GENE_SILENCING_BY_RNA 1.78 1.87 2.04 1.97 2.08 2.12 2.07 2.01 2.05 2.1 1.94 1.97 2.09 2.1 2.03 2.08 1.86 1.77 1.88 2.03 1.78 2 2.06 2.11 2.08 2.02
REACTOME_BIOLOGICAL_OXIDATIONS 1.87 1.93 2.28 2.09 2.19 2.3 2.23 2.14 2.14 2.19 2.05 2.1 2.22 2.24 2.13 2.14 2.05 1.97 2.08 2.22 1.95 2.16 2.23 2.28 2.26 2.17
REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE 1.59 1.63 1.76 1.57 1.99 2.02 1.9 1.78 1.88 1.89 1.67 1.82 1.94 1.93 1.76 1.78 1.72 1.6 1.81 1.9 1.62 1.76 1.98 1.98 1.85 1.75
REACTOME_FATTY_ACIDS 0.78 1.03 1.07 1.16 1.37 1.36 1.36 1.04 1 1.32 0.93 1.14 1.32 1.35 1.05 1 1.27 1.01 1.13 1.39 1.09 1.2 1.21 1.04 1.26 1.2
REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS 1.86 1.91 2.09 1.91 2.19 2.26 2.17 2.13 2.1 2.13 1.97 2.11 2.19 2.2 2.07 2.1 2.04 2 2.07 2.2 1.98 2.11 2.2 2.25 2.18 2.12
REACTOME_MISCELLANEOUS_SUBSTRATES 0.78 1 1.15 0.89 0.92 1 1.11 0.84 1.07 0.99 0.88 1.07 1.15 1.28 0.82 1.02 1.18 0.98 0.99 0.99 1.2 1.09 1.11 1.05 1.3 1.06
REACTOME_ENDOGENOUS_STEROLS 2.03 2.07 2.06 1.74 2.37 2.42 2.29 2.17 2.32 2.23 2.04 2.23 2.33 2.3 2.17 2.15 2.11 2.01 2.25 2.31 2.03 2.08 2.35 2.39 2.2 2.09
REACTOME_EICOSANOIDS 0.91 1.07 1.07 0.67 0.78 0.95 1.13 1.03 1.01 0.9 0.87 0.98 1.16 1.21 1 1.06 1.06 0.93 0.89 1.02 1.12 1.15 1.38 0.91 1.28 0.93
REACTOME_XENOBIOTICS 1.56 1.5 1.74 1.68 1.99 2.04 1.88 1.71 1.8 1.92 1.7 1.76 1.92 1.9 1.71 1.63 1.65 1.48 1.77 1.92 1.5 1.72 1.94 1.9 1.74 1.67
REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION 1.68 1.7 1.87 1.77 1.79 1.79 1.76 1.75 1.79 1.76 1.81 1.78 1.77 1.78 1.82 1.81 1.74 1.68 1.74 1.79 1.69 1.78 1.82 1.8 1.78 1.76
REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION 1.67 1.7 1.87 1.8 1.81 1.78 1.71 1.73 1.77 1.75 1.81 1.78 1.74 1.75 1.79 1.76 1.67 1.73 1.72 1.71 1.7 1.75 1.82 1.91 1.8 1.69
REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS 2.11 2.18 2.35 2.33 2.27 2.31 2.31 2.36 2.36 2.34 2.28 2.28 2.23 2.17 2.39 2.26 2.25 2.18 2.22 2.35 2.24 2.27 2.31 2.4 2.24 2.25
REACTOME_PRC2_METHYLATES_HISTONES_AND_DNA 1.7 1.77 1.94 1.83 1.87 1.96 1.78 1.75 1.85 1.82 1.93 1.88 1.86 1.85 1.93 1.89 1.79 1.68 1.89 1.83 1.87 1.89 2.04 2.07 1.9 1.8
REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE 2.41 2.4 2.06 2.2 2.46 2.43 2.42 2.34 2.34 2.35 2.06 2.23 2.35 2.41 2.33 2.22 2.27 2.39 2.44 2.47 2.05 2.13 2.33 2.34 2.33 2.19
REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES 1.7 1.78 1.86 1.64 1.93 1.93 1.87 1.78 1.87 1.87 1.85 1.9 2.02 1.98 1.81 1.99 1.86 1.78 1.91 1.93 1.86 2 1.95 2.06 1.99 1.92
REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION 2.31 2.39 2.57 2.44 2.58 2.68 2.57 2.5 2.55 2.66 2.51 2.62 2.6 2.61 2.61 2.59 2.4 2.31 2.46 2.55 2.4 2.48 2.65 2.69 2.62 2.5
REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX 1.18 1.27 1.57 1.48 1.41 1.43 1.41 1.41 1.39 1.45 1.16 1.37 1.46 1.49 1.46 1.48 1.41 1.21 1.29 1.4 1.4 1.57 1.52 1.54 1.64 1.6
REACTOME_ARACHIDONIC_ACID_METABOLISM 1.6 1.7 1.89 1.84 1.84 1.88 1.79 1.81 1.72 1.81 1.74 1.75 1.81 1.84 1.76 1.78 1.81 1.66 1.74 1.84 1.81 1.95 1.85 1.84 1.87 1.86
REACTOME_HYALURONAN_METABOLISM 1.49 1.35 1.88 1.57 1.64 1.7 1.75 1.75 1.53 1.73 1.59 1.64 1.71 1.74 1.71 1.87 1.36 1.52 1.66 1.6 1.63 1.9 1.73 1.77 1.86 1.9
REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS 1.69 1.68 1.87 1.75 1.87 1.89 1.82 1.7 1.82 1.74 1.79 1.8 1.87 1.9 1.8 1.78 1.73 1.67 1.81 1.83 1.7 1.74 1.83 1.83 1.83 1.72
REACTOME_ACTIVATION_OF_PPARGC1A_PGC_1ALPHA_BY_PHOSPHORYLATION 1.56 1.57 1.91 1.67 1.77 1.94 1.74 1.52 1.72 1.8 1.68 1.58 1.74 1.85 1.66 1.71 1.51 1.57 1.81 1.65 1.33 1.49 1.9 1.91 1.63 1.42
REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS 1.5 1.56 1.83 1.64 1.86 1.87 1.81 1.7 1.88 1.81 1.71 1.76 1.9 1.87 1.7 1.73 1.73 1.49 1.59 1.76 1.68 1.81 1.92 1.95 1.93 1.85
REACTOME_HYALURONAN_UPTAKE_AND_DEGRADATION 1.35 1.2 1.9 1.49 1.51 1.57 1.69 1.68 1.56 1.67 1.55 1.58 1.71 1.75 1.7 1.75 1.2 1.4 1.45 1.55 1.59 1.81 1.69 1.76 1.8 1.77
REACTOME_ABACAVIR_TRANSPORT_AND_METABOLISM 2.05 2.11 2.95 2.74 2.54 2.56 2.54 2.3 2.43 2.55 2.62 2.37 2.38 2.45 2.37 2.39 2.28 2.12 2.35 2.48 2.17 2.39 2.54 2.67 2.48 2.08
REACTOME_SYNTHESIS_OF_PROSTAGLANDINS_PG_AND_THROMBOXANES_TX 1.79 1.94 1.9 1.96 1.96 2.11 1.97 2.03 1.82 1.87 2.01 2.01 1.98 1.96 1.79 1.8 2.03 1.83 1.98 2.05 1.95 2.07 1.91 1.94 1.99 1.92
REACTOME_SCAVENGING_OF_HEME_FROM_PLASMA 2.05 2.14 3.17 2.98 2.49 2.5 2.59 2.74 2.66 2.84 2.9 2.56 2.37 2.33 3.01 2.96 3.03 2.57 2.61 2.78 2.79 3.1 3.16 2.68 3.1 3.08
REACTOME_DAP12_INTERACTIONS 1.93 1.92 2.14 1.98 2.17 2.18 2.22 2.07 2.2 2.2 2.12 2.09 2.28 2.31 2.15 2.17 1.99 1.94 2.12 2.2 2.04 2.23 2.21 2.29 2.27 2.19
REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS 2.5 2.65 3.07 2.77 2.83 2.9 2.9 2.9 2.9 2.93 2.81 2.84 2.89 2.87 3 2.96 2.87 2.63 2.81 2.94 2.79 3.01 3.02 2.99 2.98 2.9
REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING 2.21 2.16 2.3 2.36 2.14 2.15 2.12 2.05 2.12 2.2 2.29 2.21 2.13 2.21 2.13 2.18 2.14 2.15 2.22 2.14 2.05 2.01 2.1 2.15 2.03 2.06
REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS 2.17 2.18 2.22 2.28 2.17 2.25 2.07 2.08 2.1 2.19 2.19 2.16 2.16 2.25 2.2 2.19 2.09 2.1 2.25 2.18 1.98 2.08 2.15 2.24 2.12 2.16
REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION 2.88 2.91 2.99 2.9 2.97 3.02 2.99 2.84 2.92 3 3.02 3.01 2.87 2.91 2.85 2.83 3.06 2.94 2.98 2.91 2.86 2.83 2.86 2.96 2.83 2.85
REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER 1.93 1.9 2.06 2.05 2.1 2.05 1.99 2.02 2.02 2.09 1.98 2.05 2.01 2.09 2.03 2.09 1.99 2 1.98 2.02 2.04 2.06 2.1 2.14 2.07 2.04
REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY 2.05 2.01 2.18 2.2 2.13 2.04 2.02 2.2 2.1 2.11 2.08 2.11 2.01 2.03 2.13 2.08 2.11 2.17 2.03 2.04 2.19 2.24 2.12 2.11 2.15 2.12
REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION 2.14 2.11 2.33 2.33 2.33 2.25 2.2 2.24 2.2 2.29 2.21 2.26 2.2 2.3 2.21 2.32 2.22 2.22 2.17 2.26 2.29 2.29 2.3 2.35 2.26 2.25
REACTOME_VISUAL_PHOTOTRANSDUCTION 1.79 1.88 2.03 1.81 2.09 2.23 2.05 1.96 2.01 2.04 1.85 2.05 2.17 2.15 2.06 2.08 1.93 1.85 2.04 2.15 1.95 2.14 2.12 2.27 2.04 1.97
REACTOME_NOTCH2_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION 1.64 1.55 1.53 1.55 1.97 2 1.69 1.78 1.84 1.84 1.68 1.87 1.87 1.82 1.6 1.79 1.74 1.65 1.77 1.89 1.61 1.52 1.83 1.9 1.68 1.81
REACTOME_MUCOPOLYSACCHARIDOSES 1.85 1.91 2.13 1.91 1.78 2 1.97 1.95 2.02 1.99 2.1 2.04 2.08 2.15 2.07 1.89 1.91 2.01 2.06 1.99 2.15 2.08 2.04 2.17 2.06 1.86
REACTOME_ANCHORING_FIBRIL_FORMATION 0.65 0.6 0.58 1.09 0.71 0.61 0.68 0.62 0.51 0.56 0.65 0.69 0.55 0.59 0.55 0.5 0.61 0.61 0.58 0.62 0.7 0.61 0.61 0.53 0.57 0.58
REACTOME_PI3K_AKT_SIGNALING_IN_CANCER 1.9 1.97 2.01 1.93 2.28 2.34 2.2 2.11 2.24 2.25 2.01 2.2 2.29 2.28 2.12 2.12 2.1 1.89 2.13 2.25 1.91 2.09 2.32 2.39 2.15 2.07
REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER 1.79 1.85 1.86 1.76 2.21 2.26 2.08 2.02 2.16 2.11 1.88 2.09 2.23 2.2 2 2.04 2.01 1.76 2.05 2.14 1.77 1.99 2.19 2.29 2.07 2.02
REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS 0.65 0.6 0.61 1.07 0.69 0.69 0.78 0.73 0.51 0.54 0.63 0.69 0.64 0.64 0.62 0.54 0.69 0.63 0.58 0.78 0.71 0.76 0.6 0.57 0.64 0.62
REACTOME_CONDENSATION_OF_PROPHASE_CHROMOSOMES 1.65 1.65 1.95 1.92 1.97 2.02 1.86 1.78 2.08 1.99 2 1.81 2.02 1.86 2.01 1.81 1.78 1.73 1.79 1.9 1.78 1.84 2.08 1.98 1.89 1.73
REACTOME_SIGNALING_BY_TYPE_1_INSULIN_LIKE_GROWTH_FACTOR_1_RECEPTOR_IGF1R 1.91 1.95 2.01 1.85 2.3 2.36 2.17 2.17 2.29 2.26 2.06 2.25 2.34 2.3 2.13 2.2 2.15 1.93 2.18 2.27 1.91 2.12 2.35 2.43 2.19 2.15
REACTOME_SELENOAMINO_ACID_METABOLISM 2.07 2.04 2.3 2.14 2.1 2.09 2.1 2.11 2.09 2.13 2.11 2.1 2.05 2.1 2.11 2.18 2.21 2.14 2.01 2.12 2.14 2.17 2.19 2.2 2.16 2.1
REACTOME_DAP12_SIGNALING 1.92 1.87 2.09 1.99 2.13 2.12 2.13 1.96 2.19 2.09 2.08 2.07 2.18 2.22 2.02 2.07 2 1.9 2.1 2.07 1.96 2.08 2.15 2.21 2.09 1.96
REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP 1.39 1.55 1.48 1.43 1.64 1.67 1.61 1.6 1.62 1.52 1.4 1.52 1.54 1.58 1.54 1.51 1.45 1.39 1.57 1.66 1.43 1.54 1.56 1.59 1.57 1.5
REACTOME_RETINOID_CYCLE_DISEASE_EVENTS 1.7 1.8 1.86 1.72 1.57 1.92 1.89 1.45 1.67 2.02 1.31 1.64 1.77 1.8 2.03 2.11 1.45 1.25 1.49 1.65 1.82 2.12 1.61 1.99 1.67 1.69
REACTOME_THE_CANONICAL_RETINOID_CYCLE_IN_RODS_TWILIGHT_VISION 1.45 1.62 1.76 1.53 1.71 1.97 1.77 1.51 1.68 1.81 1.39 1.68 1.76 1.81 1.78 1.87 1.5 1.34 1.59 1.7 1.66 1.94 1.7 1.92 1.79 1.59
REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING 2.03 2.07 2.23 2.16 2.19 2.27 2.23 2.14 2.27 2.21 2.15 2.17 2.22 2.22 2.21 2.2 2.08 2.07 2.23 2.24 2.11 2.21 2.27 2.34 2.17 2.07
REACTOME_MASTL_FACILITATES_MITOTIC_PROGRESSION 2.47 2.48 2.8 2.79 2.76 2.89 2.85 2.64 2.97 2.67 2.78 2.45 2.98 2.78 2.8 2.63 2.41 2.29 2.52 2.75 2.57 2.69 3.02 2.82 2.75 2.47
REACTOME_SEPARATION_OF_SISTER_CHROMATIDS 2.11 2.18 2.41 2.29 2.4 2.47 2.38 2.3 2.42 2.42 2.26 2.28 2.4 2.39 2.36 2.33 2.19 2.12 2.25 2.35 2.17 2.29 2.44 2.48 2.35 2.23
REACTOME_ACTIVATION_OF_THE_PHOTOTRANSDUCTION_CASCADE 2.24 2.31 2.23 2.15 2.57 2.57 2.34 2.31 2.23 2.43 2.28 2.46 2.45 2.41 2.4 2.35 2.32 2.39 2.44 2.48 2.24 2.37 2.36 2.48 2.26 2.34
REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION 2.14 2.24 2.47 2.35 2.51 2.58 2.46 2.36 2.53 2.55 2.34 2.38 2.5 2.5 2.47 2.42 2.28 2.2 2.3 2.42 2.18 2.33 2.55 2.59 2.46 2.28
REACTOME_CONDENSATION_OF_PROMETAPHASE_CHROMOSOMES 2.31 2.35 2.37 2.45 2.62 2.71 2.66 2.58 2.66 2.54 2.54 2.4 2.72 2.63 2.72 2.63 2.56 2.45 2.56 2.71 2.38 2.69 2.59 2.52 2.75 2.62
REACTOME_THE_PHOTOTRANSDUCTION_CASCADE 1.98 2.03 2.17 2.01 2.36 2.47 2.28 2.23 2.2 2.29 2.1 2.31 2.45 2.36 2.24 2.23 2.16 2.08 2.27 2.41 2.07 2.24 2.36 2.48 2.16 2.18
REACTOME_INTERACTION_WITH_CUMULUS_CELLS_AND_THE_ZONA_PELLUCIDA 0.68 0.65 0.66 1.35 0.63 0.76 0.72 0.63 0.6 0.65 0.5 0.62 0.7 0.64 0.58 0.62 0.6 0.74 0.74 0.57 0.68 0.49 0.54 0.6 0.71 0.92
REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE 2.04 2.13 2.34 2.23 2.33 2.4 2.33 2.24 2.36 2.36 2.2 2.22 2.33 2.32 2.31 2.27 2.13 2.07 2.2 2.3 2.12 2.22 2.38 2.41 2.3 2.17
REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE 2.19 2.24 2.27 2.21 2.34 2.4 2.22 2.16 2.24 2.31 2.23 2.32 2.25 2.27 2.28 2.27 2.3 2.31 2.25 2.28 2.23 2.25 2.31 2.37 2.29 2.19
REACTOME_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP 2.27 2.28 2.36 2.28 2.42 2.48 2.32 2.34 2.25 2.42 2.3 2.41 2.32 2.31 2.23 2.27 2.33 2.27 2.3 2.37 2.25 2.25 2.4 2.44 2.36 2.33
REACTOME_CELLULAR_SENESCENCE 1.91 1.95 2.05 1.95 2.11 2.14 1.99 1.93 1.98 2.06 1.96 2.04 2.01 2.03 1.97 1.97 2.02 1.99 2.01 2.03 1.93 1.96 2.08 2.11 2.02 1.95
REACTOME_FORMATION_OF_SENESCENCE_ASSOCIATED_HETEROCHROMATIN_FOCI_SAHF 1.24 1.54 1.85 1.42 1.84 1.88 1.74 1.53 1.64 1.65 1.52 1.58 1.76 1.72 1.65 1.6 1.52 1.45 1.69 1.73 1.4 1.49 1.81 1.87 1.7 1.47
REACTOME_ONCOGENE_INDUCED_SENESCENCE 2.43 2.46 2.59 2.58 2.53 2.53 2.37 2.34 2.41 2.49 2.42 2.49 2.38 2.42 2.47 2.47 2.39 2.49 2.43 2.45 2.39 2.45 2.51 2.55 2.45 2.38
REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE 1.44 1.56 1.85 1.69 1.84 1.81 1.65 1.58 1.69 1.75 1.67 1.61 1.68 1.7 1.66 1.63 1.61 1.47 1.59 1.71 1.48 1.59 1.84 1.83 1.67 1.51
REACTOME_CYTOSOLIC_IRON_SULFUR_CLUSTER_ASSEMBLY 1.51 1.43 1.64 1.7 1.62 1.63 1.59 1.61 1.58 1.58 1.55 1.56 1.51 1.62 1.56 1.64 1.53 1.51 1.58 1.58 1.43 1.55 1.65 1.73 1.51 1.47
REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION 2.31 2.35 2.65 2.48 2.52 2.56 2.62 2.54 2.59 2.55 2.52 2.38 2.54 2.56 2.58 2.58 2.42 2.29 2.42 2.52 2.37 2.43 2.57 2.6 2.52 2.4
REACTOME_SIGNALING_BY_LEPTIN 1.28 1.49 1.35 1.38 1.79 1.78 1.72 1.61 1.75 1.74 1.41 1.69 1.85 1.82 1.81 1.62 1.76 1.41 1.52 1.66 1.42 1.67 1.88 1.98 1.8 1.67
REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER 1.62 1.64 1.84 1.78 1.78 1.75 1.71 1.73 1.77 1.74 1.76 1.74 1.69 1.66 1.77 1.7 1.64 1.67 1.66 1.7 1.65 1.67 1.79 1.85 1.71 1.64
REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE 2.86 2.84 2.65 2.89 2.83 2.94 2.66 2.53 2.76 2.6 2.58 2.67 2.68 2.79 2.86 2.74 2.51 2.87 2.9 2.95 2.55 2.54 2.63 2.79 2.56 2.55
REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS 2.24 2.23 2.33 2 2.57 2.58 2.66 2.58 2.45 2.53 2.16 2.48 2.58 2.52 2.49 2.32 2.41 2.45 2.29 2.57 2.45 2.46 2.49 2.54 2.61 2.47
REACTOME_INSULIN_PROCESSING 2.26 2.26 2.29 2.29 2.47 2.43 2.41 2.33 2.37 2.44 2.37 2.42 2.37 2.35 2.44 2.28 2.49 2.44 2.33 2.38 2.36 2.33 2.37 2.48 2.46 2.28
REACTOME_STIMULI_SENSING_CHANNELS 2.29 2.39 2.52 2.32 2.58 2.67 2.55 2.55 2.53 2.59 2.44 2.58 2.66 2.65 2.54 2.55 2.49 2.39 2.52 2.63 2.41 2.58 2.66 2.74 2.62 2.53
REACTOME_EPH_EPHRIN_SIGNALING 2.14 2.22 2.16 2.13 2.25 2.31 2.28 2.24 2.22 2.21 2.12 2.16 2.21 2.17 2.24 2.18 2.16 2.09 2.26 2.27 2.07 2.15 2.3 2.3 2.2 2.15
REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER 2.68 2.76 2.98 2.87 2.74 2.72 2.74 2.84 2.77 2.73 2.93 2.68 2.52 2.53 2.81 2.82 2.73 2.85 2.7 2.72 2.8 2.79 2.71 2.81 2.68 2.7
REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION 2.11 2.15 2.11 2.03 2.4 2.56 2.47 2.34 2.59 2.55 2.26 2.59 2.43 2.48 2.43 2.37 2.39 2.24 2.54 2.44 2.16 2.29 2.49 2.63 2.32 2.16
REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION 2.12 2.2 2.29 2.19 2.3 2.43 2.34 2.19 2.41 2.38 2.23 2.34 2.32 2.39 2.34 2.28 2.19 2.19 2.39 2.33 2.21 2.22 2.41 2.5 2.25 2.08
REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION 2.17 2.29 2.46 2.42 2.52 2.61 2.51 2.43 2.57 2.53 2.41 2.51 2.56 2.63 2.49 2.5 2.35 2.38 2.62 2.54 2.31 2.41 2.59 2.72 2.45 2.33
REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION 1.91 1.94 2.15 2.05 2 2.1 2.09 2.05 2.13 2.07 2.05 2.02 2.07 2.03 2.1 2.1 1.95 1.92 2.05 2.1 2.05 2.12 2.13 2.17 2.03 1.98
REACTOME_POU5F1_OCT4_SOX2_NANOG_ACTIVATE_GENES_RELATED_TO_PROLIFERATION 1.59 1.69 1.57 1.36 2.06 2.2 1.87 1.76 2.04 1.89 1.47 1.89 2.09 2.03 1.7 1.83 2.14 1.82 1.82 1.92 1.63 1.84 2.19 2.23 2.13 1.92
REACTOME_NOTCH2_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS 2.31 2.37 2.5 2.46 2.59 2.56 2.49 2.52 2.59 2.54 2.53 2.48 2.44 2.37 2.56 2.47 2.46 2.44 2.41 2.48 2.41 2.44 2.55 2.61 2.38 2.36
REACTOME_PEPTIDE_HORMONE_METABOLISM 2.17 2.22 2.51 2.46 2.55 2.61 2.47 2.41 2.49 2.57 2.4 2.44 2.61 2.6 2.53 2.53 2.4 2.27 2.41 2.55 2.34 2.5 2.59 2.65 2.59 2.46
REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN 1.64 1.68 1.78 1.72 1.9 1.95 1.91 1.84 1.91 1.88 1.8 1.77 1.92 1.93 1.86 1.82 1.71 1.76 1.81 1.91 1.69 1.78 1.95 1.91 1.81 1.71
REACTOME_SUMOYLATION 1.7 1.77 1.84 1.73 1.94 1.98 1.91 1.82 1.85 1.9 1.73 1.84 1.89 1.93 1.86 1.85 1.8 1.78 1.81 1.86 1.71 1.83 1.94 1.99 1.91 1.82
REACTOME_INITIATION_OF_NUCLEAR_ENVELOPE_NE_REFORMATION 2.1 2.14 2.33 2.28 2.47 2.49 2.46 2.35 2.55 2.39 2.47 2.23 2.46 2.39 2.5 2.28 2.13 2.05 2.28 2.48 2.17 2.27 2.55 2.4 2.38 2.25
REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY 2.04 2.17 2.28 2.21 2.22 2.33 2.33 2.26 2.33 2.32 2.17 2.23 2.29 2.27 2.33 2.24 2.09 2.12 2.18 2.33 2.14 2.12 2.33 2.39 2.31 2.16
REACTOME_LAMININ_INTERACTIONS 1.1 1.13 1.23 1.1 1.42 1.42 1.27 1.18 1.36 1.33 1.25 1.34 1.39 1.38 1.15 1.28 1.31 1.14 1.17 1.27 1.32 1.42 1.44 1.47 1.5 1.5
REACTOME_SYNDECAN_INTERACTIONS 1.79 1.86 2.02 1.7 2.03 2.13 2.04 1.92 2.09 2.08 1.91 2.06 2.16 2.11 2.04 2.1 1.98 1.99 2.08 2.08 1.98 2.13 2.11 2.35 2.15 2.02
REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS 1.62 1.65 1.79 1.54 1.82 1.95 1.84 1.7 1.89 1.87 1.67 1.81 1.92 1.91 1.82 1.88 1.79 1.71 1.78 1.85 1.82 1.94 1.91 2.06 1.93 1.81
REACTOME_ECM_PROTEOGLYCANS 1.82 1.94 2.04 1.8 2.16 2.2 2.07 2.01 2.15 2.15 1.91 2.1 2.22 2.22 2.05 2.08 2.1 1.93 2.04 2.19 2.02 2.13 2.18 2.24 2.18 2.12
REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS 2.27 2.48 2.53 2.25 2.41 2.52 2.46 2.49 2.5 2.51 2.22 2.54 2.52 2.53 2.52 2.5 2.41 2.26 2.49 2.53 2.42 2.54 2.47 2.59 2.46 2.42
REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS 1.48 1.49 1.64 1.6 1.6 1.67 1.68 1.55 1.58 1.63 1.44 1.52 1.59 1.66 1.6 1.58 1.48 1.52 1.49 1.56 1.39 1.54 1.66 1.64 1.62 1.51
REACTOME_HDACS_DEACETYLATE_HISTONES 1.43 1.46 1.54 1.48 1.49 1.52 1.51 1.57 1.57 1.48 1.59 1.5 1.47 1.49 1.57 1.6 1.55 1.48 1.55 1.54 1.52 1.63 1.53 1.55 1.58 1.55
REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES 1.67 1.7 1.87 1.7 1.89 1.97 1.87 1.74 1.88 1.88 1.83 1.84 1.87 1.9 1.75 1.77 1.79 1.65 1.81 1.86 1.65 1.76 1.96 1.95 1.84 1.75
REACTOME_HDMS_DEMETHYLATE_HISTONES 1.02 1.02 1.15 1.24 1.19 1.1 1.28 1.16 1.37 1.35 1.29 1.34 1.05 1.07 0.92 1.13 1.06 1.07 1.21 1.1 1.08 1.25 1.05 1.02 1.24 1.29
REACTOME_HATS_ACETYLATE_HISTONES 1.71 1.69 1.73 1.64 1.73 1.75 1.73 1.61 1.69 1.63 1.67 1.64 1.74 1.77 1.68 1.63 1.75 1.72 1.73 1.71 1.58 1.66 1.7 1.64 1.7 1.66
REACTOME_RMTS_METHYLATE_HISTONE_ARGININES 1.32 1.51 1.58 1.51 1.38 1.49 1.51 1.6 1.46 1.44 1.36 1.34 1.42 1.49 1.51 1.53 1.42 1.55 1.51 1.54 1.52 1.49 1.49 1.45 1.56 1.45
REACTOME_PROCESSING_AND_ACTIVATION_OF_SUMO 1.31 1.43 1.43 1.69 1.41 1.67 1.7 1.63 1.61 1.54 1.5 1.43 1.68 1.65 1.76 1.7 1.26 1.24 1.36 1.53 1.56 1.72 1.86 1.74 1.62 1.37
REACTOME_GLYCOGEN_STORAGE_DISEASES 2.83 2.89 3.07 2.81 2.97 2.98 2.9 3.06 3 2.98 3.03 2.96 2.99 3.01 2.95 3.04 3.02 3.01 2.93 2.97 3.13 3.21 3.09 3.12 3.02 2.95
REACTOME_SUMOYLATION_OF_TRANSCRIPTION_FACTORS 1.56 1.75 1.81 1.51 1.71 1.92 1.8 1.67 1.75 1.84 1.6 1.67 1.78 1.78 1.79 1.81 1.53 1.63 1.63 1.75 1.52 1.82 1.97 2.02 1.87 1.66
REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS 1.43 1.48 1.45 1.57 1.54 1.64 1.61 1.49 1.49 1.53 1.31 1.41 1.51 1.59 1.48 1.43 1.29 1.42 1.42 1.52 1.24 1.43 1.55 1.59 1.49 1.35
REACTOME_WNT_LIGAND_BIOGENESIS_AND_TRAFFICKING 1.63 1.75 2.21 1.94 1.8 2.02 1.91 1.94 1.99 1.98 1.94 1.88 2 2.02 1.99 1.95 1.79 1.66 1.82 1.94 1.81 1.94 2.1 2.2 1.96 1.88
REACTOME_CHROMATIN_MODIFYING_ENZYMES 1.56 1.62 1.75 1.65 1.71 1.74 1.74 1.68 1.71 1.67 1.66 1.67 1.69 1.73 1.66 1.68 1.66 1.62 1.7 1.74 1.57 1.69 1.71 1.7 1.7 1.66
REACTOME_TRP_CHANNELS 1.34 1.32 1.7 1.87 1.51 1.6 1.51 1.54 1.52 1.59 1.42 1.52 1.56 1.59 1.53 1.51 1.46 1.34 1.41 1.54 1.49 1.62 1.6 1.64 1.62 1.56
REACTOME_DEFECTS_IN_COBALAMIN_B12_METABOLISM 1.73 1.67 1.89 1.85 2 2.04 1.87 1.61 2.05 2.03 1.92 1.84 2.02 2.05 1.83 1.86 1.66 1.64 1.79 1.79 1.49 1.75 2.01 1.89 1.77 1.7
REACTOME_DEFECTS_IN_VITAMIN_AND_COFACTOR_METABOLISM 1.38 1.34 1.67 1.59 1.57 1.62 1.48 1.3 1.64 1.65 1.52 1.52 1.59 1.61 1.48 1.47 1.35 1.38 1.45 1.46 1.27 1.39 1.64 1.57 1.43 1.35
REACTOME_DETOXIFICATION_OF_REACTIVE_OXYGEN_SPECIES 1.81 1.95 2.3 2.08 2.02 2.01 2.01 2.12 2.08 2 2.01 1.97 2.01 2.07 2.11 2.27 2 1.87 1.97 1.98 2.24 2.34 2.08 2.15 2.29 2.27
REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY 1.58 1.58 1.69 1.77 1.82 1.88 1.83 1.69 1.81 1.8 1.62 1.66 1.81 1.85 1.71 1.71 1.59 1.58 1.61 1.77 1.47 1.67 1.82 1.8 1.74 1.64
REACTOME_GLYCOGEN_SYNTHESIS 2.76 2.77 2.93 2.63 2.81 2.77 2.79 2.92 2.81 2.8 2.85 2.76 2.78 2.81 2.89 2.88 2.83 2.86 2.73 2.81 3 3.07 2.94 2.97 2.89 2.8
REACTOME_REGULATION_BY_C_FLIP 1.19 1.01 1.41 1.25 1.39 1.33 1.4 1.26 1.03 1.43 1.38 1.23 1.2 1.2 0.94 1.09 1.12 1.07 1.35 1.18 1 1.1 1.02 1.19 1.33 1.24
REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE 2.2 2.18 2.19 2.14 2.28 2.36 2.34 2.24 2.27 2.31 2.09 2.22 2.22 2.29 2.28 2.24 2.2 2.2 2.23 2.31 2.2 2.21 2.31 2.33 2.17 2.09
REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR 2.35 2.37 2.46 2.45 2.49 2.56 2.51 2.51 2.5 2.55 2.4 2.51 2.47 2.46 2.52 2.54 2.4 2.29 2.36 2.51 2.41 2.45 2.54 2.55 2.51 2.37
REACTOME_HSF1_ACTIVATION 2.73 2.72 2.77 2.67 2.9 2.9 2.89 2.84 2.71 2.81 2.65 2.7 2.75 2.76 2.86 2.89 2.78 2.75 2.72 2.79 2.86 2.88 2.87 2.84 2.77 2.75
REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS 2.21 2.18 2.21 2.12 2.31 2.36 2.36 2.27 2.27 2.3 2.1 2.22 2.24 2.29 2.28 2.26 2.21 2.25 2.23 2.32 2.25 2.22 2.3 2.33 2.21 2.11
REACTOME_ATTENUATION_PHASE 2.8 2.74 2.81 2.7 2.99 2.98 2.94 2.92 2.79 2.91 2.7 2.86 2.8 2.81 2.9 2.95 2.8 2.8 2.78 2.86 2.9 2.93 2.93 2.93 2.83 2.84
REACTOME_HSF1_DEPENDENT_TRANSACTIVATION 2.58 2.51 2.59 2.47 2.75 2.74 2.69 2.66 2.56 2.68 2.5 2.62 2.56 2.59 2.63 2.69 2.55 2.59 2.56 2.63 2.67 2.66 2.7 2.69 2.58 2.55
REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY 1.16 1.13 1.31 1.26 1.3 1.28 1.23 1.2 1.33 1.29 1.22 1.3 1.34 1.32 1.21 1.29 1.21 1.3 1.27 1.26 1.17 1.21 1.32 1.41 1.29 1.23
REACTOME_METABOLISM_OF_POLYAMINES 1.71 1.71 1.92 1.77 1.86 1.96 1.94 1.79 1.91 1.81 1.73 1.72 1.91 1.8 1.82 1.8 1.62 1.7 1.77 1.93 1.84 1.95 1.91 1.93 1.86 1.74
REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS 2.61 2.67 2.78 2.72 3.07 3.02 2.93 2.7 2.97 3.02 2.81 2.75 3.03 2.96 2.75 2.77 2.85 2.44 2.65 2.81 2.53 2.68 3.03 2.98 2.91 2.69
REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE 1.87 1.95 1.93 1.97 2.21 2.29 2.18 2.08 2.22 2.15 1.88 2 2.37 2.38 2.09 2.1 2.06 1.9 2.13 2.18 1.91 2.1 2.24 2.26 2.17 2.07
REACTOME_INTEGRIN_SIGNALING 1.87 1.92 2.09 1.95 2.16 2.21 2.31 2.12 2.2 2.32 2.14 2.21 2.23 2.28 2.28 2.18 2.04 1.99 2.04 2.12 1.95 2.18 2.31 2.39 2.22 2.07
REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS 1.92 1.96 2.3 2.14 2.41 2.4 2.54 2.27 2.44 2.51 2.36 2.4 2.46 2.44 2.36 2.26 2.26 2.02 2.07 2.33 2.01 2.28 2.5 2.53 2.45 2.29
REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSAMINOGLYCAN_METABOLISM 1.58 1.63 1.89 1.59 1.77 1.84 1.79 1.74 1.72 1.67 1.68 1.74 1.84 1.91 1.83 1.81 1.79 1.74 1.8 1.86 1.82 1.86 1.89 1.85 1.83 1.82
REACTOME_DEFECTIVE_B4GALT7_CAUSES_EDS_PROGEROID_TYPE 1.55 1.62 1.8 1.44 1.78 1.89 1.77 1.62 1.8 1.71 1.52 1.77 1.87 1.84 1.77 1.74 1.81 1.74 1.77 1.92 1.74 1.88 1.95 1.99 1.74 1.73
REACTOME_DEFECTIVE_EXT2_CAUSES_EXOSTOSES_2 1.63 1.64 1.87 1.57 1.71 1.91 1.81 1.53 1.84 1.73 1.51 1.75 1.88 1.89 1.89 1.8 1.71 1.68 1.9 1.9 1.72 1.89 1.99 2.07 1.78 1.72
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53 2.01 2.05 2.2 2.1 2.2 2.23 2.17 2.15 2.18 2.21 2.11 2.11 2.18 2.19 2.15 2.15 2.07 2 2.1 2.19 2.03 2.12 2.22 2.26 2.18 2.09
REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS 1.69 1.76 2.14 1.99 2.17 2.12 2.24 2.06 2.21 2.33 2.13 2.24 2.2 2.22 2.1 1.97 2.08 1.74 1.78 2.11 1.9 2.14 2.35 2.38 2.25 2.18
REACTOME_SIGNALING_BY_GPCR 1.99 2.05 2.21 2.01 2.3 2.37 2.3 2.25 2.27 2.27 2.11 2.23 2.32 2.34 2.28 2.3 2.08 2.07 2.24 2.35 2.08 2.23 2.32 2.42 2.25 2.18
REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS 1.59 1.65 1.86 1.58 1.82 1.92 1.87 1.82 1.85 1.83 1.7 1.74 1.92 1.93 1.84 1.87 1.65 1.65 1.79 1.93 1.69 1.84 1.86 1.94 1.84 1.82
REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS 1.83 1.86 1.93 1.79 1.97 2.02 1.97 2 1.94 1.99 1.89 1.94 1.99 1.99 2.03 2.01 1.97 1.9 2 2.07 1.86 2.03 2.01 2.06 2.03 2
REACTOME_NETRIN_1_SIGNALING 1.66 1.71 1.61 1.66 1.85 1.92 1.73 1.69 1.72 1.77 1.6 1.76 1.83 1.81 1.65 1.75 1.7 1.66 1.81 1.8 1.7 1.77 1.82 1.83 1.7 1.63
REACTOME_NEPHRIN_FAMILY_INTERACTIONS 2.1 2.18 2.12 1.85 2.26 2.36 2.25 2.2 2.22 2.29 2.12 2.36 2.33 2.32 2.18 2.21 2.16 2.23 2.32 2.27 2.12 2.23 2.32 2.42 2.27 2.19
REACTOME_SEMAPHORIN_INTERACTIONS 1.89 1.95 2.02 2.02 1.96 1.97 2.04 1.94 1.91 1.89 1.97 1.95 1.93 1.89 1.95 1.98 1.97 1.91 1.96 1.94 1.94 1.92 1.98 1.94 1.94 1.88
REACTOME_L1CAM_INTERACTIONS 2.37 2.44 2.48 2.41 2.53 2.61 2.56 2.5 2.53 2.55 2.45 2.53 2.54 2.52 2.55 2.51 2.37 2.37 2.51 2.6 2.43 2.49 2.54 2.67 2.56 2.44
REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH 2.19 2.3 2.37 2.16 2.46 2.59 2.44 2.42 2.43 2.49 2.29 2.49 2.51 2.51 2.45 2.47 2.28 2.25 2.44 2.53 2.29 2.41 2.49 2.68 2.51 2.46
REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS 1.66 1.75 1.91 1.67 1.9 1.97 1.94 1.85 1.91 1.87 1.75 1.77 1.95 1.97 1.88 1.93 1.76 1.7 1.83 1.96 1.79 1.91 1.9 1.96 1.91 1.89
REACTOME_AMINE_LIGAND_BINDING_RECEPTORS 1.74 1.81 1.95 1.58 1.81 2.12 2.02 2.06 1.97 1.98 1.83 1.97 2.08 2.17 2 2.03 1.61 1.88 2.04 2.16 1.7 2 2.04 2.16 2.02 1.93
REACTOME_HORMONE_LIGAND_BINDING_RECEPTORS 0.86 0.94 1.05 0.63 0.87 0.6 0.97 0.77 0.94 0.77 0.87 0.7 0.87 0.69 0.79 0.63 0.77 0.89 0.75 0.73 0.7 0.61 0.84 0.65 0.85 0.9
REACTOME_DSCAM_INTERACTIONS 1.53 1.52 1.31 1.4 1.61 1.72 1.59 1.37 1.62 1.5 1.27 1.67 1.36 1.37 1.34 1.3 1.22 1.31 1.73 1.65 1.29 1.27 1.64 1.68 1.36 1.14
REACTOME_SIGNALING_BY_ROBO_RECEPTORS 2.08 2.1 2.25 2.17 2.26 2.29 2.27 2.18 2.24 2.27 2.14 2.21 2.22 2.21 2.19 2.19 2.13 2.08 2.16 2.26 2.09 2.19 2.29 2.3 2.23 2.13
REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX 2.17 2.19 2.25 2.33 2.25 2.33 2.21 2.21 2.23 2.28 2.29 2.23 2.24 2.3 2.28 2.22 2.13 2.13 2.26 2.26 2.21 2.25 2.33 2.41 2.24 2.15
REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_WNT_LIGAND_ANTAGONISTS 1.65 1.72 1.7 1.25 1.9 1.87 1.87 1.94 1.83 1.59 1.67 1.84 2.06 2.06 1.9 2 1.71 1.56 1.82 1.91 1.85 2 2.01 2.25 1.89 1.74
REACTOME_DISEASES_ASSOCIATED_WITH_N_GLYCOSYLATION_OF_PROTEINS 1.35 1.47 1.4 1.37 1.49 1.57 1.45 1.39 1.42 1.3 1.29 1.13 1.22 1.36 1.34 1.31 1.22 1.11 1.54 1.52 1.14 1.17 1.43 1.38 1.35 1.18
REACTOME_DISEASES_OF_GLYCOSYLATION 1.54 1.57 1.79 1.59 1.76 1.85 1.76 1.68 1.74 1.69 1.6 1.65 1.79 1.81 1.7 1.67 1.63 1.54 1.71 1.83 1.63 1.71 1.81 1.86 1.75 1.68
REACTOME_TRNA_AMINOACYLATION 1.24 1.26 1.48 1.47 1.21 1.23 1.37 1.33 1.38 1.34 1.34 1.37 1.36 1.39 1.35 1.27 1.23 1.14 1.32 1.28 1.14 1.15 1.5 1.4 1.3 1.21
REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION 0.6 0.62 1.06 0.98 0.74 0.81 0.79 0.88 0.76 0.79 0.95 0.84 0.87 0.89 0.81 0.9 0.8 0.76 0.86 0.74 0.66 0.77 0.99 0.9 0.79 0.76
REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES 1.3 1.32 1.41 1.2 1.49 1.53 1.38 1.38 1.49 1.27 1.15 1.13 1.46 1.47 1.3 1.42 1.3 1.31 1.32 1.43 1.4 1.56 1.36 1.36 1.37 1.39
REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES 2.12 2.16 2.46 2.27 2.29 2.35 2.43 2.38 2.39 2.33 2.25 2.16 2.34 2.34 2.4 2.38 2.23 2.09 2.23 2.36 2.16 2.23 2.33 2.4 2.33 2.2
REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES 2.17 2.23 2.47 2.3 2.34 2.41 2.44 2.41 2.41 2.38 2.29 2.27 2.37 2.39 2.42 2.41 2.27 2.15 2.28 2.41 2.2 2.26 2.37 2.47 2.4 2.24
REACTOME_ENERGY_DEPENDENT_REGULATION_OF_MTOR_BY_LKB1_AMPK 1.34 1.43 1.5 1.61 1.52 1.57 1.47 1.44 1.47 1.61 1.4 1.53 1.49 1.56 1.57 1.5 1.29 1.38 1.56 1.51 1.26 1.46 1.57 1.64 1.45 1.4
REACTOME_ATF4_ACTIVATES_GENES_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS 1.22 1.25 1.28 1.39 1.26 1.34 1.42 1.34 1.38 1.36 1.25 1.35 1.29 1.31 1.34 1.23 1.17 1.22 1.34 1.38 1.14 1.26 1.3 1.49 1.39 1.26
REACTOME_ATF6_ATF6_ALPHA_ACTIVATES_CHAPERONES 2.01 1.77 1.91 1.63 1.91 1.87 2.04 1.98 2.01 1.61 1.67 1.78 1.8 1.8 1.89 1.87 1.87 1.64 1.9 1.87 1.83 1.73 1.93 1.79 1.93 1.73
REACTOME_PERK_REGULATES_GENE_EXPRESSION 1.33 1.32 1.36 1.47 1.33 1.47 1.58 1.49 1.53 1.44 1.37 1.44 1.42 1.43 1.45 1.33 1.37 1.36 1.42 1.49 1.32 1.41 1.44 1.61 1.46 1.37
REACTOME_IRE1ALPHA_ACTIVATES_CHAPERONES 1.67 1.74 1.79 1.66 1.78 1.83 1.82 1.76 1.82 1.75 1.62 1.73 1.75 1.77 1.76 1.69 1.69 1.72 1.78 1.86 1.65 1.71 1.81 1.85 1.78 1.7
REACTOME_UNFOLDED_PROTEIN_RESPONSE_UPR 1.67 1.72 1.79 1.68 1.76 1.82 1.85 1.78 1.83 1.78 1.66 1.76 1.81 1.79 1.76 1.71 1.71 1.7 1.78 1.85 1.66 1.74 1.84 1.89 1.8 1.72
REACTOME_ATF6_ATF6_ALPHA_ACTIVATES_CHAPERONE_GENES 2.21 1.9 2.01 1.76 2.07 2 2.21 2.17 2.19 1.73 1.72 1.89 1.96 1.96 2.07 2.02 1.99 1.67 2.02 2.02 1.98 1.9 2.11 1.96 2.1 1.89
REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION 1.62 1.7 1.7 1.65 1.91 1.92 1.81 1.71 1.77 1.76 1.64 1.72 1.82 1.82 1.68 1.69 1.66 1.63 1.78 1.77 1.55 1.68 1.77 1.86 1.78 1.73
REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS 2.23 2.31 2.61 2.39 2.54 2.61 2.54 2.52 2.52 2.52 2.34 2.47 2.59 2.58 2.51 2.52 2.4 2.28 2.39 2.59 2.41 2.51 2.62 2.68 2.6 2.57
REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION 2.26 2.39 2.33 2.17 2.53 2.5 2.44 2.43 2.51 2.42 2.32 2.39 2.53 2.54 2.52 2.51 2.34 2.36 2.47 2.49 2.25 2.44 2.51 2.54 2.49 2.38
REACTOME_OLFACTORY_SIGNALING_PATHWAY 1.17 1.13 1.17 1.16 1.21 1.25 1.17 1.14 1.19 1.18 1.19 1.16 1.16 1.17 1.16 1.15 1.15 1.14 1.26 1.21 1.15 1.12 1.18 1.17 1.17 1.14
REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLUCAGON_LIKE_PEPTIDE_1_GLP_1 1.78 2.09 2.45 2.64 2.37 2.44 2.49 2.42 2.31 2.52 2.38 2.26 2.61 2.57 2.48 2.62 2.41 2 2.25 2.47 2.26 2.55 2.55 2.54 2.58 2.53
REACTOME_TRANSPORT_OF_SMALL_MOLECULES 2.07 2.15 2.33 2.15 2.36 2.44 2.34 2.3 2.36 2.36 2.2 2.28 2.41 2.42 2.32 2.33 2.18 2.11 2.28 2.39 2.16 2.33 2.43 2.51 2.38 2.29
REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT 1.85 1.93 2.2 2.08 2.07 2.16 2.14 2.11 2.17 2.15 2.02 2.06 2.14 2.12 2.13 2.13 1.91 1.88 2 2.13 2 2.14 2.23 2.26 2.16 2.12
REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY 1.76 1.75 1.79 1.74 2.01 2.08 1.96 1.9 1.92 1.88 1.81 1.96 1.99 2.01 1.86 1.9 1.94 1.9 1.93 2.04 1.74 1.82 1.99 2.14 1.98 1.83
REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING 2.21 2.29 2.32 2.19 2.39 2.45 2.4 2.36 2.37 2.34 2.24 2.3 2.38 2.36 2.35 2.33 2.21 2.24 2.36 2.42 2.27 2.36 2.43 2.48 2.33 2.25
REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY 2.17 2.18 2.4 2.32 2.47 2.52 2.35 2.27 2.29 2.44 2.28 2.35 2.43 2.47 2.45 2.41 2.24 2.18 2.33 2.36 2.26 2.41 2.57 2.6 2.4 2.3
REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES 1.6 1.69 1.57 1.61 1.75 1.78 1.68 1.72 1.65 1.79 1.51 1.63 1.75 1.7 1.69 1.68 1.52 1.57 1.8 1.67 1.6 1.55 1.7 1.73 1.66 1.55
REACTOME_CD28_CO_STIMULATION 2.01 2.1 2.1 2.15 2.23 2.32 2.28 2.18 2.23 2.32 2.05 2.21 2.2 2.28 2.31 2.25 2.11 2.07 2.21 2.23 2.06 2.15 2.4 2.42 2.22 2.1
REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING 2.11 2.2 2.28 2.26 2.42 2.54 2.42 2.31 2.46 2.52 2.27 2.43 2.42 2.54 2.47 2.46 2.35 2.22 2.28 2.39 2.25 2.3 2.63 2.61 2.43 2.23
REACTOME_CD28_DEPENDENT_VAV1_PATHWAY 2.21 2.4 2.22 2.25 2.44 2.59 2.59 2.35 2.36 2.47 1.94 2.28 2.4 2.48 2.57 2.36 2.14 2.16 2.42 2.53 2.06 2.25 2.46 2.63 2.55 2.31
REACTOME_CTLA4_INHIBITORY_SIGNALING 2.04 2.1 2.35 2.24 2.29 2.39 2.39 2.35 2.34 2.38 2.29 2.26 2.35 2.39 2.43 2.32 2.22 2.1 2.14 2.34 2.2 2.32 2.47 2.47 2.42 2.27
REACTOME_GLYOXYLATE_METABOLISM_AND_GLYCINE_DEGRADATION 1.62 1.76 2.05 1.76 1.87 1.98 2 1.93 1.96 1.96 1.72 1.93 1.9 1.95 2.08 2.09 1.76 1.7 1.79 2.01 1.76 1.93 2.03 2.18 2.01 1.91
REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS 1.85 1.92 1.85 1.7 1.99 1.97 1.94 1.88 1.88 1.93 1.77 1.88 1.91 1.88 1.89 1.85 1.94 1.94 1.85 1.84 1.88 1.87 1.92 1.92 1.92 1.81
REACTOME_PD_1_SIGNALING 2.11 1.97 2.34 2.14 2.31 2.27 1.98 1.89 1.9 1.93 2.01 1.94 2.15 2.2 2.05 2.19 2.3 2.03 2.08 2.21 2.33 2.42 2.38 2.41 1.95 2.01
REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING 2.46 2.51 2.61 2.6 2.59 2.66 2.57 2.52 2.63 2.65 2.5 2.62 2.6 2.59 2.56 2.6 2.43 2.46 2.56 2.65 2.45 2.39 2.59 2.72 2.63 2.45
REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC 2.46 2.53 2.75 2.73 2.63 2.72 2.66 2.62 2.73 2.77 2.57 2.72 2.65 2.64 2.65 2.71 2.44 2.52 2.6 2.73 2.48 2.39 2.71 2.87 2.72 2.44
REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY 2.57 2.78 2.82 2.79 2.67 2.87 2.8 2.79 2.82 2.86 2.7 2.91 2.75 2.73 2.77 2.77 2.61 2.59 2.69 2.85 2.68 2.48 2.78 2.97 2.88 2.63
REACTOME_FOLDING_OF_ACTIN_BY_CCT_TRIC 2.69 2.44 2.4 2.49 2.66 2.57 2.52 2.31 2.56 2.44 2.33 2.35 2.49 2.5 2.51 2.4 2.32 2.52 2.56 2.51 2.4 2.37 2.45 2.44 2.38 2.34
REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS 1.78 1.77 2.02 2.01 1.93 1.99 1.96 1.82 1.96 1.99 1.86 1.91 2.01 2 1.93 1.99 1.84 1.87 1.92 1.97 1.86 1.88 2.01 2.12 1.96 1.87
REACTOME_STRIATED_MUSCLE_CONTRACTION 1.89 1.88 1.97 1.78 2.02 2.13 2.02 1.94 1.95 2.04 1.95 2.12 2.06 2.07 1.99 1.95 1.97 1.91 2.06 2.06 1.86 1.94 2.45 2.2 2.11 2.04
REACTOME_SEROTONIN_RECEPTORS 1.99 2.08 2.03 1.84 2.02 2.35 2.16 2.1 2.18 2.17 2.1 2.19 2.26 2.4 2.06 2.21 1.47 2.02 2.08 2.27 1.73 2.12 2.31 2.27 2.26 2.09
REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS 1.33 1.31 1.47 1.21 1.7 1.72 1.59 1.54 1.61 1.57 1.36 1.51 1.67 1.71 1.5 1.54 1.5 1.37 1.46 1.62 1.41 1.51 1.65 1.72 1.6 1.54
REACTOME_PEROXISOMAL_LIPID_METABOLISM 1.38 1.57 1.82 1.6 1.75 1.75 1.65 1.56 1.71 1.73 1.69 1.68 1.73 1.69 1.66 1.71 1.64 1.56 1.62 1.69 1.56 1.68 1.78 1.8 1.76 1.71
REACTOME_SIGNAL_REGULATORY_PROTEIN_FAMILY_INTERACTIONS 1.91 2.04 2.34 2.06 2.36 2.39 2.18 2.14 2.3 2.37 2.22 2.18 2.39 2.3 2.21 2.27 2.05 2.06 2.32 2.23 2.08 2.13 2.38 2.44 2.22 2.2
REACTOME_PROTEIN_FOLDING 2.22 2.27 2.28 2.23 2.33 2.36 2.33 2.28 2.34 2.3 2.24 2.26 2.36 2.35 2.32 2.36 2.25 2.27 2.34 2.37 2.23 2.26 2.33 2.42 2.34 2.22
REACTOME_EICOSANOID_LIGAND_BINDING_RECEPTORS 0.96 0.86 0.82 0.97 1.3 1.33 0.96 0.95 1.27 1.09 1.04 1.04 1.72 1.63 1.13 1.17 1.58 1.44 1.04 1.38 1.05 1.14 1.11 1.34 1.77 1.83
REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE 2.42 2.43 2.56 2.16 2.75 2.76 2.74 2.65 2.64 2.54 2.54 2.63 2.65 2.7 2.64 2.69 2.31 2.33 2.65 2.75 2.46 2.65 2.56 2.81 2.54 2.42
REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_12 2.45 2.45 2.23 2.07 2.54 2.44 2.51 2.55 2.54 2.43 2.37 2.3 2.54 2.49 2.58 2.5 2.46 2.52 2.53 2.52 2.34 2.49 2.53 2.53 2.46 2.4
REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA 2.62 2.69 2.47 2.38 2.74 2.71 2.74 2.65 2.75 2.7 2.65 2.58 2.74 2.73 2.75 2.7 2.74 2.72 2.71 2.74 2.58 2.71 2.8 2.79 2.7 2.55
REACTOME_RAP1_SIGNALLING 2.4 2.5 2.54 2.53 2.53 2.59 2.53 2.46 2.55 2.59 2.64 2.48 2.59 2.65 2.53 2.53 2.3 2.24 2.48 2.52 2.19 2.38 2.51 2.44 2.51 2.37
REACTOME_SIGNAL_AMPLIFICATION 2.29 2.33 2.15 2.01 2.47 2.42 2.37 2.37 2.46 2.36 2.25 2.29 2.42 2.4 2.44 2.41 2.34 2.37 2.43 2.42 2.23 2.37 2.47 2.5 2.34 2.27
REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR 2.58 2.65 2.37 2.24 2.68 2.56 2.63 2.7 2.6 2.54 2.5 2.47 2.66 2.65 2.72 2.66 2.71 2.68 2.74 2.7 2.51 2.66 2.62 2.62 2.64 2.56
REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING 2.33 2.33 2.14 2.22 2.3 2.33 2.33 2.18 2.26 2.21 2.21 2.19 2.21 2.16 2.21 2.1 2.19 2.11 2.38 2.32 2.07 2.12 2.27 2.25 2.17 2.12
REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE 1.79 1.94 2.01 1.89 2.04 2.16 2.12 2.13 2.02 2.05 2.03 2.06 2.12 2.02 2.15 2.14 2.03 1.9 2.03 2.07 1.94 2.18 2.28 2.13 2.16 2.15
REACTOME_EPHRIN_SIGNALING 2.05 2.01 1.74 1.61 2.02 2.07 1.96 1.83 1.76 1.87 1.72 1.94 1.83 1.82 1.79 1.69 1.85 1.88 2.12 2.06 1.8 1.86 1.94 2.01 1.78 1.68
REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS 2.27 2.31 2.25 2.22 2.36 2.44 2.43 2.41 2.35 2.37 2.23 2.32 2.36 2.32 2.39 2.32 2.27 2.22 2.4 2.43 2.18 2.29 2.43 2.47 2.39 2.33
REACTOME_MUSCLE_CONTRACTION 2.17 2.28 2.38 2.15 2.44 2.53 2.43 2.45 2.38 2.44 2.28 2.42 2.48 2.5 2.44 2.48 2.29 2.28 2.44 2.53 2.31 2.43 2.54 2.6 2.42 2.38
REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING 2.56 2.62 2.49 2.4 2.68 2.68 2.69 2.65 2.7 2.62 2.62 2.56 2.68 2.69 2.72 2.68 2.66 2.62 2.69 2.71 2.51 2.65 2.76 2.77 2.66 2.52
REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS 1.66 1.62 1.54 1.38 1.72 1.71 1.6 1.53 1.5 1.51 1.69 1.47 1.67 1.61 1.45 1.61 1.54 1.68 1.63 1.62 1.75 1.65 1.54 1.54 1.55 1.56
REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION 2.61 2.49 2.51 2.51 2.52 2.46 2.63 2.51 2.45 2.4 2.44 2.5 2.34 2.23 2.48 2.55 2.51 2.56 2.5 2.43 2.56 2.53 2.48 2.44 2.49 2.47
REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION 1.43 1.43 1.29 1.16 1.41 1.41 1.42 1.24 1.28 1.28 1.26 1.53 1.33 1.21 1.28 1.28 1.51 1.29 1.54 1.45 1.34 1.32 1.44 1.36 1.38 1.26
REACTOME_CRMPS_IN_SEMA3A_SIGNALING 1.92 1.94 2.01 1.87 1.99 2.07 2.02 1.88 1.93 1.91 1.89 1.98 1.95 1.88 1.9 1.95 1.91 1.87 2.01 1.93 1.7 1.8 1.94 1.94 1.93 1.87
REACTOME_ACETYLCHOLINE_REGULATES_INSULIN_SECRETION 2.47 2.56 2.29 2.04 2.7 2.75 2.58 2.41 2.74 2.52 2.36 2.65 2.6 2.69 2.39 2.61 2.66 2.48 2.75 2.58 2.39 2.45 2.73 2.81 2.49 2.31
REACTOME_ADRENALINE_NORADRENALINE_INHIBITS_INSULIN_SECRETION 2.29 2.34 2.15 1.91 2.39 2.34 2.35 2.33 2.39 2.29 2.25 2.22 2.4 2.39 2.34 2.37 2.3 2.41 2.42 2.43 2.23 2.32 2.39 2.43 2.32 2.27
REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA 1.68 1.75 1.76 1.64 1.95 2 1.88 1.8 1.91 1.88 1.66 1.77 1.89 1.93 1.77 1.81 1.76 1.7 1.82 1.85 1.67 1.77 1.91 1.95 1.9 1.78
REACTOME_CIRCADIAN_CLOCK 1.81 1.87 1.95 1.89 2 2 1.96 1.83 1.93 1.9 1.86 1.9 1.89 1.93 1.83 1.86 1.8 1.8 1.91 1.94 1.73 1.76 1.91 1.88 1.82 1.8
REACTOME_FREE_FATTY_ACIDS_REGULATE_INSULIN_SECRETION 2.48 2.6 2.51 2.31 2.81 2.82 2.62 2.54 2.77 2.52 2.51 2.7 2.67 2.77 2.53 2.55 2.62 2.45 2.78 2.7 2.37 2.57 2.87 2.99 2.64 2.4
REACTOME_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION 1.75 2.06 2.38 2.55 2.28 2.37 2.39 2.34 2.26 2.43 2.29 2.21 2.51 2.48 2.43 2.53 2.34 2 2.21 2.42 2.21 2.45 2.47 2.45 2.5 2.43
REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLUCOSE_DEPENDENT_INSULINOTROPIC_POLYPEPTIDE_GIP 1.69 2.06 2.56 2.59 2.21 2.38 2.32 2.39 2.18 2.43 2.33 2.33 2.4 2.46 2.53 2.62 2.31 2.1 2.25 2.45 2.32 2.54 2.42 2.38 2.52 2.51
REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING 1.69 1.82 2 2.18 1.81 1.78 1.78 1.7 1.76 1.67 1.9 1.73 1.67 1.63 1.73 1.8 1.83 1.62 1.83 1.86 1.85 1.89 1.93 1.77 1.67 1.75
REACTOME_SIALIC_ACID_METABOLISM 1.72 1.73 1.78 1.65 1.9 1.9 1.83 1.73 1.82 1.8 1.71 1.77 1.78 1.74 1.74 1.79 1.64 1.72 1.84 1.82 1.63 1.67 1.77 1.84 1.8 1.69
REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS 1.48 1.54 1.58 1.64 1.56 1.67 1.66 1.62 1.54 1.6 1.35 1.47 1.58 1.67 1.6 1.57 1.36 1.47 1.45 1.58 1.32 1.53 1.6 1.64 1.62 1.46
REACTOME_CA2_PATHWAY 2.38 2.45 2.48 2.31 2.62 2.68 2.59 2.58 2.56 2.58 2.45 2.54 2.61 2.63 2.64 2.6 2.39 2.47 2.6 2.64 2.38 2.53 2.64 2.74 2.56 2.45
REACTOME_PCP_CE_PATHWAY 2.08 2.18 2.2 2.07 2.24 2.31 2.27 2.23 2.23 2.21 2.08 2.16 2.23 2.18 2.16 2.17 2.1 2.1 2.21 2.29 2.21 2.26 2.29 2.32 2.18 2.13
REACTOME_SUMOYLATION_OF_INTRACELLULAR_RECEPTORS 1.7 1.74 1.94 1.85 1.9 2.05 1.88 1.86 1.88 1.84 1.77 1.89 1.92 1.96 1.89 1.87 1.81 1.84 1.8 1.92 1.78 1.95 1.99 2.15 2.01 1.94
REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS 2.01 2.06 2.21 2.07 2.32 2.38 2.29 2.24 2.28 2.26 2.16 2.24 2.36 2.38 2.29 2.31 2.14 2.09 2.27 2.33 2.11 2.25 2.37 2.44 2.27 2.19
REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS 1.94 2 2.1 1.92 2.21 2.18 2.17 2.13 2.15 2.12 2.06 2.13 2.2 2.16 2.17 2.14 2.1 2.04 2.07 2.17 2.03 2.18 2.2 2.22 2.19 2.08
REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE 1.48 1.7 1.94 2.07 1.69 1.71 1.6 1.65 1.65 1.59 1.84 1.52 1.59 1.55 1.58 1.63 1.67 1.47 1.58 1.61 1.6 1.67 1.73 1.64 1.55 1.65
REACTOME_OTHER_SEMAPHORIN_INTERACTIONS 1.25 1.35 1.3 1.13 1.63 1.6 1.7 1.62 1.5 1.53 1.17 1.66 1.66 1.58 1.49 1.41 1.6 1.37 1.3 1.49 1.39 1.25 1.53 1.53 1.54 1.49
REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS 1.84 1.8 1.71 1.39 1.85 1.89 1.78 1.62 1.7 1.6 1.71 1.49 1.88 1.81 1.57 1.7 1.64 1.74 1.83 1.7 1.74 1.73 1.74 1.65 1.71 1.6
REACTOME_P2Y_RECEPTORS 1.16 1.1 1.87 1.42 1.65 1.58 1.43 1.46 1.81 1.58 1.55 1.38 1.9 1.89 1.59 1.72 1.58 1.51 1.37 1.64 1.2 1.62 1.73 1.76 1.87 1.88
REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS 1.52 1.4 1.95 1.5 1.74 1.66 1.67 1.69 1.87 1.79 1.57 1.59 1.88 1.85 1.69 1.79 1.52 1.56 1.63 1.83 1.44 1.7 1.79 1.89 1.8 1.78
REACTOME_PLATELET_HOMEOSTASIS 2.28 2.32 2.36 2.12 2.48 2.5 2.43 2.42 2.43 2.41 2.32 2.38 2.47 2.48 2.46 2.49 2.29 2.3 2.46 2.51 2.27 2.43 2.47 2.58 2.44 2.33
REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS 2.71 2.66 2.64 2.31 2.82 2.79 2.61 2.48 2.7 2.67 2.65 2.69 2.74 2.76 2.46 2.79 2.49 2.62 2.67 2.61 2.54 2.52 2.67 2.84 2.57 2.55
REACTOME_PLATELET_CALCIUM_HOMEOSTASIS 2.38 2.39 2.35 2.11 2.52 2.62 2.43 2.4 2.5 2.57 2.3 2.47 2.57 2.6 2.42 2.62 2.33 2.32 2.55 2.56 2.32 2.4 2.64 2.75 2.47 2.42
REACTOME_CGMP_EFFECTS 2.64 2.66 2.74 2.33 2.94 2.94 2.94 2.84 2.83 2.7 2.71 2.79 2.81 2.91 2.81 2.9 2.48 2.45 2.86 2.94 2.57 2.81 2.71 2.97 2.76 2.59
REACTOME_G_ALPHA_S_SIGNALLING_EVENTS 1.95 1.98 2.1 1.9 2.24 2.27 2.22 2.19 2.19 2.2 2.09 2.17 2.27 2.29 2.25 2.26 2.05 2.04 2.22 2.32 2.02 2.22 2.22 2.34 2.2 2.16
REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_1 2.48 2.54 2.24 2.18 2.61 2.56 2.54 2.5 2.59 2.51 2.45 2.44 2.57 2.56 2.6 2.56 2.55 2.59 2.64 2.6 2.39 2.55 2.62 2.65 2.52 2.4
REACTOME_G_ALPHA_I_SIGNALLING_EVENTS 2.24 2.3 2.5 2.26 2.58 2.65 2.59 2.51 2.57 2.53 2.36 2.47 2.6 2.61 2.55 2.57 2.32 2.32 2.52 2.64 2.3 2.46 2.6 2.68 2.52 2.42
REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS 2.24 2.3 2.22 2 2.42 2.4 2.42 2.43 2.38 2.31 2.28 2.29 2.44 2.47 2.39 2.41 2.34 2.4 2.44 2.5 2.26 2.31 2.42 2.46 2.33 2.29
REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING 1.76 1.74 1.29 1.73 1.77 1.76 1.58 1.49 1.54 1.5 1.43 1.75 1.6 1.42 1.35 1.5 1.51 1.51 1.81 1.79 1.53 1.6 1.6 1.74 1.38 1.55
REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN_1_SIGNALING 2.09 2.12 2.23 2.42 2.35 2.51 2.33 2.28 2.23 2.38 2.16 2.27 2.42 2.49 2.15 2.32 2.06 2.15 2.29 2.34 2.12 2.18 2.45 2.46 2.39 2.14
REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS 2.3 2.24 2.3 2.3 2.41 2.39 2.3 2.27 2.37 2.38 2.42 2.26 2.42 2.44 2.23 2.42 2.28 2.16 2.35 2.34 2.25 2.35 2.43 2.44 2.37 2.32
REACTOME_NCAM1_INTERACTIONS 2.01 2.14 2.15 1.91 2.28 2.43 2.28 2.32 2.24 2.31 2.09 2.35 2.31 2.32 2.31 2.3 2.06 2.05 2.28 2.4 2.13 2.24 2.34 2.53 2.32 2.29
REACTOME_CALCITONIN_LIKE_LIGAND_RECEPTORS 0.91 0.89 1.7 1.49 1.23 1.31 1.16 1.25 1.31 1.38 1.34 1.23 1.34 1.32 1.28 1.47 1.18 1.11 1.19 1.42 1.25 1.55 1.53 1.48 1.43 1.43
REACTOME_TIGHT_JUNCTION_INTERACTIONS 1.63 1.65 1.77 1.53 1.93 1.9 1.83 1.84 1.82 1.83 1.7 1.74 1.84 1.84 1.73 1.82 1.72 1.46 1.75 1.87 1.58 1.69 1.89 2 1.89 1.89
REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS 2.3 2.37 2.47 2.22 2.56 2.56 2.56 2.58 2.53 2.49 2.48 2.42 2.62 2.64 2.67 2.61 2.57 2.47 2.58 2.68 2.42 2.67 2.55 2.6 2.67 2.6
REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS 1.83 1.9 1.94 1.82 2.05 2.24 2.19 2.07 2.08 2.1 1.85 2.01 2.18 2.18 2.18 2.11 1.81 1.96 2.06 2.11 1.86 1.99 2.1 2.18 2.03 1.98
REACTOME_CELL_CELL_JUNCTION_ORGANIZATION 2.15 2.14 2.23 2.1 2.41 2.44 2.36 2.28 2.32 2.36 2.22 2.24 2.4 2.41 2.28 2.33 2.15 2 2.29 2.34 2.15 2.25 2.42 2.5 2.36 2.3
REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN 1.51 1.72 2.16 1.94 1.99 1.96 1.91 2.1 1.89 2.01 1.95 1.98 1.98 2.05 2.14 2.11 1.81 1.77 2 2.12 1.87 2.15 2.04 2.14 2.12 2.17
REACTOME_REGULATION_OF_INSULIN_SECRETION 2.31 2.41 2.33 2.19 2.54 2.55 2.45 2.4 2.5 2.41 2.32 2.44 2.49 2.53 2.43 2.44 2.4 2.44 2.54 2.55 2.31 2.42 2.53 2.61 2.49 2.39
REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS 1.63 1.64 1.91 1.72 1.97 2.06 1.84 1.79 1.98 1.98 1.78 1.93 1.95 1.97 1.74 1.76 1.84 1.63 1.78 1.89 1.7 1.86 1.97 2.06 1.99 1.94
REACTOME_BICARBONATE_TRANSPORTERS 2.07 2.14 2.45 2.09 2.19 2.5 2.39 2.16 2.3 2.03 2.17 2.23 2.54 2.52 2.2 2.29 2.02 2.45 2.42 2.38 2.27 2.39 2.35 2.62 2.2 2.1
REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES 2.01 2.08 2.22 2.08 2.34 2.45 2.32 2.21 2.32 2.26 2.12 2.19 2.44 2.45 2.26 2.29 2.11 2.1 2.26 2.32 2.15 2.26 2.41 2.48 2.31 2.22
REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES 1.86 1.94 2.08 1.98 2.21 2.29 2.1 2 2.12 2.1 1.95 2.1 2.18 2.16 1.98 1.95 1.93 1.73 1.97 2.14 1.78 1.95 2.23 2.23 2.04 1.95
REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT 1.87 1.93 2.1 1.95 2.18 2.29 2.13 2.05 2.18 2.15 1.98 2.09 2.24 2.26 2.07 2.07 1.99 1.9 2.06 2.16 1.96 2.1 2.24 2.31 2.18 2.09
REACTOME_METAL_ION_SLC_TRANSPORTERS 1.26 1.27 1.79 1.68 1.52 1.64 1.49 1.37 1.66 1.57 1.48 1.4 1.58 1.62 1.28 1.46 1.32 1.23 1.48 1.43 1.19 1.39 1.7 1.75 1.61 1.62
REACTOME_ERCC6_CSB_AND_EHMT2_G9A_POSITIVELY_REGULATE_RRNA_EXPRESSION 1.66 1.56 1.72 1.64 1.66 1.72 1.63 1.57 1.76 1.6 1.61 1.59 1.6 1.6 1.63 1.53 1.49 1.53 1.61 1.78 1.54 1.51 1.66 1.63 1.6 1.6
REACTOME_SPHINGOLIPID_METABOLISM 1.79 1.81 1.95 1.86 2.01 2.03 2.02 1.93 2.04 1.98 1.93 2 2.02 1.99 1.92 1.91 1.82 1.73 1.89 2.01 1.8 1.9 2.04 2.08 2.02 1.94
REACTOME_ACTIVATION_OF_RAC1 1.73 1.64 1.11 1.51 1.76 1.74 1.62 1.42 1.66 1.69 1.35 1.69 1.55 1.43 1.48 1.45 1.35 1.4 1.78 1.64 1.41 1.45 1.78 1.75 1.26 1.32
REACTOME_ORGANIC_ANION_TRANSPORTERS 1.89 1.85 2.09 2.26 2.14 2.28 2.03 1.98 2 1.97 2.06 1.92 2.32 2.29 2.26 1.94 2.02 1.98 2.11 2.16 1.93 2.01 2.27 2.29 2.06 1.96
REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR 2.52 2.58 2.29 2.14 2.64 2.61 2.55 2.52 2.61 2.54 2.4 2.48 2.59 2.6 2.6 2.59 2.54 2.61 2.66 2.6 2.43 2.57 2.64 2.69 2.52 2.41
REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY 1.5 1.55 1.54 1.58 1.53 1.59 1.63 1.45 1.63 1.59 1.47 1.46 1.56 1.57 1.6 1.49 1.45 1.36 1.57 1.49 1.37 1.35 1.68 1.66 1.57 1.38
REACTOME_DEADENYLATION_OF_MRNA 1.59 1.66 1.92 1.83 1.51 1.61 1.78 1.6 1.91 1.8 1.67 1.52 1.76 1.7 1.86 1.76 1.55 1.45 1.61 1.56 1.41 1.36 1.97 1.97 1.79 1.42
REACTOME_MRNA_DECAY_BY_3_TO_5_EXORIBONUCLEASE 1.16 1.06 1.14 1.15 1.38 1.24 1.3 1.07 1.15 1.23 1.09 1.11 1.14 1.31 1.18 1.13 0.97 0.94 1.23 1.15 0.88 0.96 1.19 1.08 1.02 1.04
REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE 1.69 1.82 1.38 1.64 1.67 1.81 1.72 1.53 1.68 1.59 1.56 1.65 1.63 1.59 1.61 1.44 1.62 1.56 1.81 1.64 1.6 1.58 1.75 1.74 1.69 1.55
REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING 2.23 2.34 2.28 2.27 2.57 2.62 2.36 2.41 2.47 2.61 2.47 2.5 2.53 2.55 2.56 2.42 2.39 2.14 2.6 2.63 2.2 2.41 2.74 2.79 2.46 2.5
REACTOME_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS 2.39 2.52 2.45 2.22 2.63 2.61 2.54 2.53 2.62 2.49 2.44 2.47 2.64 2.66 2.59 2.6 2.46 2.48 2.6 2.64 2.41 2.55 2.64 2.67 2.59 2.5
REACTOME_PASSIVE_TRANSPORT_BY_AQUAPORINS 1.99 2.16 2.54 2.1 2.22 2.31 2.1 2.19 2.26 2.27 2.11 2.17 2.37 2.35 2.23 2.48 2.36 2.15 2.19 2.37 2.62 2.7 2.45 2.52 2.45 2.47
REACTOME_PLATELET_SENSITIZATION_BY_LDL 1.81 1.9 2.05 1.96 2.02 2.13 2.01 2.04 2.06 1.99 2 1.99 2.06 2 2.13 1.97 1.76 1.95 1.96 2.07 1.82 2.02 2.1 2.13 2.04 1.86
REACTOME_LYSOSOME_VESICLE_BIOGENESIS 2.31 2.31 2.25 2.09 2.27 2.25 2.39 2.23 2.4 2.34 2.16 2.29 2.28 2.36 2.28 2.29 2.28 2.28 2.3 2.39 2.18 2.12 2.38 2.4 2.26 2.16
REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS 2.08 2.08 2.04 1.97 2.06 2.15 2.13 2.06 2.13 2.1 1.96 2.05 2.14 2.18 2.05 2.02 2.01 2.01 2.12 2.19 1.97 1.93 2.12 2.12 2.01 1.92
REACTOME_ZINC_TRANSPORTERS 1.28 1.28 1.99 1.84 1.64 1.73 1.55 1.52 1.76 1.64 1.67 1.45 1.69 1.72 1.3 1.6 1.38 1.28 1.51 1.49 1.22 1.55 1.83 1.8 1.58 1.56
REACTOME_RECYCLING_PATHWAY_OF_L1 2.44 2.54 2.5 2.46 2.53 2.63 2.52 2.52 2.57 2.6 2.53 2.56 2.55 2.52 2.58 2.56 2.46 2.42 2.5 2.59 2.51 2.45 2.59 2.71 2.64 2.5
REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION 1.85 1.77 1.92 1.63 1.94 2.02 1.86 1.78 1.75 1.86 1.86 1.84 1.89 1.93 1.81 1.9 1.67 1.99 1.93 1.93 1.85 1.87 1.84 1.92 1.82 1.75
REACTOME_DEPOLYMERISATION_OF_THE_NUCLEAR_LAMINA 2.02 2.04 2.11 1.81 2.35 2.48 2.44 2.37 2.47 2.21 2.2 2.21 2.45 2.41 2.48 2.33 2.14 2.18 2.33 2.44 2.19 2.27 2.48 2.39 2.27 2.07
REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS 1.87 1.92 1.94 1.78 2.26 2.29 2.17 2.15 2.16 2.22 1.8 2.2 2.23 2.25 1.99 2.04 2.1 1.91 2.07 2.27 2.05 2.21 2.07 2.17 2.12 2.16
REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_ADENYLATE_CYCLASE 2.13 2.38 2.2 2.12 2.37 2.39 2.29 2.15 2.42 2.21 2.18 2.28 2.38 2.44 2.22 2.18 1.89 1.98 2.43 2.31 1.61 1.82 2.38 2.26 2.18 2.12
REACTOME_CREB1_PHOSPHORYLATION_THROUGH_NMDA_RECEPTOR_MEDIATED_ACTIVATION_OF_RAS_SIGNALING 1.86 1.87 1.81 1.72 1.99 2.03 1.85 1.83 1.85 1.86 1.89 1.93 1.88 1.92 1.87 1.86 1.68 1.94 2.04 1.96 1.93 1.9 1.87 2.03 1.84 1.74
REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS 2.2 2.28 2.23 2.07 2.4 2.47 2.3 2.25 2.28 2.28 2.2 2.32 2.32 2.33 2.23 2.27 2.07 2.2 2.37 2.37 2.16 2.19 2.34 2.44 2.26 2.15
REACTOME_RAS_ACTIVATION_UPON_CA2_INFLUX_THROUGH_NMDA_RECEPTOR 1.84 1.84 1.87 1.79 2.08 2.11 1.91 1.92 1.9 1.92 1.91 1.97 1.95 1.99 1.87 1.88 1.65 1.96 2.1 2.05 1.95 1.98 1.9 2.02 1.85 1.77
REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS 2.56 2.58 2.63 2.45 2.77 2.82 2.81 2.75 2.75 2.72 2.62 2.69 2.8 2.8 2.83 2.74 2.57 2.53 2.72 2.82 2.64 2.77 2.81 2.93 2.79 2.72
REACTOME_SIGNAL_TRANSDUCTION_BY_L1 2.44 2.55 2.4 2.41 2.51 2.64 2.54 2.44 2.54 2.58 2.46 2.64 2.45 2.45 2.47 2.48 2.31 2.34 2.64 2.64 2.39 2.45 2.46 2.64 2.44 2.32
REACTOME_SMOOTH_MUSCLE_CONTRACTION 1.77 1.92 2 1.89 1.98 2.08 2.1 2.09 2.01 2.08 1.95 2.05 1.98 1.93 2.13 2.14 1.96 1.84 1.93 2.07 2.15 2.14 2.4 2.12 2.04 2
REACTOME_AQUAPORIN_MEDIATED_TRANSPORT 2.36 2.47 2.51 2.22 2.67 2.64 2.56 2.57 2.62 2.55 2.47 2.53 2.68 2.71 2.62 2.66 2.47 2.46 2.62 2.7 2.41 2.58 2.65 2.74 2.63 2.53
REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX 2.53 2.46 2.74 2.65 2.81 2.79 2.7 2.72 2.66 2.69 2.71 2.71 2.73 2.68 2.66 2.65 2.68 2.56 2.53 2.62 2.67 2.77 2.7 2.81 2.61 2.62
REACTOME_TYPE_I_HEMIDESMOSOME_ASSEMBLY 1.78 1.67 1.61 1.35 2.27 2.32 1.9 1.62 1.93 2.03 1.67 1.99 2.14 2.12 1.77 1.73 1.99 1.61 1.98 1.89 1.84 2.06 1.96 1.92 1.95 1.97
REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN 1.5 1.52 1.63 1.55 1.6 1.64 1.61 1.51 1.58 1.53 1.51 1.47 1.54 1.48 1.49 1.48 1.41 1.41 1.57 1.62 1.4 1.41 1.55 1.62 1.51 1.4
REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION 1.95 1.99 2.08 1.99 2.08 2.15 2.11 2.08 2.11 2.1 2 2.06 2.07 2.08 2.07 2.08 1.98 1.93 2.06 2.13 1.98 2.02 2.14 2.2 2.08 2.02
REACTOME_SYNTHESIS_OF_SUBSTRATES_IN_N_GLYCAN_BIOSYTHESIS 1.55 1.56 1.7 1.6 1.65 1.69 1.65 1.57 1.63 1.61 1.58 1.55 1.62 1.57 1.55 1.55 1.48 1.51 1.61 1.66 1.47 1.48 1.61 1.69 1.58 1.47
REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS 2.13 2.13 2.26 2.14 2.05 2.19 2.18 2.1 2.14 2.15 2.21 2.1 2.15 2.19 2.27 2.18 1.91 2.01 2.19 2.14 2.11 2.09 2.23 2.26 2.06 1.97
REACTOME_INTERLEUKIN_1_FAMILY_SIGNALING 1.93 1.98 2.29 2.13 2.22 2.3 2.28 2.21 2.27 2.25 2.16 2.15 2.27 2.23 2.26 2.21 2.04 2.01 2.1 2.23 2.07 2.22 2.31 2.37 2.18 2.11
REACTOME_CELL_JUNCTION_ORGANIZATION 1.99 1.98 2.06 1.91 2.26 2.3 2.17 2.1 2.17 2.19 2.05 2.13 2.25 2.25 2.1 2.14 2.05 1.88 2.14 2.18 2.04 2.12 2.3 2.32 2.21 2.15
REACTOME_INTERLEUKIN_12_FAMILY_SIGNALING 2.49 2.56 2.65 2.45 2.76 2.8 2.71 2.6 2.74 2.7 2.58 2.58 2.77 2.75 2.64 2.74 2.6 2.5 2.63 2.74 2.56 2.67 2.72 2.78 2.68 2.61
REACTOME_INTERLEUKIN_17_SIGNALING 2.17 2.27 2.33 2.16 2.36 2.44 2.35 2.35 2.34 2.37 2.38 2.38 2.33 2.36 2.41 2.35 2.21 2.23 2.28 2.35 2.24 2.33 2.39 2.49 2.36 2.28
REACTOME_SIGNALING_BY_INTERLEUKINS 2.05 2.13 2.33 2.17 2.38 2.45 2.37 2.31 2.37 2.39 2.26 2.31 2.4 2.4 2.36 2.35 2.22 2.14 2.27 2.37 2.17 2.32 2.42 2.51 2.35 2.27
REACTOME_OTHER_INTERLEUKIN_SIGNALING 2.18 2.15 2.06 2.07 2.28 2.4 2.3 2.17 2.24 2.26 2.1 2.27 2.39 2.37 2.19 2.26 2.25 2.38 2.41 2.4 2.05 2.11 2.24 2.42 2.2 2.1
REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES 2.07 2.13 2 1.9 2.18 2.28 2.13 2.12 2.11 2.18 2.29 2.33 2.01 2.07 2.05 2.01 2.07 2.02 2.07 2.15 1.93 1.88 2.07 2.18 2.15 2.02
REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION 2.41 2.43 2.62 2.53 2.57 2.58 2.43 2.46 2.41 2.48 2.61 2.5 2.52 2.49 2.53 2.58 2.49 2.48 2.47 2.43 2.54 2.64 2.52 2.65 2.48 2.55
REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1 2.54 2.56 2.75 2.64 2.7 2.71 2.52 2.61 2.54 2.61 2.68 2.62 2.68 2.67 2.75 2.77 2.62 2.58 2.57 2.53 2.66 2.81 2.64 2.77 2.65 2.68
REACTOME_ACTIVATION_OF_THE_AP_1_FAMILY_OF_TRANSCRIPTION_FACTORS 2.36 2.44 2.26 2.06 2.71 2.74 2.49 2.32 2.48 2.39 2.64 2.6 2.24 2.31 2.15 2.07 2.46 2.39 2.49 2.53 1.97 1.84 2.28 2.61 2.52 2.1
REACTOME_BUTYRATE_RESPONSE_FACTOR_1_BRF1_BINDS_AND_DESTABILIZES_MRNA 1.57 1.57 1.37 1.28 1.55 1.61 1.64 1.54 1.49 1.59 1.39 1.51 1.55 1.59 1.57 1.53 1.55 1.53 1.48 1.51 1.72 1.64 1.57 1.53 1.45 1.44
REACTOME_AUF1_HNRNP_D0_BINDS_AND_DESTABILIZES_MRNA 2.15 2.1 2.12 2.02 2.19 2.2 2.16 2.09 2.14 2.07 2.01 2.1 2.17 2.06 2.12 2.14 2.07 2.12 2.16 2.23 2.32 2.3 2.18 2.19 2.05 2.07
REACTOME_TRISTETRAPROLIN_TTP_ZFP36_BINDS_AND_DESTABILIZES_MRNA 1.55 1.5 1.51 1.55 1.69 1.74 1.65 1.58 1.59 1.65 1.59 1.63 1.52 1.58 1.57 1.47 1.49 1.43 1.6 1.57 1.45 1.35 1.62 1.67 1.38 1.33
REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS 1.95 1.92 1.95 1.88 2.01 2.04 1.98 1.93 1.96 1.96 1.9 1.93 1.98 1.92 1.96 1.95 1.94 1.92 1.98 2.02 2.08 2.04 2.02 2.03 1.87 1.86
REACTOME_KSRP_KHSRP_BINDS_AND_DESTABILIZES_MRNA 1.59 1.59 1.49 1.51 1.58 1.55 1.54 1.58 1.41 1.57 1.49 1.41 1.42 1.51 1.53 1.45 1.59 1.38 1.59 1.54 1.57 1.5 1.57 1.61 1.46 1.37
REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS 1.52 1.7 1.72 1.92 1.52 1.63 1.53 1.38 1.62 1.47 1.72 1.81 1.79 1.75 1.19 1.56 1.47 1.67 1.54 1.57 1.68 1.86 1.56 1.61 1.87 1.78
REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING 2.31 2.39 2.19 2.11 2.4 2.37 2.33 2.34 2.39 2.25 2.31 2.3 2.44 2.42 2.34 2.39 2.32 2.39 2.43 2.4 2.25 2.41 2.39 2.44 2.4 2.29
REACTOME_INTERLEUKIN_2_FAMILY_SIGNALING 1.79 1.92 2 1.92 2.22 2.32 2.19 2.11 2.18 2.2 2.01 2.16 2.29 2.29 2.11 2.09 2.02 1.93 2.09 2.16 1.85 2.06 2.26 2.3 2.13 2.06
REACTOME_TRANSCRIPTIONAL_REGULATION_OF_PLURIPOTENT_STEM_CELLS 2.06 2.16 2.04 1.72 2.45 2.53 2.39 2.28 2.36 2.32 2.07 2.29 2.52 2.51 2.31 2.33 2.33 2.17 2.36 2.45 2.16 2.23 2.48 2.56 2.48 2.37
REACTOME_MITOTIC_G2_G2_M_PHASES 2.1 2.16 2.42 2.26 2.32 2.39 2.39 2.29 2.37 2.34 2.24 2.21 2.33 2.33 2.34 2.33 2.16 2.09 2.23 2.34 2.15 2.25 2.36 2.42 2.31 2.19
REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION 1.83 1.89 2.2 2.09 2.07 2.16 2.11 2.04 2.13 2.12 2.04 2.01 2.12 2.1 2.12 2.09 1.92 1.88 1.97 2.09 1.97 2.12 2.17 2.17 2.06 1.99
REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS 1.57 1.63 1.62 1.62 1.66 1.75 1.7 1.61 1.64 1.67 1.49 1.58 1.66 1.72 1.66 1.57 1.57 1.61 1.6 1.67 1.46 1.55 1.74 1.74 1.63 1.5
REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS 2.63 2.74 2.51 2.37 2.82 2.79 2.76 2.68 2.74 2.78 2.61 2.65 2.78 2.79 2.76 2.76 2.76 2.75 2.83 2.79 2.64 2.74 2.83 2.89 2.78 2.61
REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS 1.7 1.75 1.65 1.7 1.76 1.86 1.79 1.73 1.7 1.77 1.51 1.69 1.75 1.83 1.69 1.63 1.63 1.75 1.72 1.78 1.54 1.66 1.77 1.8 1.72 1.63
REACTOME_ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS 1.93 1.97 2.15 1.99 2.06 2.13 2.15 2.06 2.09 2.07 1.97 2 2.07 2.01 2.02 2.06 1.91 1.94 2.01 2.09 2.05 2.13 2.12 2.12 2.04 2.02
REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS 1.65 1.82 1.84 1.8 1.89 1.97 1.89 1.82 1.78 1.87 1.57 1.78 1.85 1.92 1.85 1.86 1.63 1.62 1.67 1.78 1.57 1.75 1.87 1.97 1.86 1.71
REACTOME_DEGRADATION_OF_AXIN 1.91 1.88 2 1.9 2.02 2.06 2.05 1.95 2.04 1.93 1.89 1.94 2.04 1.93 1.96 1.98 1.84 1.88 1.96 2.05 2.08 2.09 2.03 2.07 1.94 1.94
REACTOME_DEGRADATION_OF_DVL 1.88 1.87 2.03 1.92 2 2.02 2 1.92 2.03 1.92 1.92 1.92 2.01 1.92 1.96 1.99 1.82 1.84 1.94 2.06 2.04 2.08 2.03 2.08 1.96 1.93
REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE 1.99 2.04 2.17 2.03 2.14 2.2 2.18 2.08 2.16 2.22 2.09 2.09 2.13 2.13 2.06 2.07 1.98 2.03 1.99 2.14 1.93 1.97 2.18 2.24 2.08 2.03
REACTOME_REGULATION_OF_FZD_BY_UBIQUITINATION 2.63 2.73 2.89 2.67 2.92 2.94 2.8 2.83 2.78 2.84 2.71 2.89 2.82 2.83 2.81 2.83 2.77 2.81 2.77 2.86 2.88 2.96 2.84 2.96 2.85 2.84
REACTOME_REPRESSION_OF_WNT_TARGET_GENES 1.51 1.67 1.57 1.25 1.77 1.94 1.71 1.73 1.75 1.67 1.5 1.61 1.81 1.86 1.72 1.57 1.53 1.65 1.74 1.83 1.62 1.71 1.69 1.87 1.71 1.61
REACTOME_SUMOYLATION_OF_DNA_METHYLATION_PROTEINS 1.83 1.88 1.67 1.73 1.95 2.04 1.88 1.8 1.71 1.87 1.65 1.78 1.9 1.92 1.81 1.67 1.83 1.86 1.94 1.92 1.71 1.84 1.86 1.86 1.85 1.8
REACTOME_SUMOYLATION_OF_IMMUNE_RESPONSE_PROTEINS 1.45 1.49 1.3 1.35 1.5 1.55 1.52 1.76 1.19 1.32 1.09 1.22 1.49 1.42 1.44 1.5 1.61 1.43 1.29 1.44 1.51 1.68 1.28 1.47 1.75 1.67
REACTOME_SIGNALING_BY_WNT_IN_CANCER 1.99 2.08 2.22 2.03 2.21 2.28 2.26 2.13 2.17 2.25 2.09 2.14 2.23 2.24 2.19 2.09 1.98 2.04 2.11 2.18 1.97 2.14 2.2 2.34 2.16 2.05
REACTOME_SIGNALING_BY_CTNNB1_PHOSPHO_SITE_MUTANTS 1.5 1.54 1.63 1.66 1.54 1.53 1.84 1.6 1.69 1.62 1.71 1.59 1.62 1.67 1.57 1.58 1.42 1.44 1.6 1.62 1.45 1.46 1.61 1.62 1.55 1.51
REACTOME_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES 1.73 1.83 2.3 2.07 1.86 1.99 1.99 1.88 2.07 1.99 2.05 1.88 2.04 1.98 2.03 2.03 1.83 1.8 1.85 1.89 1.87 2.04 2.06 2.04 1.99 1.8
REACTOME_PRESYNAPTIC_FUNCTION_OF_KAINATE_RECEPTORS 2.59 2.63 2.42 2.21 2.69 2.63 2.61 2.65 2.67 2.5 2.56 2.51 2.68 2.66 2.68 2.67 2.63 2.67 2.74 2.7 2.48 2.64 2.7 2.75 2.63 2.5
REACTOME_GPCR_LIGAND_BINDING 1.66 1.72 1.89 1.67 1.88 1.98 1.92 1.88 1.89 1.89 1.76 1.82 1.96 1.97 1.91 1.93 1.74 1.74 1.87 1.98 1.75 1.89 1.92 1.99 1.9 1.88
REACTOME_DEFECTIVE_GALNT3_CAUSES_FAMILIAL_HYPERPHOSPHATEMIC_TUMORAL_CALCINOSIS_HFTC 1.25 1.27 0.82 0.87 1.24 0.96 1.19 1.16 0.79 1.06 1.01 1.07 0.96 0.87 1.16 1.29 1.43 1.22 0.95 1 1.19 1.38 0.79 0.99 1.58 1.53
REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TN_POLYAGGLUTINATION_SYNDROME_TNPS 1.48 1.48 1.6 1.55 1.93 1.79 1.64 1.41 1.58 1.69 1.58 1.48 1.59 1.59 1.6 1.68 1.64 1.35 1.25 1.42 1.38 1.71 1.57 1.64 1.83 1.82
REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD4 2.02 2.08 2.06 1.88 2.19 2.25 2.28 2.12 2.21 2.22 2 2.07 2.16 2.22 2.14 2.17 1.95 2.08 2.18 2.21 1.9 1.96 2.28 2.22 2.07 1.9
REACTOME_INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING 2.27 2.36 2.44 2.38 2.56 2.64 2.55 2.57 2.52 2.56 2.47 2.53 2.59 2.63 2.54 2.53 2.46 2.36 2.56 2.56 2.36 2.55 2.63 2.72 2.5 2.45
REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD2_FZD5_AND_ROR2 2.4 2.46 2.6 2.38 2.59 2.65 2.59 2.72 2.59 2.67 2.37 2.5 2.58 2.54 2.56 2.55 2.47 2.44 2.51 2.72 2.45 2.58 2.64 2.71 2.6 2.49
REACTOME_O_LINKED_GLYCOSYLATION 1.3 1.33 1.52 1.39 1.68 1.72 1.57 1.56 1.63 1.63 1.4 1.49 1.69 1.71 1.56 1.6 1.44 1.37 1.53 1.61 1.35 1.53 1.68 1.75 1.6 1.55
REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS 1.08 1.15 1.27 1.05 1.48 1.52 1.38 1.39 1.49 1.4 1.14 1.35 1.52 1.54 1.27 1.34 1.31 1.2 1.33 1.46 1.22 1.24 1.51 1.56 1.35 1.32
REACTOME_MITOPHAGY 2.01 2.08 2.16 2.15 2.32 2.28 2.19 2.07 2.12 2.21 2.08 2.16 2.33 2.19 2.14 2.12 2.12 2.15 2.24 2.09 2.12 2.27 2.28 2.17 2.22 2.32
REACTOME_PINK1_PRKN_MEDIATED_MITOPHAGY 2.3 2.36 2.45 2.4 2.63 2.58 2.51 2.33 2.4 2.51 2.25 2.46 2.64 2.49 2.4 2.37 2.31 2.38 2.52 2.29 2.42 2.54 2.61 2.45 2.48 2.57
REACTOME_UPTAKE_AND_FUNCTION_OF_ANTHRAX_TOXINS 1.4 1.77 1.81 1.65 1.77 1.97 1.81 1.64 1.68 1.73 1.86 1.61 1.88 1.78 1.94 1.89 1.85 1.92 1.78 1.76 1.84 1.89 1.74 1.65 1.88 1.79
REACTOME_RIPK1_MEDIATED_REGULATED_NECROSIS 2.71 2.68 2.9 2.77 2.9 2.91 2.93 2.93 2.78 2.88 2.88 2.8 2.82 2.87 2.88 2.88 2.76 2.77 2.85 2.91 2.79 2.88 2.89 3.02 2.86 2.8
REACTOME_REGULATED_NECROSIS 2.4 2.37 2.57 2.47 2.56 2.62 2.6 2.59 2.5 2.57 2.53 2.5 2.52 2.56 2.56 2.58 2.44 2.47 2.52 2.55 2.47 2.54 2.57 2.71 2.56 2.51
REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY 2.1 2.14 2.14 2.24 2.21 2.21 2.2 2.12 2.26 2.29 2.12 2.17 2.13 2.14 2.25 2.29 2.06 2.08 2.16 2.06 2.06 2.06 2.41 2.35 2.11 1.99
REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION 1.95 1.93 1.99 1.89 1.96 2.07 2.01 1.97 1.97 1.99 2 2.1 1.94 2.03 1.98 2.03 1.9 2.14 2.18 2.06 2.08 2.01 2.02 2.11 2 1.99
REACTOME_MISCELLANEOUS_TRANSPORT_AND_BINDING_EVENTS 2.06 2.11 2.23 1.98 2.44 2.45 2.46 2.26 2.36 2.43 2.22 2.19 2.55 2.56 2.41 2.46 2.12 2.06 2.33 2.33 2 2.29 2.46 2.45 2.41 2.17
REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION 1.88 1.85 2.01 1.98 1.94 1.94 1.9 1.83 1.92 1.85 1.91 1.85 1.86 1.89 1.93 1.84 1.83 1.8 1.85 1.95 1.83 1.82 1.85 1.87 1.84 1.87
REACTOME_B_WICH_COMPLEX_POSITIVELY_REGULATES_RRNA_EXPRESSION 2.02 2 2.19 2.12 2.09 2.06 2.05 1.98 2.01 1.98 2.08 1.99 2 2.05 2.1 2.02 2.02 1.94 1.98 2.05 1.98 2 1.95 2 1.98 2.03
REACTOME_NEGATIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION 1.4 1.46 1.7 1.6 1.55 1.56 1.51 1.57 1.51 1.55 1.65 1.56 1.54 1.55 1.62 1.64 1.52 1.43 1.46 1.57 1.47 1.61 1.61 1.58 1.57 1.62
REACTOME_MYOGENESIS 1.96 2.13 2.05 1.93 2.34 2.4 2.24 2.16 2.33 2.25 2 2.12 2.22 2.3 2.12 2.14 2.15 1.94 2.14 2.23 1.93 2 2.35 2.36 2.22 2.13
REACTOME_DISEASES_OF_IMMUNE_SYSTEM 1.16 1.31 1.5 1.41 1.44 1.54 1.46 1.48 1.33 1.28 1.28 1.28 1.53 1.45 1.36 1.38 1.41 1.26 1.28 1.42 1.41 1.73 1.46 1.46 1.8 1.87
REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE 2.02 2.05 2.17 1.96 2.04 2.03 2.15 2.12 2.15 2.12 2.09 2.08 2.11 2.09 2.08 2.19 2.16 2.14 2.04 2.07 2.29 2.18 2.15 2.12 2.18 2.16
REACTOME_UPTAKE_AND_ACTIONS_OF_BACTERIAL_TOXINS 2.42 2.43 2.52 2.48 2.55 2.64 2.6 2.51 2.5 2.54 2.47 2.43 2.51 2.5 2.63 2.58 2.46 2.57 2.52 2.56 2.45 2.52 2.53 2.61 2.56 2.43
REACTOME_CASPASE_ACTIVATION_VIA_EXTRINSIC_APOPTOTIC_SIGNALLING_PATHWAY 1.55 1.62 1.88 1.51 1.77 1.88 1.96 1.83 1.79 1.88 1.68 1.76 1.85 1.83 1.72 1.64 1.54 1.65 1.88 1.94 1.62 1.64 1.86 1.91 1.89 1.71
REACTOME_TNFR1_INDUCED_PROAPOPTOTIC_SIGNALING 1.53 1.52 1.76 1.63 1.79 1.93 1.83 1.91 1.8 1.93 1.74 1.92 1.93 1.92 1.75 1.92 1.58 1.68 1.69 1.92 1.64 1.8 1.84 2.12 1.97 1.9
REACTOME_PROGRAMMED_CELL_DEATH 2.21 2.24 2.39 2.27 2.39 2.47 2.45 2.37 2.39 2.43 2.32 2.32 2.41 2.4 2.4 2.38 2.26 2.22 2.34 2.43 2.26 2.35 2.44 2.5 2.39 2.28
REACTOME_REGULATION_OF_TNFR1_SIGNALING 2.21 2.24 2.43 2.35 2.35 2.38 2.39 2.45 2.35 2.43 2.39 2.37 2.42 2.43 2.43 2.48 2.33 2.34 2.28 2.43 2.4 2.45 2.4 2.52 2.44 2.41
REACTOME_TNFR1_INDUCED_NFKAPPAB_SIGNALING_PATHWAY 2.16 2.15 2.38 2.33 2.34 2.35 2.29 2.38 2.31 2.35 2.37 2.34 2.39 2.4 2.37 2.47 2.28 2.25 2.24 2.34 2.32 2.43 2.37 2.48 2.4 2.38
REACTOME_HEDGEHOG_LIGAND_BIOGENESIS 1.93 1.96 2.1 1.96 2.06 2.13 2.08 2.02 2.09 2.04 1.95 2 2.08 1.99 2.06 2.04 1.84 1.87 2 2.14 2.07 2.13 2.14 2.16 2.05 2
REACTOME_SIGNALING_BY_HEDGEHOG 1.85 1.95 2.08 1.95 2.07 2.11 2.1 2.03 2.14 2.05 1.94 2.02 2.08 2.04 2.06 2.05 1.87 1.86 2.01 2.11 1.92 2 2.12 2.18 2.07 1.96
REACTOME_MISMATCH_REPAIR 1.14 1.18 1.64 1.52 1.47 1.45 1.44 1.37 1.35 1.46 1.44 1.3 1.46 1.45 1.33 1.38 1.35 1.15 1.37 1.37 1.23 1.45 1.5 1.58 1.52 1.38
REACTOME_SIGNALING_BY_RETINOIC_ACID 1.65 1.75 2 1.77 1.95 2.03 2 1.88 1.99 1.99 1.85 1.96 1.89 1.97 1.98 1.99 1.76 1.74 1.96 2.04 1.81 1.86 2.05 2.16 2.05 1.89
REACTOME_RA_BIOSYNTHESIS_PATHWAY 1.23 1.37 1.73 1.55 1.64 1.61 1.58 1.59 1.58 1.54 1.54 1.54 1.52 1.56 1.57 1.58 1.59 1.29 1.6 1.67 1.58 1.63 1.57 1.65 1.63 1.56
REACTOME_MITOCHONDRIAL_TRANSLATION 1.47 1.53 1.73 1.61 1.63 1.63 1.68 1.53 1.71 1.7 1.68 1.6 1.59 1.61 1.55 1.62 1.58 1.45 1.59 1.58 1.48 1.58 1.71 1.64 1.65 1.53
REACTOME_AFLATOXIN_ACTIVATION_AND_DETOXIFICATION 1.71 1.79 2.21 2.11 1.99 2.02 1.91 2.02 1.96 2.07 2.12 1.94 2.11 2.06 2.09 2.15 1.93 1.7 1.91 2.04 1.81 2.22 2.09 2.05 2.19 2.18
REACTOME_ORGANIC_CATION_TRANSPORT 1.24 1.21 1.09 1.06 1.8 1.86 1.45 1.3 1.56 1.51 1.27 1.36 1.59 1.55 1.34 1.24 1.3 1.12 1.52 1.49 0.99 1.29 1.31 1.5 1.52 1.48
REACTOME_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT 1.03 1.03 0.91 0.87 1.49 1.55 1.19 1.06 1.27 1.26 1.04 1.15 1.32 1.29 1.1 1.03 1.07 0.95 1.32 1.24 0.86 1.1 1.08 1.25 1.28 1.27
REACTOME_METABOLISM_OF_LIPIDS 1.79 1.86 2.03 1.89 2.11 2.16 2.07 1.99 2.1 2.1 1.92 2 2.11 2.11 2.01 2.02 1.92 1.82 1.98 2.07 1.83 1.97 2.14 2.17 2.07 1.97
REACTOME_PHASE_4_RESTING_MEMBRANE_POTENTIAL 1.41 1.4 1.68 1.32 1.67 1.7 1.48 1.62 1.65 1.57 1.63 1.51 1.54 1.61 1.6 1.67 1.38 1.35 1.47 1.72 1.45 1.53 1.68 1.75 1.53 1.59
REACTOME_CARDIAC_CONDUCTION 2.22 2.35 2.44 2.19 2.53 2.6 2.47 2.51 2.46 2.48 2.34 2.47 2.54 2.58 2.49 2.55 2.34 2.35 2.52 2.61 2.34 2.48 2.52 2.66 2.47 2.43
REACTOME_PHASE_0_RAPID_DEPOLARISATION 1.99 2.08 2.25 2.07 2.32 2.34 2.34 2.36 2.3 2.27 2.15 2.22 2.31 2.31 2.33 2.3 1.99 2.09 2.33 2.42 2.12 2.25 2.37 2.48 2.25 2.2
REACTOME_PHASE_2_PLATEAU_PHASE 2.01 2.21 2.15 1.89 2.39 2.47 2.26 2.49 2.23 2.29 2.05 2.48 2.47 2.5 2.43 2.46 2.2 2.25 2.63 2.57 2.14 2.35 2.39 2.62 2.31 2.37
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS 1.45 1.51 1.7 1.72 1.55 1.61 1.68 1.65 1.58 1.65 1.51 1.52 1.57 1.65 1.62 1.67 1.46 1.49 1.45 1.67 1.48 1.6 1.6 1.66 1.6 1.6
REACTOME_PHYSIOLOGICAL_FACTORS 2.55 2.67 2.69 2.12 2.95 2.99 2.83 2.7 2.79 2.83 2.54 2.82 2.94 2.98 2.57 2.74 3.04 2.87 2.77 2.84 2.73 2.77 2.89 2.89 2.76 2.66
REACTOME_ION_HOMEOSTASIS 2.42 2.5 2.56 2.42 2.68 2.71 2.57 2.61 2.6 2.62 2.47 2.58 2.67 2.73 2.59 2.69 2.47 2.51 2.62 2.65 2.48 2.64 2.58 2.77 2.59 2.57
REACTOME_METABOLIC_DISORDERS_OF_BIOLOGICAL_OXIDATION_ENZYMES 1.12 1.19 1.62 1.34 1.49 1.56 1.39 1.36 1.51 1.47 1.38 1.44 1.54 1.49 1.27 1.39 1.34 1.16 1.46 1.45 1.23 1.32 1.59 1.66 1.4 1.38
REACTOME_PIWI_INTERACTING_RNA_PIRNA_BIOGENESIS 2.2 2.34 2.75 2.63 2.61 2.63 2.69 2.63 2.64 2.71 2.64 2.55 2.69 2.65 2.71 2.79 2.41 2.2 2.37 2.59 2.35 2.66 2.66 2.73 2.72 2.68
REACTOME_IRAK4_DEFICIENCY_TLR2_4 1.11 1.33 1.77 1.49 1.38 1.51 1.32 1.24 1.31 0.97 1.37 1.08 1.42 1.32 1.35 1.54 1.13 1.19 1.16 1.29 1.55 1.82 1.49 1.42 2 2.06
REACTOME_DECTIN_1_MEDIATED_NONCANONICAL_NF_KB_SIGNALING 1.92 1.93 2.1 1.98 2.08 2.14 2.08 2.02 2.08 2.03 1.98 2.01 2.06 2.02 2.04 2.08 1.86 1.88 2 2.11 2.05 2.1 2.1 2.15 2.03 2.03
REACTOME_CLEC7A_DECTIN_1_INDUCES_NFAT_ACTIVATION 2.27 2.35 2.66 2.68 2.34 2.4 2.42 2.24 2.54 2.44 2.45 2.42 2.42 2.41 2.33 2.41 2.14 2.34 2.51 2.46 2.11 2.38 2.49 2.53 2.34 2.26
REACTOME_CLEC7A_DECTIN_1_SIGNALING 2.01 2.02 2.22 2.13 2.14 2.21 2.16 2.11 2.18 2.15 2.14 2.12 2.16 2.16 2.15 2.16 2 2.01 2.14 2.19 2.07 2.16 2.23 2.28 2.15 2.11
REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSYLATION_PRECURSOR_BIOSYNTHESIS 1.35 1.44 1.46 1.61 1.34 1.5 1.49 1.42 1.52 1.38 1.45 1.42 1.45 1.4 1.44 1.33 1.31 1.21 1.37 1.43 1.44 1.33 1.45 1.64 1.43 1.39
REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME 1.91 1.95 2.07 1.97 2.07 2.09 2.05 2.02 2.08 2 1.97 2.02 2.07 1.98 2.02 2.05 1.89 1.92 2.01 2.09 2.07 2.12 2.1 2.09 2.01 2
REACTOME_HEDGEHOG_OFF_STATE 1.93 2.03 2.17 2.03 2.13 2.17 2.18 2.11 2.19 2.11 2.01 2.09 2.15 2.11 2.14 2.14 1.95 1.95 2.1 2.19 2 2.07 2.17 2.23 2.14 2.03
REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS 1.73 1.88 2.06 2.04 2.06 2.11 2.03 1.98 2.04 2.1 1.91 2 2.06 2.08 2.06 2.06 1.87 1.77 1.93 2.07 1.87 1.96 2.07 2.24 2.08 2.06
REACTOME_CILIUM_ASSEMBLY 1.83 1.87 2.14 2.01 2.05 2.09 2.07 2.02 2.06 2.02 1.95 1.95 2.01 2.03 2.04 2 1.91 1.82 1.98 2.05 1.83 1.92 2.06 2.12 2.01 1.9
REACTOME_ABC_TRANSPORTER_DISORDERS 1.96 2.02 2.31 2.18 2.17 2.27 2.23 2.2 2.26 2.21 2.11 2.14 2.22 2.18 2.21 2.23 1.98 1.98 2.11 2.23 2.14 2.24 2.32 2.36 2.24 2.18
REACTOME_SLC_TRANSPORTER_DISORDERS 1.64 1.73 1.97 1.89 2.01 2.1 1.96 1.83 1.97 1.95 1.82 1.87 2.05 2.08 1.86 1.93 1.75 1.69 1.86 1.94 1.76 1.91 2.02 2.13 2.04 1.96
REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS 1.84 1.94 2.23 2.11 2.15 2.26 2.18 2.11 2.2 2.18 2.05 2.08 2.22 2.22 2.15 2.17 1.92 1.89 2.05 2.17 2 2.15 2.26 2.34 2.22 2.14
REACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE 1.99 2 2.34 2.17 2.19 2.23 2.28 2.24 2.26 2.23 2.14 2.06 2.2 2.22 2.26 2.23 2.09 1.95 2.11 2.22 2.02 2.11 2.22 2.29 2.2 2.08
REACTOME_VXPX_CARGO_TARGETING_TO_CILIUM 1.58 1.46 1.77 1.64 1.7 1.83 1.7 1.57 1.73 1.69 1.64 1.59 1.64 1.74 1.74 1.64 1.42 1.39 1.73 1.69 1.41 1.66 1.77 1.75 1.58 1.55
REACTOME_CARGO_TRAFFICKING_TO_THE_PERICILIARY_MEMBRANE 1.52 1.52 1.78 1.68 1.74 1.8 1.7 1.6 1.69 1.65 1.6 1.69 1.69 1.69 1.69 1.66 1.56 1.53 1.75 1.73 1.42 1.59 1.78 1.78 1.61 1.55
REACTOME_BBSOME_MEDIATED_CARGO_TARGETING_TO_CILIUM 1.43 1.59 1.57 1.56 1.76 1.7 1.63 1.56 1.59 1.51 1.44 1.68 1.65 1.64 1.57 1.62 1.67 1.53 1.76 1.65 1.44 1.56 1.69 1.69 1.61 1.51
REACTOME_INTRAFLAGELLAR_TRANSPORT 2.04 2.1 2.38 2.26 2.23 2.23 2.27 2.28 2.28 2.21 2.17 2.14 2.16 2.17 2.25 2.16 2.17 2.03 2.09 2.26 2.03 2.1 2.21 2.28 2.24 2.12
REACTOME_PYROPTOSIS 1.85 1.84 2.05 1.96 1.91 2 2.08 2.01 2.02 1.99 1.91 1.95 2 2.01 2.02 2.03 1.83 1.87 1.93 1.93 1.94 1.88 2.05 2.14 2.03 1.98
REACTOME_DECTIN_2_FAMILY 1.49 1.48 1.5 1.47 1.71 1.65 1.47 1.31 1.33 1.46 1.24 1.38 1.48 1.51 1.43 1.47 1.56 1.38 1.43 1.37 1.29 1.49 1.33 1.41 1.71 1.66
REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS 2.08 2.11 2.32 2.21 2.29 2.4 2.32 2.25 2.33 2.33 2.24 2.26 2.32 2.33 2.33 2.3 2.12 2.11 2.28 2.32 2.12 2.27 2.4 2.44 2.31 2.23
REACTOME_CD209_DC_SIGN_SIGNALING 1.82 1.91 1.85 1.7 2.08 2.11 2.12 2 1.98 2.08 1.76 1.97 1.97 1.96 2.01 1.94 1.81 1.95 2.06 2 1.78 1.85 2.05 2.02 2.06 1.89
REACTOME_RHO_GTPASES_ACTIVATE_PKNS 2.45 2.5 2.55 2.59 2.51 2.57 2.38 2.38 2.44 2.48 2.42 2.4 2.37 2.39 2.4 2.37 2.45 2.26 2.53 2.56 2.36 2.48 2.56 2.64 2.43 2.4
REACTOME_RHO_GTPASES_ACTIVATE_CIT 2.19 2.32 2.51 2.69 2.38 2.39 2.32 2.15 2.35 2.35 2.3 2.27 2.26 2.21 2.19 2.27 2.25 2.03 2.23 2.34 2.28 2.33 2.47 2.42 2.18 2.16
REACTOME_RHO_GTPASES_ACTIVATE_KTN1 2.35 2.32 2.09 2.36 2.48 2.41 2.31 1.97 2.3 2.39 2.17 2.6 2.21 2.11 2.13 2.03 2.31 2.31 2.41 2.39 2.44 2.2 2.48 2.38 2.16 2.06
REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS 2.88 2.97 3.02 3.1 2.96 3.07 2.98 2.9 3.02 3.06 2.97 3.04 3 2.98 2.98 2.97 2.83 2.77 2.94 3.05 2.86 2.86 3.02 3.19 3.11 2.92
REACTOME_RHO_GTPASES_ACTIVATE_ROCKS 1.91 2.07 2.22 2.31 1.89 1.97 1.9 1.93 1.87 1.84 2.05 1.72 1.79 1.79 1.84 1.91 1.88 1.79 1.87 1.89 1.84 1.82 1.8 1.92 1.78 1.86
REACTOME_RHO_GTPASES_ACTIVATE_PAKS 1.57 1.64 1.67 1.91 1.55 1.55 1.56 1.4 1.54 1.57 1.49 1.45 1.33 1.33 1.55 1.46 1.28 1.26 1.55 1.5 1.56 1.41 1.73 1.6 1.31 1.44
REACTOME_TP53_REGULATES_METABOLIC_GENES 2.15 2.19 2.18 2.19 2.18 2.22 2.11 2.21 2.11 2.18 2.14 2.11 2.08 2.13 2.12 2.15 2.08 2.02 2.14 2.17 2.12 2.15 2.17 2.16 2.11 2.09
REACTOME_HEDGEHOG_ON_STATE 1.82 1.91 2.08 1.98 2.06 2.1 2.06 2.02 2.1 2.03 1.92 1.97 2.04 1.98 2.02 2.01 1.86 1.85 1.95 2.08 1.99 2.08 2.1 2.17 2.04 1.96
REACTOME_REGULATION_OF_TP53_ACTIVITY 1.97 1.98 2.13 1.98 2.17 2.18 2.1 2.05 2.11 2.14 2.06 2.06 2.12 2.13 2.07 2.08 2.05 1.98 2.06 2.1 1.99 2.07 2.17 2.19 2.11 2.05
REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_DEATH_GENES 1.83 1.89 1.97 1.88 2.06 2.16 1.98 1.97 2.09 2.14 1.84 2.02 2.06 2.1 2 1.93 1.96 1.84 1.91 2.04 1.82 1.88 2.08 2.15 2.08 1.98
REACTOME_ACTIVATION_OF_SMO 1.7 1.84 1.76 1.73 1.98 2.05 1.92 1.98 1.83 1.98 1.85 1.89 1.92 1.89 2.04 1.97 1.8 1.8 1.95 2.01 1.85 2.04 1.87 2.02 1.97 1.86
REACTOME_CONSTITUTIVE_SIGNALING_BY_EGFRVIII 1.83 1.76 1.85 1.73 2.05 2.03 2.11 2.05 2.05 2.02 1.89 1.96 1.94 1.96 1.94 2 1.93 1.77 1.95 1.85 1.82 1.99 1.97 1.9 1.95 1.86
REACTOME_PCNA_DEPENDENT_LONG_PATCH_BASE_EXCISION_REPAIR 1.3 1.29 1.7 1.65 1.55 1.55 1.58 1.39 1.47 1.54 1.46 1.44 1.55 1.56 1.28 1.41 1.4 1.24 1.42 1.49 1.37 1.32 1.5 1.61 1.43 1.3
REACTOME_VESICLE_MEDIATED_TRANSPORT 2.11 2.18 2.3 2.21 2.31 2.37 2.32 2.26 2.33 2.32 2.21 2.25 2.31 2.33 2.31 2.27 2.2 2.14 2.27 2.34 2.13 2.23 2.35 2.39 2.29 2.21
REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR2 1.84 1.83 1.92 1.72 2.22 2.32 2.03 2.08 2.16 2.2 2.06 2.28 2.31 2.27 1.98 2.11 2.25 1.86 2.03 2.18 1.91 2.09 2.28 2.35 2.09 2.24
REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR4 1.69 1.73 1.76 1.53 2.02 2.17 1.85 1.87 1.99 2.11 1.9 2.14 2.16 2.11 1.87 2.01 2.14 1.82 1.92 2 1.89 2.04 2.11 2.22 1.98 2.12
REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR1 1.88 1.85 1.87 1.63 2.28 2.35 2.1 2.09 2.23 2.2 2.06 2.2 2.34 2.26 2.04 2.11 2.17 1.86 2.14 2.21 1.84 2.04 2.26 2.38 2.1 2.11
REACTOME_SHC_MEDIATED_CASCADE_FGFR1 1.74 1.69 1.98 1.67 2.11 2.24 2.09 2.07 2.14 2.13 2.07 2.14 2.3 2.2 2.05 2.15 2.14 1.88 2.02 2.18 1.8 2.05 2.22 2.34 2.08 2.13
REACTOME_PI_3K_CASCADE_FGFR1 2.12 2.16 2.11 1.86 2.58 2.63 2.35 2.35 2.56 2.53 2.36 2.54 2.65 2.54 2.32 2.38 2.48 2.08 2.41 2.53 2.05 2.27 2.6 2.74 2.37 2.38
REACTOME_FRS_MEDIATED_FGFR1_SIGNALING 1.83 1.83 1.98 1.69 2.25 2.35 2.13 2.14 2.24 2.22 2.14 2.23 2.38 2.28 2.13 2.19 2.22 1.94 2.14 2.25 1.88 2.13 2.3 2.45 2.16 2.19
REACTOME_PI_3K_CASCADE_FGFR2 2.22 2.28 2.25 2.02 2.7 2.75 2.47 2.47 2.68 2.65 2.45 2.64 2.75 2.67 2.42 2.48 2.58 2.14 2.5 2.63 2.14 2.38 2.71 2.84 2.49 2.49
REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR2 2.04 2.06 2.11 1.86 2.49 2.55 2.3 2.29 2.45 2.42 2.26 2.4 2.53 2.46 2.24 2.31 2.34 1.99 2.31 2.41 1.97 2.21 2.46 2.58 2.29 2.31
REACTOME_FRS_MEDIATED_FGFR2_SIGNALING 1.94 1.97 2.13 1.85 2.38 2.48 2.26 2.27 2.37 2.35 2.24 2.35 2.5 2.41 2.24 2.31 2.33 2.01 2.24 2.37 1.98 2.24 2.42 2.56 2.28 2.31
REACTOME_SHC_MEDIATED_CASCADE_FGFR3 1.85 1.81 2.19 1.72 2.27 2.39 2.26 2.24 2.26 2.31 2.21 2.3 2.45 2.38 2.22 2.34 2.28 2.02 2.22 2.36 2.07 2.3 2.36 2.52 2.23 2.32
REACTOME_FRS_MEDIATED_FGFR3_SIGNALING 1.88 1.9 2.13 1.7 2.34 2.42 2.24 2.25 2.31 2.34 2.23 2.32 2.46 2.39 2.24 2.31 2.29 2.02 2.27 2.37 2.08 2.31 2.38 2.57 2.25 2.32
REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR3 1.94 1.94 2.04 1.68 2.38 2.42 2.22 2.21 2.34 2.33 2.17 2.31 2.42 2.36 2.17 2.24 2.24 1.93 2.26 2.33 1.98 2.2 2.36 2.51 2.19 2.24
REACTOME_PI_3K_CASCADE_FGFR3 2.19 2.25 2.31 1.91 2.7 2.74 2.51 2.5 2.67 2.7 2.48 2.66 2.78 2.7 2.48 2.56 2.59 2.2 2.56 2.69 2.27 2.5 2.73 2.91 2.51 2.55
REACTOME_FRS_MEDIATED_FGFR4_SIGNALING 1.82 1.91 2.01 1.77 2.23 2.36 2.14 2.14 2.27 2.28 2.08 2.21 2.39 2.3 2.17 2.19 2.22 1.96 2.15 2.24 1.97 2.18 2.3 2.47 2.21 2.2
REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR4 1.93 2 1.99 1.79 2.35 2.43 2.19 2.16 2.36 2.35 2.1 2.27 2.43 2.35 2.16 2.19 2.24 1.93 2.22 2.28 1.95 2.14 2.35 2.49 2.21 2.19
REACTOME_SHC_MEDIATED_CASCADE_FGFR4 1.73 1.76 2.01 1.75 2.1 2.26 2.1 2.06 2.16 2.19 2.02 2.13 2.31 2.22 2.08 2.16 2.15 1.91 2.03 2.16 1.89 2.1 2.22 2.34 2.13 2.15
REACTOME_PI_3K_CASCADE_FGFR4 2.13 2.27 2.15 1.96 2.59 2.66 2.39 2.36 2.63 2.62 2.33 2.55 2.68 2.59 2.38 2.4 2.51 2.11 2.44 2.54 2.15 2.34 2.63 2.79 2.45 2.41
REACTOME_NEGATIVE_REGULATION_OF_FGFR1_SIGNALING 2.74 2.77 2.92 2.69 3.02 3.09 2.91 2.98 2.92 2.97 2.98 3.01 3.07 3.01 2.89 2.93 2.97 2.82 2.93 3.07 2.86 2.95 3.03 3.2 2.98 3
REACTOME_NEGATIVE_REGULATION_OF_FGFR2_SIGNALING 2.81 2.87 3.05 2.81 3.09 3.17 3.02 3.08 3.03 3.07 3.06 3.09 3.14 3.09 2.99 3.04 3.03 2.87 3.01 3.16 2.92 3.03 3.13 3.31 3.08 3.08
REACTOME_NEGATIVE_REGULATION_OF_FGFR3_SIGNALING 2.68 2.72 2.97 2.69 2.96 3.02 2.92 2.98 2.88 2.97 2.97 2.97 3.01 2.97 2.91 2.94 2.89 2.79 2.9 3.06 2.87 2.97 3.01 3.21 2.97 3.02
REACTOME_NEGATIVE_REGULATION_OF_FGFR4_SIGNALING 2.73 2.85 2.99 2.82 2.99 3.09 2.95 3 2.97 3.03 2.95 2.99 3.07 3.01 2.96 2.95 2.96 2.84 2.94 3.07 2.94 2.99 3.06 3.25 3.05 3.02
REACTOME_SIGNALING_BY_FGFR1 2.33 2.34 2.45 2.23 2.58 2.63 2.48 2.51 2.51 2.52 2.5 2.53 2.6 2.56 2.42 2.48 2.5 2.35 2.51 2.57 2.4 2.49 2.55 2.71 2.51 2.51
REACTOME_SIGNALING_BY_FGFR2 2.26 2.31 2.48 2.34 2.56 2.6 2.49 2.51 2.51 2.52 2.44 2.45 2.57 2.53 2.44 2.55 2.42 2.32 2.47 2.56 2.36 2.46 2.54 2.7 2.5 2.48
REACTOME_SIGNALING_BY_FGFR3 2.44 2.44 2.64 2.38 2.7 2.74 2.65 2.67 2.66 2.67 2.65 2.66 2.71 2.68 2.6 2.61 2.58 2.45 2.64 2.72 2.55 2.65 2.7 2.86 2.65 2.66
REACTOME_SIGNALING_BY_FGFR4 2.46 2.53 2.6 2.44 2.69 2.77 2.63 2.66 2.68 2.7 2.6 2.66 2.73 2.68 2.6 2.61 2.62 2.49 2.65 2.71 2.58 2.63 2.71 2.86 2.68 2.65
REACTOME_SIGNALING_BY_FGFR2_IN_DISEASE 1.93 1.98 2.19 2.02 2.29 2.33 2.21 2.26 2.27 2.29 2.22 2.27 2.35 2.29 2.15 2.3 2.19 1.9 2.14 2.31 1.97 2.16 2.3 2.45 2.26 2.25
REACTOME_SIGNALING_BY_FGFR4_IN_DISEASE 1.73 1.73 1.42 1.24 2.02 1.91 1.83 1.76 1.95 1.78 1.61 1.74 1.82 1.79 1.67 1.67 1.77 1.56 1.92 1.76 1.59 1.65 1.75 1.87 1.81 1.68
REACTOME_SIGNALING_BY_FGFR1_IN_DISEASE 1.79 1.88 1.85 1.57 2.16 2.2 2.02 2.03 2.09 2.13 1.95 2.17 2.16 2.1 1.93 1.96 2.1 1.82 2.08 2.1 1.82 1.97 2.16 2.25 2.02 2.02
REACTOME_TRANSLESION_SYNTHESIS_BY_POLK 2.39 2.39 2.39 2.3 2.58 2.43 2.46 2.45 2.46 2.47 2.46 2.53 2.47 2.48 2.43 2.46 2.58 2.56 2.47 2.39 2.68 2.55 2.47 2.53 2.41 2.44
REACTOME_TERMINATION_OF_TRANSLESION_DNA_SYNTHESIS 2.01 1.99 2.15 2 2.19 2.12 2.13 2.11 2.09 2.13 2.07 2.11 2.16 2.15 2.09 2.14 2.14 2.08 2.06 2.08 2.21 2.2 2.15 2.22 2.11 2.11
REACTOME_REGULATION_OF_RAS_BY_GAPS 1.8 1.82 2 1.88 1.94 1.95 1.95 1.86 1.95 1.82 1.88 1.86 1.91 1.84 1.84 1.89 1.78 1.8 1.9 1.94 1.99 1.99 1.95 1.98 1.89 1.84
REACTOME_FGFRL1_MODULATION_OF_FGFR1_SIGNALING 1.5 1.46 1.68 1.33 1.93 2.15 1.75 1.72 2 1.92 1.68 2.03 2.25 2.19 1.83 1.97 1.86 1.82 2.11 2.01 1.62 1.82 2.22 2.36 1.77 1.81
REACTOME_RESPONSE_TO_METAL_IONS 2.63 2.5 2.98 2.61 2.71 2.79 2.8 2.78 2.52 2.75 2.62 2.7 2.77 2.89 2.79 2.65 2.56 2.56 2.84 2.97 2.7 2.81 2.72 2.88 2.59 2.68
REACTOME_DISEASES_OF_CARBOHYDRATE_METABOLISM 2.4 2.51 2.67 2.49 2.5 2.64 2.53 2.6 2.57 2.58 2.6 2.55 2.64 2.64 2.56 2.51 2.57 2.52 2.57 2.64 2.64 2.71 2.62 2.74 2.61 2.54
REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS 1.9 1.97 2.1 1.99 2.14 2.2 2.17 2.09 2.14 2.17 2.04 2.1 2.16 2.14 2.11 2.09 1.97 1.93 2.05 2.13 1.97 2.06 2.19 2.26 2.12 2.02
REACTOME_INFECTIOUS_DISEASE 2.09 2.14 2.28 2.18 2.3 2.35 2.31 2.25 2.32 2.33 2.19 2.27 2.32 2.33 2.3 2.3 2.18 2.12 2.24 2.34 2.13 2.25 2.35 2.41 2.31 2.23
REACTOME_RHO_GTPASES_ACTIVATE_WASPS_AND_WAVES 2.54 2.55 2.28 2.46 2.52 2.57 2.58 2.35 2.49 2.44 2.4 2.43 2.52 2.5 2.39 2.34 2.29 2.31 2.57 2.53 2.29 2.32 2.51 2.52 2.32 2.31
REACTOME_RHO_GTPASES_ACTIVATE_FORMINS 2.28 2.38 2.56 2.46 2.6 2.65 2.55 2.44 2.59 2.62 2.45 2.47 2.57 2.58 2.55 2.51 2.4 2.31 2.4 2.52 2.31 2.44 2.62 2.66 2.55 2.41
REACTOME_TNFR2_NON_CANONICAL_NF_KB_PATHWAY 1.98 2.05 2.38 2.27 2.29 2.37 2.31 2.26 2.35 2.32 2.22 2.19 2.33 2.32 2.28 2.31 2.07 2.02 2.2 2.32 2.09 2.27 2.37 2.46 2.3 2.23
REACTOME_RHO_GTPASES_ACTIVATE_NADPH_OXIDASES 2.54 2.65 2.68 2.48 2.9 2.99 2.81 2.65 2.75 2.81 2.6 2.84 2.78 2.77 2.64 2.62 2.54 2.42 2.83 2.85 2.52 2.52 3.01 3.1 2.62 2.48
REACTOME_DISEASES_OF_METABOLISM 1.65 1.7 1.94 1.76 1.88 1.97 1.87 1.83 1.89 1.87 1.78 1.81 1.94 1.95 1.83 1.82 1.78 1.69 1.85 1.94 1.77 1.87 1.93 2.01 1.88 1.83
REACTOME_TNFS_BIND_THEIR_PHYSIOLOGICAL_RECEPTORS 0.8 0.79 0.84 0.94 0.88 0.83 0.83 0.84 0.84 0.82 0.93 0.8 0.81 0.85 0.8 0.85 0.87 0.8 0.81 0.8 0.8 0.95 0.79 0.77 0.98 1.09
REACTOME_RAF_ACTIVATION 1.62 1.7 1.65 1.59 1.71 1.73 1.82 1.61 1.78 1.65 1.75 1.59 1.63 1.61 1.56 1.61 1.56 1.66 1.77 1.71 1.71 1.56 1.71 1.72 1.6 1.47
REACTOME_MAP2K_AND_MAPK_ACTIVATION 2.45 2.56 2.69 2.56 2.64 2.7 2.82 2.66 2.72 2.81 2.74 2.68 2.71 2.74 2.82 2.74 2.47 2.51 2.59 2.64 2.52 2.68 2.76 2.88 2.76 2.59
REACTOME_CONSTITUTIVE_SIGNALING_BY_AKT1_E17K_IN_CANCER 1.5 1.53 1.57 1.58 1.68 1.74 1.73 1.59 1.75 1.8 1.65 1.73 1.64 1.68 1.7 1.68 1.58 1.59 1.6 1.61 1.44 1.46 1.85 1.84 1.63 1.42
REACTOME_NEGATIVE_REGULATION_OF_MAPK_PATHWAY 2.29 2.31 2.36 2.23 2.4 2.43 2.42 2.39 2.36 2.4 2.42 2.47 2.28 2.29 2.37 2.33 2.25 2.31 2.33 2.33 2.33 2.34 2.38 2.46 2.39 2.34
REACTOME_TNF_RECEPTOR_SUPERFAMILY_TNFSF_MEMBERS_MEDIATING_NON_CANONICAL_NF_KB_PATHWAY 0.99 0.83 1 1.2 1.15 1.18 0.96 0.98 1.18 1.12 1.2 1.06 1.14 1.29 1.09 1.08 1.16 0.87 1.04 1.11 0.89 1.09 1.3 1.16 1.23 1.05
REACTOME_DEFECTIVE_CFTR_CAUSES_CYSTIC_FIBROSIS 1.89 1.88 2.03 1.94 1.99 2.05 2.04 1.98 2.03 1.97 1.89 1.97 2.03 1.94 2 1.99 1.82 1.85 1.95 2.07 2.09 2.1 2.06 2.11 1.98 1.96
REACTOME_LGI_ADAM_INTERACTIONS 2.08 2.1 2.12 1.49 2.16 2.25 2.14 2.09 2.02 2.03 2.11 2.08 2.24 2.22 1.99 2.18 1.9 2.01 2.12 2.14 2.09 2.24 2.17 2.14 2.18 2.13
REACTOME_MAPK_FAMILY_SIGNALING_CASCADES 2.12 2.2 2.34 2.18 2.39 2.47 2.42 2.32 2.4 2.4 2.27 2.32 2.41 2.39 2.35 2.35 2.18 2.16 2.3 2.37 2.19 2.32 2.44 2.5 2.36 2.27
REACTOME_SURFACTANT_METABOLISM 1.2 1.18 1.79 1.52 1.55 1.66 1.49 1.5 1.56 1.65 1.32 1.49 1.66 1.69 1.65 1.66 1.28 1.23 1.63 1.74 1.41 1.58 1.65 1.89 1.54 1.54
REACTOME_MAP3K8_TPL2_DEPENDENT_MAPK1_3_ACTIVATION 2.59 2.76 2.83 2.74 2.72 2.66 2.75 2.84 2.68 2.75 2.86 2.71 2.72 2.78 2.96 2.92 2.79 2.82 2.62 2.67 2.94 3.01 2.83 2.82 2.81 2.7
REACTOME_HDR_THROUGH_SINGLE_STRAND_ANNEALING_SSA 1.22 1.21 1.39 1.27 1.6 1.59 1.36 1.29 1.36 1.43 1.27 1.31 1.4 1.44 1.36 1.39 1.21 1.14 1.4 1.33 1.16 1.39 1.47 1.44 1.36 1.39
REACTOME_HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR 1.76 1.75 2.03 1.87 2.03 2.01 1.96 1.88 1.91 2.01 1.93 1.9 1.96 1.98 1.92 2 1.85 1.75 1.89 1.91 1.84 2.01 2.01 2.02 1.93 1.93
REACTOME_REGULATION_OF_TLR_BY_ENDOGENOUS_LIGAND 0.89 1.05 1.66 1.36 1.37 1.37 1.15 1.05 1.16 0.69 1.06 0.87 1.3 1.22 1.33 1.43 0.86 1.09 0.97 1.11 1.47 1.78 1.32 1.31 1.95 2.06
REACTOME_MAPK6_MAPK4_SIGNALING 2.05 2.07 2.25 2.22 2.24 2.31 2.23 2.19 2.24 2.22 2.11 2.18 2.23 2.17 2.24 2.22 2.06 2.06 2.19 2.27 2.15 2.24 2.29 2.3 2.19 2.15
REACTOME_DEUBIQUITINATION 1.84 1.89 2.05 1.97 2.03 2.08 2.05 1.97 2.05 2.04 1.95 1.94 2.06 2.05 2.05 1.99 1.89 1.83 1.95 2 1.88 2.01 2.09 2.12 2.04 1.96
REACTOME_UCH_PROTEINASES 1.98 1.99 2.08 1.96 2.07 2.14 2.07 2.03 2.09 2.06 1.99 1.99 2.09 2.04 2.1 2.06 1.89 1.94 2.06 2.09 2.02 2.11 2.07 2.1 2.06 2.03
REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES 1.8 1.82 2.03 1.96 1.97 2 2.01 1.92 2 1.98 1.93 1.9 1.99 1.99 2 1.96 1.84 1.78 1.87 1.96 1.87 1.97 2.05 2.07 1.99 1.91
REACTOME_OVARIAN_TUMOR_DOMAIN_PROTEASES 2.43 2.52 2.59 2.59 2.59 2.64 2.65 2.55 2.61 2.65 2.54 2.55 2.63 2.63 2.63 2.56 2.54 2.51 2.5 2.56 2.58 2.67 2.71 2.75 2.62 2.55
REACTOME_METALLOPROTEASE_DUBS 2.65 2.63 2.79 2.62 2.81 2.86 2.88 2.83 2.8 2.8 2.77 2.79 2.85 2.77 2.82 2.73 2.8 2.78 2.7 2.68 2.86 2.89 2.78 2.81 2.87 2.89
REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR 1.65 1.66 1.86 1.69 1.88 1.9 1.86 1.78 1.85 1.88 1.77 1.79 1.87 1.89 1.85 1.87 1.7 1.65 1.76 1.81 1.68 1.86 1.91 1.94 1.86 1.79
REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES 1.2 1.24 1.53 1.48 1.63 1.64 1.47 1.24 1.44 1.57 1.35 1.42 1.46 1.47 1.44 1.38 1.24 1.14 1.4 1.41 1.13 1.42 1.62 1.62 1.36 1.36
REACTOME_HOMOLOGY_DIRECTED_REPAIR 1.61 1.63 1.88 1.72 1.85 1.89 1.86 1.8 1.82 1.88 1.77 1.79 1.85 1.86 1.84 1.85 1.71 1.63 1.74 1.81 1.68 1.88 1.9 1.93 1.84 1.8
REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES_THROUGH_SYNTHESIS_DEPENDENT_STRAND_ANNEALING_SDSA 1.27 1.3 1.58 1.5 1.74 1.74 1.54 1.28 1.51 1.66 1.41 1.48 1.53 1.57 1.5 1.46 1.26 1.17 1.48 1.45 1.17 1.46 1.71 1.71 1.43 1.42
REACTOME_NONHOMOLOGOUS_END_JOINING_NHEJ 1.5 1.53 1.54 1.44 1.66 1.74 1.71 1.54 1.65 1.71 1.58 1.58 1.64 1.66 1.73 1.6 1.4 1.47 1.58 1.49 1.48 1.66 1.65 1.75 1.67 1.51
REACTOME_HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE 1.19 1.21 1.44 1.38 1.57 1.59 1.4 1.22 1.36 1.48 1.33 1.32 1.41 1.47 1.34 1.41 1.17 1.08 1.39 1.38 1.09 1.4 1.49 1.48 1.38 1.37
REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE 2.12 2.16 2.22 2.05 2.24 2.28 2.23 2.19 2.18 2.24 2.13 2.18 2.21 2.22 2.21 2.23 2.08 2.14 2.18 2.16 2.16 2.25 2.24 2.28 2.22 2.19
REACTOME_PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS 1.82 1.85 2.03 1.92 2.02 2.03 1.98 1.97 1.94 2.02 1.94 1.93 1.97 2 2.01 1.99 1.87 1.85 1.92 1.94 1.88 2.04 2.04 2.06 1.98 1.94
REACTOME_CARGO_CONCENTRATION_IN_THE_ER 2.21 2.28 2.46 2.51 2.34 2.51 2.48 2.42 2.44 2.49 2.45 2.4 2.43 2.48 2.42 2.41 2.31 2.19 2.36 2.53 2.21 2.32 2.52 2.61 2.41 2.34
REACTOME_DNA_DAMAGE_RECOGNITION_IN_GG_NER 2.2 2.23 2.33 2.24 2.22 2.26 2.21 2.22 2.31 2.27 2.28 2.24 2.22 2.25 2.28 2.26 2.24 2.16 2.23 2.21 2.22 2.2 2.34 2.27 2.3 2.19
REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER 1.81 1.82 1.92 1.93 1.83 1.83 1.85 1.86 1.85 1.85 1.91 1.82 1.8 1.86 1.95 1.89 1.83 1.86 1.8 1.78 1.91 1.87 1.93 1.91 1.81 1.75
REACTOME_GAP_FILLING_DNA_REPAIR_SYNTHESIS_AND_LIGATION_IN_GG_NER 2.2 2.18 2.31 2.11 2.39 2.3 2.31 2.32 2.27 2.33 2.29 2.31 2.34 2.35 2.24 2.34 2.36 2.28 2.24 2.26 2.41 2.38 2.31 2.4 2.28 2.29
REACTOME_NUCLEOTIDE_EXCISION_REPAIR 1.73 1.77 1.93 1.84 1.81 1.82 1.84 1.82 1.87 1.85 1.85 1.81 1.83 1.87 1.87 1.85 1.78 1.71 1.77 1.81 1.78 1.8 1.89 1.91 1.84 1.78
REACTOME_GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER 1.81 1.83 1.96 1.85 1.89 1.89 1.88 1.85 1.92 1.9 1.89 1.86 1.88 1.92 1.92 1.89 1.83 1.8 1.84 1.84 1.84 1.84 1.95 1.93 1.89 1.8
REACTOME_DUAL_INCISION_IN_GG_NER 1.82 1.82 2.01 1.84 2.02 1.95 1.96 1.93 1.99 1.99 2.01 1.97 1.99 2.02 1.97 2.02 1.95 1.92 1.92 1.92 2 2 2 2.05 1.94 1.94
REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION 1.9 1.96 2.14 2.02 2.14 2.2 2.14 2.07 2.14 2.15 2.02 2.06 2.15 2.16 2.11 2.08 1.98 1.91 2.05 2.14 1.94 2.04 2.18 2.24 2.12 2.04
REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE 1.45 1.51 2.01 1.84 1.78 1.86 1.66 1.6 1.81 1.93 1.73 1.73 1.82 1.79 1.79 1.83 1.66 1.59 1.69 1.74 1.56 1.69 1.88 1.94 1.93 1.78
REACTOME_RESPIRATORY_ELECTRON_TRANSPORT 1.76 1.85 1.89 1.89 1.76 1.78 1.79 1.86 1.83 1.77 1.85 1.72 1.81 1.8 1.83 1.82 1.76 1.71 1.73 1.82 1.82 1.79 1.78 1.74 1.8 1.81
REACTOME_INFLAMMASOMES 2.57 2.5 2.51 2.33 2.83 2.85 2.77 2.74 2.7 2.76 2.51 2.71 2.79 2.72 2.63 2.62 2.78 2.53 2.61 2.74 2.56 2.57 2.72 2.79 2.87 2.8
REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS 1.41 1.45 1.66 1.49 1.54 1.72 1.92 1.66 1.9 1.87 1.49 1.61 1.77 1.85 1.86 1.7 1.41 1.55 1.57 1.82 1.41 1.46 1.72 1.76 1.71 1.47
REACTOME_FORMATION_OF_TC_NER_PRE_INCISION_COMPLEX 1.72 1.78 1.95 1.91 1.69 1.73 1.79 1.81 1.8 1.77 1.84 1.76 1.75 1.77 1.77 1.76 1.78 1.63 1.7 1.79 1.77 1.79 1.82 1.86 1.8 1.8
REACTOME_TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR_TC_NER 1.68 1.73 1.95 1.85 1.81 1.79 1.84 1.81 1.84 1.84 1.85 1.8 1.83 1.85 1.81 1.83 1.79 1.7 1.74 1.82 1.8 1.81 1.86 1.9 1.81 1.8
REACTOME_DUAL_INCISION_IN_TC_NER 1.71 1.76 1.95 1.85 1.85 1.81 1.87 1.87 1.88 1.87 1.88 1.86 1.86 1.91 1.89 1.9 1.84 1.77 1.79 1.85 1.87 1.91 1.89 1.96 1.85 1.88
REACTOME_TRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL 1.26 1.34 1.42 1.52 1.39 1.46 1.31 1.34 1.36 1.4 1.44 1.41 1.36 1.4 1.32 1.31 1.34 1.34 1.35 1.36 1.26 1.31 1.41 1.35 1.45 1.3
REACTOME_FANCONI_ANEMIA_PATHWAY 2.09 2.13 2.41 2.28 2.29 2.27 2.24 2.33 2.24 2.27 2.33 2.24 2.28 2.24 2.3 2.33 2.23 2.2 2.19 2.24 2.29 2.38 2.33 2.35 2.3 2.3
REACTOME_INTERLEUKIN_6_FAMILY_SIGNALING 1.98 2.12 2.2 2.02 2.37 2.4 2.33 2.21 2.4 2.43 2.24 2.38 2.47 2.51 2.28 2.36 2.31 2.07 2.2 2.39 2.2 2.33 2.47 2.5 2.33 2.31
REACTOME_INTERLEUKIN_10_SIGNALING 1.36 1.36 1.5 1.53 1.54 1.61 1.57 1.51 1.48 1.47 1.33 1.5 1.57 1.53 1.42 1.43 1.62 1.45 1.31 1.51 1.6 1.63 1.52 1.53 1.74 1.78
REACTOME_TRNA_PROCESSING_IN_THE_NUCLEUS 1.5 1.52 1.61 1.6 1.71 1.65 1.64 1.6 1.59 1.62 1.51 1.49 1.6 1.67 1.62 1.67 1.4 1.49 1.47 1.56 1.35 1.57 1.61 1.67 1.63 1.54
REACTOME_ERBB2_REGULATES_CELL_MOTILITY 1.9 2 2.12 2.25 2.37 2.42 2.32 2.01 2.31 2.21 2.1 2.14 2.3 2.2 2.01 2.06 2.08 1.83 2.07 2.2 1.93 2.11 2.28 2.27 2.14 1.99
REACTOME_INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING 1.9 1.98 2.15 1.97 2.27 2.31 2.23 2.15 2.25 2.24 2.05 2.21 2.28 2.28 2.2 2.23 2.23 2.02 2.11 2.21 2.11 2.19 2.32 2.39 2.26 2.21
REACTOME_IL_6_TYPE_CYTOKINE_RECEPTOR_LIGAND_INTERACTIONS 2.14 2.22 2.38 2.25 2.45 2.49 2.39 2.29 2.48 2.45 2.41 2.44 2.58 2.64 2.34 2.47 2.44 2.25 2.33 2.5 2.35 2.45 2.54 2.53 2.45 2.48
REACTOME_RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL 1.21 1.22 1.39 1.39 1.27 1.31 1.27 1.28 1.28 1.28 1.24 1.18 1.22 1.25 1.22 1.24 1.2 1.11 1.24 1.25 1.19 1.23 1.33 1.26 1.27 1.25
REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_GENES 1.67 1.72 1.97 1.89 1.99 2 2.02 1.87 1.96 1.97 1.79 1.8 1.98 1.98 1.94 1.91 1.8 1.7 1.76 2 1.74 1.87 2.04 2.05 1.98 1.77
REACTOME_NEUREXINS_AND_NEUROLIGINS 1.84 1.9 1.62 1.54 1.97 1.97 1.93 1.84 1.94 1.87 1.73 1.84 1.8 1.86 1.78 1.78 1.69 1.79 1.93 1.89 1.71 1.72 1.87 1.89 1.88 1.75
REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES 1.79 1.84 1.65 1.66 1.92 1.92 1.88 1.78 1.87 1.86 1.71 1.78 1.8 1.83 1.75 1.76 1.61 1.73 1.89 1.84 1.66 1.68 1.85 1.85 1.82 1.69
REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_DNA_REPAIR_GENES 1.57 1.61 1.91 1.86 1.82 1.84 1.84 1.75 1.85 1.85 1.84 1.76 1.8 1.82 1.81 1.89 1.69 1.55 1.71 1.78 1.61 1.77 1.85 1.87 1.86 1.77
REACTOME_NEUTROPHIL_DEGRANULATION 2.16 2.24 2.38 2.24 2.43 2.48 2.42 2.36 2.4 2.41 2.3 2.37 2.42 2.44 2.37 2.36 2.3 2.2 2.35 2.42 2.23 2.33 2.47 2.51 2.41 2.3
REACTOME_COMPLEX_I_BIOGENESIS 1.77 1.87 1.97 1.9 1.79 1.82 1.86 1.92 1.89 1.82 1.89 1.72 1.86 1.87 1.94 1.94 1.79 1.71 1.75 1.85 1.77 1.84 1.81 1.8 1.85 1.89
REACTOME_SIGNALING_BY_MODERATE_KINASE_ACTIVITY_BRAF_MUTANTS 2.36 2.48 2.61 2.47 2.56 2.62 2.76 2.58 2.65 2.7 2.66 2.57 2.61 2.63 2.69 2.66 2.37 2.47 2.51 2.59 2.49 2.57 2.65 2.77 2.64 2.46
REACTOME_SIGNALING_BY_BRAF_AND_RAF_FUSIONS 2.24 2.34 2.42 2.25 2.41 2.48 2.56 2.44 2.46 2.54 2.45 2.42 2.48 2.5 2.55 2.49 2.25 2.3 2.37 2.44 2.3 2.41 2.5 2.57 2.45 2.32
REACTOME_ONCOGENIC_MAPK_SIGNALING 2.15 2.25 2.33 2.17 2.31 2.37 2.47 2.32 2.38 2.43 2.36 2.31 2.37 2.39 2.41 2.37 2.15 2.22 2.26 2.33 2.22 2.29 2.42 2.45 2.36 2.21
REACTOME_ANTIMICROBIAL_PEPTIDES 1.44 1.44 1.4 1.43 1.45 1.43 1.42 1.43 1.38 1.35 1.41 1.4 1.41 1.42 1.45 1.51 1.47 1.46 1.42 1.4 1.5 1.62 1.39 1.42 1.68 1.79
REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_CYTOCHROME_C_RELEASE 1.99 2.07 2.02 2.01 2.22 2.31 2.08 2.14 2.24 2.25 1.93 2.15 2.14 2.19 2.16 2.12 2.06 2.05 2.17 2.15 1.99 2 2.22 2.27 2.16 2.15
REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_SEVERAL_ADDITIONAL_CELL_DEATH_GENES_WHOSE_SPECIFIC_ROLES_IN_P53_DEPENDENT_APOPTOSIS_REMAIN_UNCERTAIN 1.95 2.12 2.25 1.98 2.23 2.35 2.02 2.09 2.27 2.38 2.05 2.38 2.21 2.27 2.18 2.11 2.24 1.93 2.03 2.22 2 2.11 2.21 2.45 2.32 2.24
REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CASPASE_ACTIVATORS_AND_CASPASES 1.24 1.17 1.19 1.41 1.59 1.65 1.23 1.09 1.31 1.46 1.24 1.23 1.42 1.4 1.35 1.22 1.22 1.16 1.21 1.23 1.08 1.36 1.47 1.36 1.25 1.18
REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_DEATH_RECEPTORS_AND_LIGANDS 1.39 1.56 1.53 1.44 1.47 1.6 1.55 1.56 1.6 1.75 1.5 1.72 1.44 1.68 1.52 1.55 1.49 1.61 1.71 1.75 1.35 1.49 1.63 1.88 1.6 1.41
REACTOME_FGFR2_ALTERNATIVE_SPLICING 1.6 1.69 1.92 1.97 1.86 1.85 1.84 1.88 1.83 1.84 1.89 1.79 1.88 1.85 1.77 2 1.71 1.63 1.75 1.87 1.74 1.78 1.87 1.97 1.92 1.88
REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_G2_CELL_CYCLE_ARREST 1.59 1.64 1.96 1.89 1.95 1.99 1.96 1.7 1.79 1.78 1.7 1.71 1.91 1.92 1.88 1.9 1.76 1.73 1.71 1.89 1.71 1.88 1.91 1.97 1.94 1.71
REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_ADDITIONAL_CELL_CYCLE_GENES_WHOSE_EXACT_ROLE_IN_THE_P53_PATHWAY_REMAIN_UNCERTAIN 1.84 1.94 2.01 1.82 1.97 2.01 2.24 1.99 2.15 2.14 1.88 1.9 2.08 2.05 2.1 2.06 1.83 1.79 1.99 2.08 1.79 2 2.24 2.28 2.11 1.83
REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_G1_CELL_CYCLE_ARREST 1.45 1.53 1.9 1.93 1.94 1.91 1.65 1.86 1.87 1.93 1.7 1.8 1.82 1.76 1.77 1.72 1.89 1.53 1.4 1.98 1.68 1.74 1.82 1.8 1.79 1.77
REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION 2 2.01 2.26 2.08 2.21 2.23 2.13 2.08 2.11 2.18 2.13 2.06 2.14 2.16 2.12 2.16 2.08 2.03 2.13 2.14 2.03 2.14 2.18 2.18 2.13 2.1
REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ACETYLATION 1.9 1.87 1.93 1.83 1.92 1.9 1.89 1.79 1.88 1.86 1.91 1.94 1.83 1.83 1.88 1.91 1.92 1.86 1.86 1.85 1.88 1.86 1.96 1.97 1.89 1.85
REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ASSOCIATION_WITH_CO_FACTORS 1.95 2.08 2.12 2.06 2.17 2.28 2.08 2.11 2.13 2.35 2.15 2.27 2.19 2.28 2.21 2.26 2.2 2.09 2.15 2.19 2.1 2.26 2.31 2.47 2.17 2.14
REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_METHYLATION 2.65 2.7 2.77 2.64 2.79 2.7 2.68 2.71 2.64 2.67 2.68 2.66 2.67 2.68 2.6 2.79 2.65 2.71 2.67 2.65 2.78 2.79 2.74 2.79 2.72 2.69
REACTOME_KERATINIZATION 1.39 1.36 1.42 1.4 1.32 1.3 1.41 1.39 1.34 1.34 1.44 1.39 1.35 1.32 1.38 1.33 1.42 1.4 1.28 1.35 1.41 1.37 1.32 1.27 1.37 1.37
REACTOME_REGULATION_OF_TP53_EXPRESSION_AND_DEGRADATION 2.35 2.29 2.56 2.45 2.53 2.55 2.48 2.44 2.49 2.56 2.42 2.41 2.5 2.51 2.49 2.49 2.39 2.29 2.31 2.44 2.36 2.47 2.62 2.64 2.51 2.43
REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS 1.73 1.81 1.92 1.71 1.97 2.13 1.99 1.82 1.93 1.93 1.75 1.89 2.02 2.02 1.98 2 1.82 1.8 1.97 2.05 1.94 2.07 2.02 2.17 1.98 1.83
REACTOME_SIGNALING_BY_MET 1.81 1.88 2.12 1.99 2.12 2.13 2.1 2.04 2.2 2.14 1.98 2.07 2.15 2.16 2.08 2.05 2.03 1.87 1.98 2.1 1.9 2.06 2.17 2.25 2.08 2.08
REACTOME_NEGATIVE_REGULATION_OF_MET_ACTIVITY 2.02 2.04 2.37 2.33 2.22 2.16 2.28 2.22 2.14 2.17 2.23 2.04 2.19 2.24 2.28 2.27 2.19 2.15 2.11 2.18 2.26 2.3 2.24 2.2 2.2 2.23
REACTOME_PTEN_REGULATION 1.89 1.93 1.97 1.93 2 2.03 1.98 1.93 1.99 1.97 1.92 1.95 1.97 1.96 1.99 1.94 1.88 1.89 1.98 2.04 1.94 1.99 2.02 2.06 1.93 1.91
REACTOME_RNA_POLYMERASE_II_TRANSCRIBES_SNRNA_GENES 1.48 1.45 1.58 1.63 1.56 1.55 1.59 1.55 1.6 1.56 1.58 1.53 1.58 1.59 1.55 1.6 1.51 1.47 1.46 1.57 1.46 1.53 1.57 1.56 1.63 1.51
REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT 2.12 2.18 2.15 2.1 2.22 2.29 2.17 2.16 2.24 2.22 2.15 2.22 2.18 2.21 2.2 2.19 2.11 2.08 2.21 2.24 2.08 2.15 2.26 2.3 2.2 2.13
REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE 1.42 1.39 1.44 1.45 1.43 1.41 1.47 1.47 1.4 1.43 1.44 1.49 1.43 1.41 1.45 1.39 1.45 1.43 1.38 1.44 1.46 1.41 1.41 1.42 1.45 1.44
REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC 2.33 2.4 2.51 2.44 2.55 2.64 2.59 2.47 2.57 2.59 2.44 2.49 2.58 2.6 2.58 2.49 2.37 2.32 2.47 2.54 2.31 2.41 2.59 2.63 2.52 2.38
REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC 2.11 2.22 2.39 2.32 2.24 2.4 2.3 2.29 2.4 2.39 2.34 2.36 2.3 2.33 2.32 2.36 2.17 2.11 2.25 2.35 2.17 2.17 2.4 2.48 2.4 2.21
REACTOME_INTRA_GOLGI_TRAFFIC 1.7 1.83 1.86 1.86 1.78 1.89 1.9 1.82 1.88 1.81 1.8 1.77 1.77 1.82 1.82 1.87 1.76 1.8 1.88 1.83 1.79 1.84 1.89 1.86 1.77 1.75
REACTOME_RETROGRADE_TRANSPORT_AT_THE_TRANS_GOLGI_NETWORK 1.45 1.49 1.58 1.55 1.43 1.54 1.63 1.62 1.54 1.53 1.5 1.42 1.51 1.54 1.57 1.51 1.41 1.55 1.53 1.59 1.41 1.49 1.59 1.55 1.45 1.45
REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC 1.98 2.06 2.16 2.11 2.15 2.25 2.2 2.13 2.21 2.2 2.11 2.12 2.18 2.21 2.19 2.15 2.04 2.01 2.12 2.19 1.98 2.08 2.23 2.24 2.14 2.06
REACTOME_COOPERATION_OF_PDCL_PHLP1_AND_TRIC_CCT_IN_G_PROTEIN_BETA_FOLDING 2.36 2.37 2.23 2.15 2.5 2.4 2.42 2.37 2.44 2.32 2.28 2.21 2.45 2.44 2.4 2.46 2.35 2.42 2.5 2.43 2.25 2.37 2.41 2.43 2.36 2.22
REACTOME_CDC6_ASSOCIATION_WITH_THE_ORC_ORIGIN_COMPLEX 1.32 1.32 2.47 2.47 1.52 1.72 1.69 1.71 1.74 1.75 1.84 1.54 1.66 1.72 1.81 1.87 1.46 1.28 1.72 1.76 1.49 1.86 1.81 1.82 1.67 1.68
REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX 1.94 1.96 2.3 2.16 2.13 2.22 2.19 2.14 2.21 2.13 2.08 2.07 2.17 2.11 2.2 2.16 1.97 1.98 2.07 2.18 2.1 2.24 2.24 2.24 2.1 2.04
REACTOME_MITOTIC_PROPHASE 1.9 1.95 2.09 2 2.1 2.17 2.14 2.05 2.14 2.1 2.08 2 2.15 2.14 2.14 2.04 1.94 1.95 2.02 2.15 1.96 2.05 2.2 2.13 2.04 1.92
REACTOME_MITOTIC_PROMETAPHASE 2.06 2.15 2.37 2.23 2.37 2.44 2.37 2.29 2.38 2.39 2.23 2.24 2.36 2.37 2.37 2.33 2.22 2.1 2.22 2.33 2.1 2.25 2.39 2.44 2.35 2.2
REACTOME_MITOTIC_TELOPHASE_CYTOKINESIS 1.5 1.45 1.91 1.6 2.02 1.96 1.86 1.67 1.98 2.06 1.83 1.79 2 1.85 1.89 1.79 1.75 1.48 1.63 1.67 1.55 1.74 2.11 2.03 1.8 1.68
REACTOME_M_PHASE 2.02 2.1 2.3 2.17 2.28 2.35 2.3 2.22 2.3 2.29 2.17 2.17 2.29 2.29 2.28 2.25 2.12 2.04 2.17 2.27 2.09 2.2 2.32 2.35 2.25 2.14
REACTOME_ORC1_REMOVAL_FROM_CHROMATIN 1.9 1.94 2.3 2.11 2.11 2.17 2.16 2.11 2.17 2.11 2.08 2.03 2.15 2.09 2.17 2.14 1.95 1.93 2.02 2.15 2.09 2.21 2.22 2.22 2.1 2.04
REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX 0.96 1.06 1.77 1.7 1.24 1.35 1.31 1.32 1.29 1.42 1.44 1.23 1.29 1.36 1.31 1.46 1.19 1 1.22 1.31 1.13 1.39 1.43 1.46 1.32 1.36
REACTOME_DNA_REPLICATION_PRE_INITIATION 1.9 1.97 2.32 2.16 2.13 2.22 2.22 2.16 2.22 2.21 2.13 2.06 2.19 2.17 2.2 2.2 1.99 1.96 2.06 2.18 2.05 2.22 2.27 2.26 2.12 2.08
REACTOME_SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE 1.88 1.9 2.18 2.05 2.08 2.13 2.08 2.03 2.08 2.07 1.99 1.97 2.07 2.03 2.04 2.04 1.91 1.87 2 2.07 1.99 2.09 2.11 2.11 2.02 1.98
REACTOME_POLYMERASE_SWITCHING 0.88 0.82 1.32 1.15 1.1 1.09 1.26 1.18 1.14 1.28 1.07 1.04 1.2 1.2 1.06 1.31 1.12 0.71 0.94 1.06 1.06 1.24 1.23 1.19 1.23 1.14
REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND 0.86 0.88 1.38 1.35 1.01 1.05 1.31 1.26 1.06 1.21 1.08 1.06 1.15 1.13 1.11 1.21 1.2 0.95 0.91 1.12 1.19 1.28 1.18 1.26 1.33 1.21
REACTOME_LAGGING_STRAND_SYNTHESIS 0.94 0.9 1.28 1.18 1.11 1.13 1.25 1.16 1.1 1.22 1.09 1.1 1.17 1.18 1.04 1.2 1.14 0.86 0.98 1.07 1.11 1.19 1.2 1.22 1.26 1.12
REACTOME_DNA_STRAND_ELONGATION 0.93 0.87 1.23 1.13 1.1 1.14 1.17 1.15 1.07 1.21 1.07 1.09 1.08 1.12 1 1.16 1.16 0.85 0.96 1.04 1.02 1.15 1.19 1.19 1.16 1.07
REACTOME_G1_S_SPECIFIC_TRANSCRIPTION 1.43 1.41 1.88 1.86 1.72 1.77 1.8 1.62 1.67 1.64 1.63 1.6 1.78 1.74 1.7 1.72 1.6 1.51 1.55 1.72 1.49 1.7 1.69 1.69 1.74 1.62
REACTOME_CYCLIN_D_ASSOCIATED_EVENTS_IN_G1 2.08 2.05 2.25 2.26 2.22 2.25 2.16 2.17 2.14 2.23 2.17 2.17 2.16 2.16 2.2 2.21 2.12 2.13 2.11 2.23 2.14 2.23 2.23 2.24 2.16 2.14
REACTOME_S_PHASE 1.79 1.8 2.08 1.94 2.01 2.04 2 1.93 2 2.02 1.93 1.92 1.99 2 1.97 1.97 1.87 1.79 1.88 1.95 1.88 1.97 2.06 2.03 1.95 1.86
REACTOME_CYCLIN_A_B1_B2_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION 2.24 2.26 2.6 2.45 2.57 2.65 2.51 2.3 2.62 2.58 2.45 2.35 2.53 2.56 2.5 2.4 2.21 2.16 2.38 2.51 2.13 2.36 2.62 2.65 2.45 2.25
REACTOME_CELL_CYCLE_MITOTIC 1.95 2.02 2.22 2.1 2.22 2.28 2.22 2.13 2.21 2.23 2.1 2.11 2.21 2.22 2.2 2.17 2.06 1.98 2.1 2.19 2 2.12 2.25 2.28 2.17 2.06
REACTOME_DNA_REPLICATION 1.82 1.84 2.14 2.01 2.03 2.08 2.05 1.98 2.05 2.07 1.99 1.94 2.03 2.03 1.99 2.01 1.89 1.81 1.93 2 1.89 2 2.1 2.08 1.97 1.92
REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT 2.24 2.24 2.22 2.15 2.36 2.41 2.32 2.25 2.26 2.31 2.18 2.13 2.28 2.3 2.31 2.21 2.14 2.04 2.29 2.28 2.08 2.26 2.28 2.35 2.26 2.12
REACTOME_G2_M_CHECKPOINTS 2.12 2.16 2.39 2.25 2.33 2.4 2.35 2.28 2.35 2.33 2.24 2.17 2.32 2.32 2.35 2.3 2.13 2.07 2.24 2.31 2.15 2.32 2.38 2.39 2.3 2.19
REACTOME_STABILIZATION_OF_P53 1.99 1.97 2.14 1.99 2.11 2.15 2.13 2.05 2.1 2.05 1.97 2 2.12 2.02 2.07 2.12 1.9 1.95 2.03 2.15 2.13 2.2 2.13 2.18 2.07 2.04
REACTOME_G1_S_DNA_DAMAGE_CHECKPOINTS 1.98 1.99 2.28 2.15 2.17 2.24 2.2 2.13 2.18 2.18 2.08 2.07 2.2 2.13 2.18 2.18 2.02 1.98 2.05 2.23 2.14 2.25 2.23 2.26 2.14 2.1
REACTOME_MITOTIC_SPINDLE_CHECKPOINT 2.06 2.14 2.35 2.24 2.44 2.49 2.33 2.23 2.39 2.43 2.22 2.25 2.38 2.39 2.31 2.28 2.2 2.09 2.23 2.3 2.05 2.23 2.42 2.44 2.31 2.19
REACTOME_CELL_CYCLE_CHECKPOINTS 2.06 2.11 2.34 2.22 2.34 2.4 2.3 2.23 2.33 2.35 2.2 2.18 2.32 2.32 2.3 2.25 2.14 2.04 2.2 2.28 2.08 2.24 2.36 2.38 2.27 2.16
REACTOME_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY 1.81 1.82 2.07 1.98 1.97 2.02 2 1.95 2 1.98 1.9 1.92 1.98 1.95 2.01 1.98 1.85 1.84 1.86 2.01 1.99 2.05 2.04 2.04 1.96 1.88
REACTOME_GLYCOLYSIS 2.25 2.3 2.4 2.37 2.4 2.5 2.47 2.43 2.38 2.46 2.27 2.4 2.45 2.49 2.48 2.41 2.29 2.33 2.38 2.52 2.27 2.41 2.45 2.56 2.45 2.41
REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS 1.29 1.42 1.63 1.58 1.56 1.6 1.54 1.51 1.52 1.52 1.59 1.48 1.52 1.6 1.69 1.51 1.51 1.32 1.52 1.44 1.35 1.39 1.77 1.68 1.54 1.44
REACTOME_GLUCONEOGENESIS 2.87 2.97 3.11 3.02 3.03 3.23 3.09 3.14 2.97 3.13 2.95 3.06 3.1 3.15 3.1 3.12 2.95 2.94 3.17 3.21 2.94 3.01 3.11 3.25 3.1 3.1
REACTOME_PYRUVATE_METABOLISM 2.23 2.23 2.34 2.28 2.39 2.5 2.41 2.39 2.34 2.36 2.27 2.4 2.39 2.45 2.45 2.49 2.25 2.19 2.36 2.37 2.31 2.35 2.45 2.56 2.4 2.35
REACTOME_GLUCOSE_METABOLISM 2.24 2.32 2.45 2.36 2.43 2.54 2.48 2.47 2.4 2.48 2.3 2.41 2.47 2.51 2.49 2.45 2.29 2.31 2.44 2.55 2.25 2.38 2.48 2.58 2.45 2.41
REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM 1.03 0.95 1.17 1.07 1.01 1.01 1.24 0.98 1.23 1.09 1.14 1.03 1.06 1.12 1.15 1.09 1.1 1.06 1.09 1.21 1.14 1.05 1.19 1.18 1.18 0.96
REACTOME_TRYPTOPHAN_CATABOLISM 1.64 1.84 2.03 1.79 1.98 2.31 2.17 1.95 2.2 1.94 1.78 1.89 2.36 2.44 2.04 1.96 1.99 1.85 1.85 2.02 2.09 2 2.18 2.19 2.33 2.03
REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES 1.9 1.94 2.25 2.08 2.17 2.23 2.19 2.12 2.19 2.2 2.09 2.1 2.2 2.19 2.15 2.15 2.06 1.94 2.03 2.19 2 2.15 2.22 2.26 2.21 2.1
REACTOME_PENTOSE_PHOSPHATE_PATHWAY 1.32 1.61 1.78 1.41 1.66 1.85 1.81 1.74 1.77 1.79 1.62 1.45 1.87 1.68 1.71 1.63 1.7 1.5 1.52 1.8 1.6 1.63 1.73 1.75 1.83 1.79
REACTOME_ETHANOL_OXIDATION 2.24 2.28 2.28 2.2 2.46 2.53 2.35 2.44 2.4 2.33 2.19 2.39 2.38 2.5 2.39 2.32 2.44 2.31 2.48 2.58 2.35 2.39 2.57 2.59 2.36 2.3
REACTOME_METABOLISM_OF_CARBOHYDRATES 1.9 1.97 2.12 2.01 2.08 2.17 2.09 2.1 2.06 2.09 2 2.05 2.13 2.16 2.12 2.1 2.02 2 2.09 2.15 2 2.1 2.14 2.21 2.12 2.07
REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE 1.36 1.6 1.2 1.33 1.2 1.28 1.35 1.34 1.3 1.28 1.29 1.29 1.26 1.4 1.22 1.4 1.61 1.58 1.44 1.42 1.61 1.3 1.22 1.33 1.42 1.52
REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE 1.94 2.01 2.02 1.97 2.03 2.14 2.1 2.11 2.02 2.04 1.95 2.07 2.08 2.15 2.11 2.18 2.04 1.98 2.08 2.12 2.07 2.06 2.07 2.18 2.09 2.08
REACTOME_MRNA_CAPPING 1.19 1.22 1.32 1.38 1.21 1.23 1.27 1.33 1.29 1.23 1.33 1.21 1.23 1.25 1.16 1.37 1.18 1.11 1.14 1.25 1.21 1.22 1.27 1.27 1.34 1.21
REACTOME_MRNA_SPLICING_MINOR_PATHWAY 1.66 1.67 1.69 1.64 1.69 1.76 1.65 1.61 1.69 1.69 1.66 1.59 1.59 1.62 1.53 1.6 1.52 1.52 1.67 1.64 1.5 1.5 1.65 1.65 1.69 1.56
REACTOME_MRNA_SPLICING 1.6 1.6 1.57 1.56 1.69 1.69 1.64 1.56 1.62 1.65 1.6 1.6 1.62 1.63 1.56 1.59 1.59 1.57 1.64 1.62 1.56 1.55 1.64 1.64 1.62 1.56
REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM 1.39 1.41 1.53 1.49 1.58 1.61 1.55 1.47 1.47 1.57 1.44 1.51 1.54 1.59 1.52 1.54 1.46 1.46 1.43 1.55 1.4 1.53 1.56 1.57 1.51 1.48
REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA 1.57 1.59 1.6 1.59 1.69 1.7 1.65 1.59 1.62 1.66 1.59 1.62 1.63 1.66 1.6 1.63 1.59 1.58 1.62 1.65 1.56 1.59 1.65 1.66 1.65 1.59
REACTOME_TRNA_PROCESSING 1.38 1.43 1.52 1.56 1.57 1.56 1.51 1.49 1.49 1.51 1.46 1.45 1.5 1.57 1.49 1.53 1.35 1.4 1.42 1.48 1.32 1.46 1.52 1.55 1.56 1.43
REACTOME_RRNA_PROCESSING 1.62 1.6 1.81 1.74 1.68 1.66 1.69 1.73 1.64 1.7 1.65 1.67 1.62 1.67 1.67 1.72 1.71 1.66 1.6 1.7 1.66 1.73 1.71 1.7 1.73 1.69
REACTOME_EUKARYOTIC_TRANSLATION_INITIATION 2.24 2.25 2.49 2.36 2.28 2.33 2.38 2.35 2.4 2.43 2.33 2.38 2.31 2.35 2.32 2.36 2.41 2.28 2.2 2.35 2.34 2.39 2.44 2.4 2.47 2.33
REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S 2.27 2.26 2.48 2.36 2.34 2.38 2.46 2.38 2.49 2.52 2.34 2.4 2.36 2.37 2.38 2.35 2.43 2.33 2.19 2.41 2.39 2.47 2.51 2.4 2.57 2.39
REACTOME_TRANSLATION 1.81 1.84 2.05 1.95 1.88 1.91 1.97 1.91 1.98 1.99 1.93 1.93 1.9 1.92 1.88 1.93 1.92 1.8 1.83 1.9 1.85 1.92 2.02 1.97 2 1.88
REACTOME_PYRIMIDINE_SALVAGE 1.37 1.42 1.75 1.69 1.38 1.68 1.52 1.77 1.7 1.52 1.43 1.55 1.69 1.7 1.81 1.76 1.35 1.41 1.59 1.68 1.22 1.29 1.87 1.93 1.42 1.45
REACTOME_PYRIMIDINE_CATABOLISM 0.48 0.57 0.69 0.66 0.87 0.96 0.7 0.71 0.81 0.8 0.58 0.84 0.98 1.02 0.82 0.96 0.8 0.67 0.64 0.66 0.82 1.09 0.96 0.93 0.76 0.74
REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_INITIATION 1.54 1.54 1.75 1.69 1.59 1.61 1.56 1.58 1.6 1.54 1.61 1.56 1.52 1.54 1.61 1.58 1.53 1.52 1.5 1.62 1.56 1.57 1.58 1.58 1.54 1.6
REACTOME_RNA_POLYMERASE_I_PROMOTER_ESCAPE 1.42 1.49 1.76 1.69 1.49 1.52 1.49 1.55 1.45 1.45 1.61 1.51 1.42 1.45 1.58 1.59 1.48 1.46 1.4 1.5 1.5 1.57 1.49 1.53 1.49 1.59
REACTOME_RNA_POLYMERASE_III_CHAIN_ELONGATION 1.5 1.66 2.01 2.04 1.65 1.59 1.72 1.89 1.64 1.61 1.79 1.71 1.61 1.59 1.73 1.92 1.72 1.61 1.44 1.73 1.8 1.81 1.59 1.78 1.82 1.85
REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS 1.44 1.26 1.59 1.79 1.59 1.65 1.55 1.34 1.5 1.38 1.35 1.23 1.48 1.41 1.15 1.31 1.56 1.41 1.44 1.61 1.29 1.2 1.44 1.39 1.49 1.25
REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION 1.4 1.38 1.54 1.43 1.55 1.53 1.52 1.38 1.46 1.52 1.47 1.46 1.49 1.52 1.44 1.41 1.43 1.39 1.4 1.45 1.37 1.44 1.57 1.52 1.43 1.37
REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION 1.76 1.8 1.98 1.86 1.99 2.03 1.96 1.93 1.96 1.99 1.88 1.91 1.98 2 1.95 1.96 1.84 1.79 1.91 1.98 1.8 1.93 2.01 2.05 1.98 1.91
REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_TERMINATION 1.49 1.56 1.9 1.83 1.59 1.62 1.61 1.64 1.58 1.57 1.69 1.58 1.53 1.56 1.67 1.68 1.55 1.54 1.49 1.64 1.57 1.65 1.59 1.62 1.59 1.69
REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION 1.57 1.57 1.77 1.7 1.61 1.65 1.59 1.6 1.61 1.56 1.64 1.59 1.55 1.57 1.64 1.58 1.56 1.55 1.52 1.66 1.6 1.59 1.63 1.62 1.57 1.61
REACTOME_BASE_EXCISION_REPAIR 1.34 1.37 1.54 1.47 1.59 1.54 1.56 1.44 1.48 1.49 1.42 1.42 1.49 1.5 1.34 1.4 1.42 1.3 1.41 1.54 1.32 1.35 1.5 1.6 1.49 1.37
REACTOME_CHROMOSOME_MAINTENANCE 1.56 1.64 1.94 1.85 1.81 1.83 1.81 1.76 1.82 1.86 1.78 1.76 1.81 1.82 1.84 1.85 1.73 1.58 1.71 1.81 1.69 1.8 1.89 1.94 1.86 1.79
REACTOME_DEATH_RECEPTOR_SIGNALLING 1.81 1.85 2 1.88 2.05 2.08 2.07 2.03 2.01 2.05 1.91 1.99 2.06 2.02 2.01 1.97 1.9 1.83 1.92 2.06 1.9 2 2.05 2.1 2.04 1.95
REACTOME_DNA_DAMAGE_BYPASS 1.87 1.89 2.1 1.98 2.06 2.03 2.04 2.01 2.02 2.05 1.99 2.02 2.03 2.07 2.03 2.03 2.01 1.94 1.95 1.98 2.09 2.08 2.08 2.12 2.03 2
REACTOME_DNA_REPAIR 1.64 1.69 1.92 1.81 1.84 1.85 1.86 1.78 1.85 1.86 1.79 1.78 1.83 1.86 1.85 1.85 1.7 1.64 1.75 1.83 1.69 1.8 1.9 1.93 1.86 1.78
REACTOME_BASE_EXCISION_REPAIR_AP_SITE_FORMATION 1.45 1.53 1.51 1.45 1.71 1.56 1.54 1.49 1.51 1.5 1.55 1.43 1.43 1.48 1.43 1.48 1.47 1.41 1.43 1.6 1.37 1.45 1.57 1.66 1.56 1.48
REACTOME_RESOLUTION_OF_ABASIC_SITES_AP_SITES 1.17 1.23 1.47 1.42 1.44 1.44 1.47 1.33 1.34 1.39 1.27 1.32 1.39 1.4 1.19 1.27 1.29 1.19 1.28 1.43 1.21 1.22 1.37 1.49 1.38 1.25
REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_TERMINATION 1.83 1.95 1.98 2.05 2.03 1.94 1.96 2.13 1.92 1.85 1.92 2.02 1.96 1.96 1.97 2.07 2.08 1.96 1.76 2.02 2.06 2.01 1.88 1.96 2.11 2.08
REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION 1.74 1.78 1.74 1.81 1.85 1.76 1.81 1.81 1.81 1.72 1.8 1.75 1.87 1.82 1.72 1.8 1.86 1.82 1.68 1.83 1.76 1.75 1.73 1.73 1.88 1.77
REACTOME_PURINE_SALVAGE 1.33 1.35 2.11 1.89 1.4 1.44 1.52 1.54 1.58 1.63 1.74 1.62 1.48 1.53 1.69 1.66 1.35 1.41 1.36 1.51 1.6 1.79 1.78 1.65 1.64 1.46
REACTOME_PURINE_CATABOLISM 1.28 1.22 1.45 1.19 1.49 1.68 1.54 1.16 1.35 1.57 1.23 1.42 1.43 1.45 1.38 1.28 1.41 1.4 1.46 1.35 1.22 1.29 1.54 1.61 1.6 1.38
REACTOME_SIGNAL_ATTENUATION 2.4 2.41 2.26 2.1 2.6 2.48 2.32 2.41 2.41 2.31 2.37 2.54 2.29 2.29 2.52 2.26 2.4 2.51 2.63 2.56 2.42 2.36 2.42 2.65 2.51 2.28
REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE 2.09 2.13 2.18 1.94 2.44 2.49 2.29 2.3 2.4 2.38 2.21 2.39 2.45 2.4 2.29 2.31 2.3 2.12 2.34 2.42 2.11 2.26 2.48 2.59 2.35 2.28
REACTOME_SIGNALING_BY_INSULIN_RECEPTOR 2.33 2.38 2.53 2.27 2.56 2.67 2.55 2.55 2.56 2.57 2.42 2.51 2.61 2.56 2.51 2.53 2.44 2.33 2.49 2.6 2.34 2.49 2.62 2.73 2.6 2.48
REACTOME_CHK1_CHK2_CDS1_MEDIATED_INACTIVATION_OF_CYCLIN_B_CDK1_COMPLEX 3.64 3.58 3.61 3.62 3.81 3.96 3.75 3.62 3.74 3.73 3.56 3.46 3.78 3.75 3.74 3.53 3.52 3.29 3.7 3.83 3.37 3.65 3.71 3.82 3.75 3.47
REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA 1.26 1.24 1.49 1.38 1.43 1.37 1.42 1.31 1.44 1.45 1.39 1.4 1.36 1.39 1.36 1.29 1.33 1.24 1.21 1.33 1.31 1.3 1.54 1.5 1.34 1.22
REACTOME_MRNA_EDITING 1.64 1.68 1.74 1.73 2.07 2.07 2.18 2.03 1.92 2.2 1.77 1.9 2.09 2.14 2.03 1.99 1.69 1.65 1.95 2.04 1.68 2.1 2.08 2.21 1.9 1.93
REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS 2.02 2.1 2.27 2.08 2.44 2.44 2.42 2.29 2.46 2.41 2.15 2.2 2.51 2.49 2.24 2.34 2.28 2.11 2.31 2.37 2.12 2.22 2.42 2.45 2.39 2.32
REACTOME_TRIGLYCERIDE_BIOSYNTHESIS 1.31 1.53 2.01 1.81 1.78 2.03 1.9 1.89 1.96 1.99 1.71 1.87 2.03 2.11 2.02 1.99 1.76 1.63 1.81 1.88 1.63 2.05 2.07 2.3 2.1 1.87
REACTOME_APOPTOTIC_EXECUTION_PHASE 2.05 2.11 2.25 2.13 2.39 2.42 2.4 2.27 2.33 2.38 2.2 2.29 2.43 2.41 2.33 2.28 2.26 2.1 2.22 2.35 2.18 2.3 2.4 2.41 2.36 2.26
REACTOME_DISSOLUTION_OF_FIBRIN_CLOT 1.69 1.68 2 1.83 2.19 2.22 2.21 2.08 1.94 1.87 1.89 1.71 2.23 2.25 1.94 2.19 1.95 1.6 1.93 2.22 1.91 2.09 1.98 2 2.21 2.17
REACTOME_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACYL_COAS 1.97 2.1 2.29 2.09 2.51 2.51 2.54 2.26 2.54 2.42 2.19 2.26 2.61 2.57 2.26 2.35 2.28 2.1 2.38 2.47 2.09 2.2 2.51 2.53 2.47 2.38
REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN 1.24 1.31 1.32 1.08 1.76 1.75 1.51 1.35 1.5 1.67 1.29 1.67 1.61 1.52 1.48 1.41 1.59 1.37 1.48 1.54 1.49 1.56 1.7 1.71 1.76 1.84
REACTOME_TNF_SIGNALING 1.99 2.02 2.23 2.14 2.14 2.18 2.16 2.22 2.15 2.19 2.18 2.15 2.2 2.22 2.22 2.26 2.1 2.09 2.09 2.21 2.17 2.25 2.2 2.29 2.21 2.17
REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION 2.19 2.25 2.33 2.23 2.43 2.48 2.42 2.39 2.41 2.43 2.29 2.39 2.45 2.48 2.42 2.39 2.31 2.24 2.39 2.46 2.26 2.36 2.48 2.55 2.42 2.34
REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2 2.25 2.32 2.45 2.31 2.52 2.58 2.54 2.52 2.5 2.51 2.36 2.47 2.55 2.57 2.5 2.47 2.42 2.3 2.41 2.57 2.38 2.46 2.55 2.61 2.56 2.48
REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION 1.76 1.83 2.01 1.81 2.08 2.17 2.15 2.06 2.12 2.2 1.99 2.14 2.12 2.19 2.16 2.08 1.98 1.93 2.04 2.12 1.89 2.06 2.23 2.35 2.11 2.07
REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_1_PROMOTER 1.3 1.42 1.65 1.68 1.4 1.36 1.48 1.54 1.41 1.36 1.51 1.43 1.38 1.36 1.42 1.58 1.44 1.43 1.3 1.45 1.48 1.47 1.34 1.46 1.53 1.52
REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER 1.65 1.68 1.86 1.89 1.75 1.64 1.7 1.74 1.7 1.65 1.8 1.62 1.73 1.69 1.63 1.8 1.7 1.63 1.53 1.73 1.63 1.71 1.64 1.69 1.78 1.7
REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION_OF_SATURATED_FATTY_ACIDS 1.89 1.95 2.2 2.14 2.4 2.32 2.03 2.2 2.18 2.17 2.08 2.14 2.18 2.25 2.17 2.25 2.1 2.02 2.28 2.13 1.93 2.35 2.22 2.17 2.23 2.11
REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION 1.37 1.46 1.95 1.76 1.82 1.76 1.68 1.67 1.8 1.73 1.76 1.7 1.8 1.81 1.74 1.75 1.62 1.53 1.76 1.71 1.59 1.81 1.83 1.81 1.85 1.72
REACTOME_INSULIN_RECEPTOR_RECYCLING 2.77 2.85 3.09 2.87 2.83 2.96 2.98 2.98 2.87 2.9 2.83 2.79 2.89 2.82 2.95 2.91 2.77 2.79 2.83 2.98 2.8 2.96 2.89 3.05 3.07 2.87
REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS 1.17 1.2 1.39 1.29 1.4 1.3 1.36 1.24 1.43 1.47 1.4 1.41 1.31 1.36 1.37 1.28 1.32 1.2 1.22 1.31 1.16 1.26 1.57 1.52 1.25 1.11
REACTOME_THE_NLRP3_INFLAMMASOME 2.74 2.62 2.58 2.4 2.93 2.9 2.85 2.89 2.78 2.88 2.65 2.82 2.86 2.81 2.75 2.76 2.85 2.69 2.76 2.82 2.67 2.7 2.82 2.9 2.98 2.88
REACTOME_INTERFERON_GAMMA_SIGNALING 1.87 1.87 2.07 1.89 2.13 2.19 2.14 2.03 2.08 2.19 2.01 2.07 2.2 2.2 2.12 2.15 1.97 1.86 2.04 2.14 2.06 2.19 2.22 2.28 2.15 2.07
REACTOME_REGULATION_OF_IFNG_SIGNALING 1.54 1.65 1.84 1.62 2.07 2.18 1.99 1.98 2.05 2.22 1.98 1.95 2.21 2.17 2.1 2.05 1.96 1.56 1.81 1.98 1.83 2.15 2.2 2.17 2.06 1.95
REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING 3 3.05 3.24 2.93 3.56 3.61 3.4 3.2 3.42 3.42 3.28 3.35 3.38 3.4 3.2 3.13 3.28 3.04 3.11 3.27 3.08 3.06 3.39 3.51 2.93 2.79
REACTOME_TRANSPORT_OF_ORGANIC_ANIONS 1.96 1.96 2.13 1.67 2.47 2.61 2.29 2.16 2.37 2.19 2 2.13 2.56 2.42 2.07 1.86 2.12 1.7 1.9 2.18 1.76 1.99 2.53 2.4 2.21 2.11
REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK 1.94 2.04 2 1.84 2.25 2.31 2.02 2.09 2.04 2.21 2.15 2.17 2.13 2.21 2.11 2.23 2.17 2.07 2.14 2.12 2.09 2.15 2.17 2.32 2.13 2.05
REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING 1.5 1.47 1.56 1.71 2.05 2.04 1.84 1.65 1.85 1.78 1.44 1.72 1.95 1.83 1.58 1.74 1.49 1.31 1.69 1.78 1.41 1.57 1.85 1.92 1.77 1.62
REACTOME_SIGNALING_BY_PTK6 2.16 2.16 2.24 2.29 2.4 2.39 2.29 2.22 2.37 2.33 2.22 2.29 2.34 2.31 2.2 2.27 2.31 2.09 2.23 2.33 2.24 2.31 2.35 2.4 2.28 2.21
REACTOME_PTK6_REGULATES_RHO_GTPASES_RAS_GTPASE_AND_MAP_KINASES 2.07 1.92 1.73 1.9 2.22 2.11 1.9 1.61 1.99 1.93 1.81 1.99 1.75 1.72 1.58 1.71 1.85 1.51 2.07 2.02 1.8 1.73 1.94 1.92 1.59 1.62
REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES 1.77 1.73 1.7 1.69 1.98 2 1.78 1.62 1.8 1.9 1.69 1.8 1.78 1.83 1.71 1.74 1.53 1.72 1.81 1.85 1.6 1.67 1.94 1.86 1.78 1.66
REACTOME_BUTYROPHILIN_BTN_FAMILY_INTERACTIONS 0.93 1.23 1 1.04 1.09 1.05 1.14 1.07 1.08 1.24 1.09 0.92 1.01 1.21 0.86 0.99 0.99 1.18 1.05 1.07 1.19 0.94 0.91 1 1.13 1.18
REACTOME_SIGNALING_BY_FGFR2_IIIA_TM 1.39 1.37 1.4 1.57 1.54 1.49 1.51 1.54 1.53 1.51 1.61 1.5 1.55 1.53 1.39 1.58 1.49 1.26 1.34 1.5 1.36 1.36 1.46 1.45 1.54 1.36
REACTOME_MET_ACTIVATES_RAS_SIGNALING 1.38 1.29 2.05 1.73 1.64 1.74 1.9 1.73 1.88 1.61 1.71 1.46 1.81 1.85 1.87 1.82 1.56 1.45 1.72 1.69 1.47 1.76 1.82 1.63 1.69 1.63
REACTOME_PROTEIN_UBIQUITINATION 1.8 1.82 1.84 1.84 1.83 1.87 1.83 1.82 1.83 1.9 1.85 1.79 1.79 1.83 1.91 1.83 1.81 1.78 1.81 1.8 1.9 1.83 1.83 1.87 1.83 1.85
REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT 2.31 2.36 2.58 2.44 2.51 2.59 2.58 2.5 2.57 2.56 2.45 2.48 2.56 2.48 2.55 2.55 2.33 2.36 2.4 2.58 2.47 2.52 2.58 2.64 2.55 2.43
REACTOME_SIGNALING_BY_FGFR3_FUSIONS_IN_CANCER 1.48 1.39 0.88 0.62 1.6 1.44 1.32 1.31 1.28 1.29 1.24 1.32 1.16 1.24 1 1.11 1.41 1.19 1.6 1.22 1.34 1.35 1.07 1.02 1.19 1.2
REACTOME_RET_SIGNALING 1.98 2.14 2.03 1.83 2.33 2.4 2.2 2.13 2.3 2.29 2.07 2.24 2.33 2.33 2.19 2.24 2.19 2.06 2.25 2.26 2.02 2.13 2.29 2.37 2.22 2.16
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_VENTX 1.74 1.75 1.65 1.68 1.91 1.93 1.76 1.73 1.69 1.9 1.61 1.75 1.79 1.72 1.58 1.69 1.77 1.64 1.81 1.69 1.55 1.6 1.76 1.76 1.78 1.78
REACTOME_TBC_RABGAPS 1.78 1.85 1.96 1.81 1.87 1.91 1.89 1.85 1.96 1.89 1.96 1.86 1.86 1.96 1.82 1.89 1.91 1.93 1.86 1.91 1.93 1.96 1.94 1.91 1.95 1.82
REACTOME_AURKA_ACTIVATION_BY_TPX2 2.21 2.26 2.6 2.44 2.45 2.51 2.57 2.49 2.52 2.5 2.4 2.29 2.48 2.5 2.53 2.52 2.33 2.18 2.35 2.47 2.25 2.37 2.48 2.53 2.47 2.34
REACTOME_INTERLEUKIN_20_FAMILY_SIGNALING 1.6 1.73 1.86 1.73 2.14 2.19 2.06 1.92 2.05 2.2 1.82 2.04 2.11 2.1 2.03 2 1.97 1.71 1.82 1.94 1.73 2.05 2.14 2.24 2.16 2.04
REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT 2.22 2.29 2.42 2.36 2.42 2.52 2.46 2.37 2.48 2.48 2.37 2.38 2.45 2.48 2.46 2.41 2.27 2.21 2.36 2.43 2.21 2.32 2.5 2.52 2.42 2.29
REACTOME_CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS 2.2 2.28 2.48 2.41 2.43 2.51 2.5 2.43 2.45 2.46 2.34 2.37 2.46 2.47 2.5 2.43 2.31 2.29 2.4 2.49 2.25 2.38 2.47 2.55 2.48 2.41
REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS 2.23 2.29 2.43 2.37 2.4 2.46 2.45 2.36 2.4 2.38 2.31 2.32 2.42 2.43 2.46 2.39 2.28 2.26 2.38 2.45 2.24 2.34 2.43 2.48 2.43 2.37
REACTOME_DEREGULATED_CDK5_TRIGGERS_MULTIPLE_NEURODEGENERATIVE_PATHWAYS_IN_ALZHEIMER_S_DISEASE_MODELS 2.55 2.63 2.59 2.43 2.69 2.84 2.73 2.7 2.59 2.57 2.46 2.57 2.59 2.67 2.59 2.57 2.62 2.56 2.74 2.77 2.47 2.57 2.59 2.73 2.71 2.58
REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING 2.36 2.39 2.62 2.6 2.65 2.61 2.66 2.62 2.63 2.66 2.61 2.59 2.62 2.59 2.6 2.66 2.57 2.5 2.42 2.52 2.62 2.73 2.67 2.72 2.6 2.56
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS 1.49 1.69 1.61 1.64 1.79 1.91 1.83 1.74 1.77 1.76 1.49 1.74 1.93 1.89 1.84 1.8 1.66 1.66 1.79 1.88 1.63 1.78 1.86 1.99 1.81 1.72
REACTOME_VLDLR_INTERNALISATION_AND_DEGRADATION 2.08 2.19 1.97 1.9 2.19 2.24 2.17 2.25 2.23 2.17 1.93 1.9 2.13 2.09 2.26 2.12 2.16 2.26 2.24 2.23 2.11 2.16 2.08 2.18 2.27 2.19
REACTOME_SYNTHESIS_OF_ACTIVE_UBIQUITIN_ROLES_OF_E1_AND_E2_ENZYMES 2.1 2.12 2.01 2.06 2.24 2.21 2.08 2.13 2.14 2.22 2.09 2.16 2.11 2.1 2.14 2.16 2.19 2.18 2.18 2.1 2.31 2.2 2.16 2.22 2.13 2.26
REACTOME_E3_UBIQUITIN_LIGASES_UBIQUITINATE_TARGET_PROTEINS 1.79 1.8 1.87 1.85 1.71 1.77 1.78 1.81 1.73 1.82 1.86 1.74 1.72 1.78 1.88 1.78 1.76 1.76 1.73 1.77 1.87 1.79 1.76 1.78 1.77 1.77
REACTOME_NEGATIVE_REGULATION_OF_ACTIVITY_OF_TFAP2_AP_2_FAMILY_TRANSCRIPTION_FACTORS 1.32 1.5 1.48 1.16 1.56 1.7 1.76 1.74 1.6 1.63 1.42 1.46 1.83 1.73 1.81 1.73 1.36 1.31 1.46 1.67 1.27 1.64 1.76 1.81 1.74 1.44
REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS 1.67 1.83 1.81 1.83 2.06 2.1 2.06 1.87 2.05 1.99 1.66 1.91 2.16 2.09 1.93 1.97 1.8 1.79 1.82 2.1 1.67 1.94 2.15 2.26 2.04 1.89
REACTOME_TFAP2_AP_2_FAMILY_REGULATES_TRANSCRIPTION_OF_GROWTH_FACTORS_AND_THEIR_RECEPTORS 1.45 1.53 1.55 1.43 1.81 1.89 1.88 1.53 1.7 1.67 1.47 1.68 1.91 1.88 1.79 1.71 1.76 1.85 1.82 1.84 1.57 1.72 1.79 1.94 1.72 1.65
REACTOME_RAB_GERANYLGERANYLATION 2.15 2.23 2.29 2.02 2.37 2.4 2.39 2.26 2.4 2.36 2.25 2.24 2.42 2.42 2.31 2.26 2.31 2.2 2.26 2.39 2.19 2.25 2.33 2.37 2.34 2.23
REACTOME_MET_ACTIVATES_PTK2_SIGNALING 1 1.05 1.3 1.15 1.35 1.34 1.22 1.25 1.31 1.37 1.18 1.36 1.24 1.26 1.19 1.24 1.27 1.09 1.12 1.26 1.26 1.35 1.42 1.39 1.37 1.43
REACTOME_INLB_MEDIATED_ENTRY_OF_LISTERIA_MONOCYTOGENES_INTO_HOST_CELL 2.07 2.06 2.37 2.44 2.09 2 2.14 2.2 1.95 2.07 2.27 2.06 2.11 2.13 2.27 2.35 2.18 2.22 2.19 2.15 2.41 2.39 2.17 2.18 2.18 2.19
REACTOME_MET_ACTIVATES_RAP1_AND_RAC1 1.82 1.8 1.77 1.95 2.04 2.05 2.18 1.74 2.09 2.03 1.76 1.96 2.07 2.05 1.92 1.84 1.78 1.43 1.99 2.04 1.61 1.89 2.11 2.02 1.84 1.82
REACTOME_MET_RECEPTOR_RECYCLING 1.28 1.44 1.68 1.57 1.55 1.62 1.74 1.63 1.63 1.62 1.45 1.51 1.68 1.7 1.73 1.69 1.51 1.26 1.52 1.7 1.3 1.62 1.75 1.63 1.69 1.57
REACTOME_MET_PROMOTES_CELL_MOTILITY 1.4 1.48 1.65 1.52 1.75 1.76 1.67 1.65 1.81 1.78 1.55 1.75 1.75 1.76 1.63 1.61 1.66 1.4 1.59 1.74 1.5 1.67 1.82 1.87 1.72 1.73
REACTOME_RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS 2.01 2.04 2.07 2.05 2.15 2.17 2.14 2.09 2.12 2.11 1.99 2.01 2.14 2.14 2.06 2.04 2.09 2.01 2.08 2.15 2.01 2.01 2.13 2.12 2.06 1.98
REACTOME_LISTERIA_MONOCYTOGENES_ENTRY_INTO_HOST_CELLS 2.06 2.09 2.37 2.48 2.12 2.08 2.12 2.1 2.04 2.18 2.4 2.12 2.2 2.22 2.26 2.36 2.3 2.3 2.22 2.23 2.3 2.35 2.19 2.2 2.29 2.24
REACTOME_RUNX1_AND_FOXP3_CONTROL_THE_DEVELOPMENT_OF_REGULATORY_T_LYMPHOCYTES_TREGS 1.18 1.18 1.39 1.25 1.59 1.64 1.5 1.68 1.54 1.74 1.39 1.63 1.69 1.68 1.78 1.78 1.55 1.29 1.37 1.63 1.52 1.61 1.83 1.79 1.72 1.85
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 1.81 1.86 2.1 2 2.03 2.07 2.01 1.95 2 2.02 1.89 1.93 2.03 1.95 2 1.98 1.84 1.82 1.92 2.04 1.9 1.96 2.06 2.14 1.95 1.89
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX2 1.85 1.91 2.12 2.04 2.07 2.15 2.09 2 2.1 2.09 2.01 2.02 2.07 2.06 2.08 2.07 1.89 1.86 2.01 2.12 1.97 2.05 2.15 2.21 2.07 1.98
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 1.86 1.92 2.13 1.96 2.14 2.21 2.1 2.1 2.09 2.13 2.01 2.06 2.15 2.13 2.1 2.11 1.96 1.94 2.06 2.17 2 2.13 2.15 2.25 2.08 2.05
REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION 2.36 2.4 2.15 2.22 2.35 2.38 2.17 2.02 2.31 2.25 2.08 2.26 2.19 2.21 2.21 2.18 2.21 2.25 2.43 2.34 1.96 2.02 2.22 2.44 2.32 2.22
REACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY 1.21 1.28 1.05 1.23 1.51 1.54 1.28 1.28 1.44 1.43 1.21 1.34 1.42 1.39 1.4 1.32 1.24 1.31 1.45 1.34 1.22 1.32 1.49 1.62 1.29 1.35
REACTOME_RECEPTOR_MEDIATED_MITOPHAGY 1.72 1.95 1.93 2.03 2.02 2 1.91 1.91 2 2.02 1.91 1.98 1.99 1.86 1.99 1.89 1.98 1.91 1.96 1.91 1.83 2.08 2.05 1.98 2.03 2.12
REACTOME_DIGESTION 1.69 1.82 1.75 1.82 1.85 1.82 1.7 1.46 1.79 1.95 1.65 1.71 1.89 1.88 1.59 1.67 1.74 1.83 1.79 1.74 1.68 1.79 1.82 1.8 1.91 1.92
REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION 1.43 1.5 1.74 1.69 1.87 1.88 1.71 1.82 1.73 1.87 1.67 1.81 1.79 1.77 1.72 1.84 1.71 1.67 1.76 1.82 1.63 1.74 1.84 1.93 1.8 1.81
REACTOME_ESR_MEDIATED_SIGNALING 1.98 2.02 2.13 2.06 2.21 2.21 2.18 2.16 2.15 2.17 2.11 2.14 2.17 2.16 2.17 2.18 2.07 2.04 2.1 2.19 2.01 2.11 2.21 2.27 2.16 2.1
REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS 1.96 1.97 2.18 2.02 2.12 2.16 2.08 2.07 2.08 2.09 1.97 2.02 2.11 2.02 2.04 2.05 1.91 1.92 2.05 2.16 2.07 2.12 2.14 2.21 2.06 2.02
REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN 1.55 1.61 1.66 1.55 1.67 1.71 1.67 1.68 1.62 1.66 1.54 1.66 1.71 1.7 1.66 1.59 1.72 1.72 1.71 1.69 1.63 1.68 1.64 1.67 1.62 1.57
REACTOME_REGULATION_OF_RUNX2_EXPRESSION_AND_ACTIVITY 1.85 1.87 2.08 1.93 2.01 2.07 2.05 1.98 2.03 1.96 1.91 1.95 2.03 1.97 2.02 2 1.82 1.83 1.97 2.05 1.98 2.07 2.08 2.13 1.99 1.95
REACTOME_RUNX2_REGULATES_OSTEOBLAST_DIFFERENTIATION 1.85 1.84 2.02 1.89 1.98 2.04 1.94 1.83 1.95 1.99 1.98 2 1.95 1.98 1.86 1.92 1.97 1.89 1.93 2.07 1.88 1.96 2.11 2.13 2.04 1.94
REACTOME_RUNX2_REGULATES_BONE_DEVELOPMENT 1.78 1.83 1.95 1.86 1.9 2 1.89 1.8 1.9 1.97 1.9 1.93 1.9 1.91 1.85 1.88 1.89 1.82 1.85 2.04 1.86 1.87 2.04 2.09 2 1.88
REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING 1.28 1.15 1.2 1.17 1.45 1.41 1.16 1.21 1.29 1.21 1.04 1.27 1.24 1.24 1.19 1.08 1.22 1.38 1.42 1.23 1.1 1.09 1.21 1.33 1.23 1.18
REACTOME_REGULATION_OF_RUNX3_EXPRESSION_AND_ACTIVITY 1.84 1.85 1.92 1.82 1.95 1.99 1.94 1.88 1.92 1.88 1.81 1.87 1.96 1.84 1.91 1.91 1.79 1.84 1.92 2.01 1.99 2.01 1.95 2.04 1.86 1.87
REACTOME_REGULATION_OF_PTEN_GENE_TRANSCRIPTION 1.9 1.97 1.91 1.87 2.01 2.03 1.96 1.94 1.95 2 1.9 1.99 1.94 2 1.99 1.9 1.88 1.93 2.02 2.06 1.86 1.9 2.01 2.1 1.92 1.89
REACTOME_COLLAGEN_CHAIN_TRIMERIZATION 0.73 0.72 0.71 0.69 0.91 0.78 0.76 0.74 0.79 0.78 0.7 0.77 0.73 0.78 0.76 0.74 0.7 0.67 0.7 0.75 0.71 0.73 0.83 0.76 0.71 0.74
REACTOME_REGULATION_OF_PTEN_STABILITY_AND_ACTIVITY 1.92 1.9 1.99 1.93 2.01 2.04 2.03 1.92 2 1.94 1.92 1.92 2.02 1.93 1.98 1.98 1.9 1.9 1.97 2.06 2.07 2.1 2.01 2.02 1.95 1.93
REACTOME_MITOCHONDRIAL_CALCIUM_ION_TRANSPORT 1.76 1.79 2.09 1.96 1.89 1.9 1.9 1.66 1.82 1.8 1.81 1.63 1.83 1.81 1.47 1.74 1.73 1.77 1.61 1.74 1.84 1.61 1.79 1.79 1.78 1.66
REACTOME_CRISTAE_FORMATION 1.59 1.46 1.55 1.71 1.53 1.51 1.54 1.3 1.7 1.62 1.39 1.43 1.57 1.69 1.37 1.32 1.51 1.19 1.45 1.63 1.4 1.42 1.67 1.33 1.49 1.4
REACTOME_GENE_AND_PROTEIN_EXPRESSION_BY_JAK_STAT_SIGNALING_AFTER_INTERLEUKIN_12_STIMULATION 2.56 2.63 2.66 2.49 2.76 2.83 2.77 2.63 2.76 2.72 2.63 2.55 2.79 2.77 2.67 2.74 2.6 2.52 2.66 2.78 2.58 2.69 2.66 2.72 2.63 2.57
REACTOME_NEDDYLATION 1.76 1.8 2.02 1.92 2.01 2.05 1.96 1.9 1.99 2 1.96 1.89 2.02 2.02 1.97 1.94 1.83 1.74 1.91 1.98 1.8 1.94 2.04 2.08 1.96 1.9
REACTOME_RUNX3_REGULATES_P14_ARF 1.26 1.2 1.01 1.01 1.59 1.56 1.34 1.38 1.24 1.47 1.03 1.27 1.5 1.33 1.52 1.44 1.32 1.25 1.45 1.53 1.14 1.18 1.42 1.64 1.43 1.41
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_E2F6 1.95 1.99 2.14 2.01 2.13 2.15 2.13 1.9 2.13 2.1 2.01 1.95 2.03 2.12 2.15 2.03 2.03 1.9 2.01 2.04 1.8 2 2.19 2.12 2.07 1.97
REACTOME_METABOLISM_OF_RNA 1.72 1.73 1.83 1.78 1.86 1.88 1.85 1.8 1.82 1.86 1.77 1.79 1.83 1.85 1.81 1.83 1.77 1.72 1.78 1.85 1.75 1.82 1.87 1.87 1.86 1.78
REACTOME_CELLULAR_RESPONSES_TO_EXTERNAL_STIMULI 2.01 2.03 2.21 2.1 2.17 2.22 2.17 2.14 2.15 2.19 2.08 2.13 2.16 2.17 2.15 2.17 2.09 2.05 2.11 2.2 2.07 2.16 2.21 2.23 2.18 2.1
REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN 2.28 2.34 2.55 2.49 2.58 2.66 2.52 2.47 2.6 2.65 2.44 2.62 2.57 2.5 2.53 2.36 2.27 2.25 2.42 2.56 2.22 2.23 2.62 2.67 2.53 2.37
REACTOME_NUCLEOBASE_CATABOLISM 1.44 1.51 1.6 1.33 1.75 1.85 1.65 1.54 1.58 1.66 1.43 1.57 1.58 1.61 1.59 1.57 1.49 1.52 1.64 1.66 1.42 1.53 1.77 1.86 1.7 1.56
REACTOME_NUCLEOBASE_BIOSYNTHESIS 1.4 1.27 1.6 1.76 1.67 1.71 1.64 1.47 1.48 1.44 1.37 1.34 1.49 1.47 1.3 1.44 1.56 1.59 1.4 1.58 1.29 1.33 1.42 1.49 1.58 1.4
REACTOME_NUCLEOTIDE_SALVAGE 1.36 1.45 2.02 1.85 1.45 1.63 1.58 1.7 1.63 1.66 1.67 1.61 1.67 1.67 1.86 1.78 1.39 1.49 1.55 1.66 1.5 1.65 1.88 1.85 1.67 1.54
REACTOME_METABOLISM_OF_STEROIDS 1.81 1.9 2.14 1.96 2.2 2.26 2.17 2.13 2.2 2.21 1.99 2.1 2.2 2.21 2.12 2.12 2.01 1.88 2.02 2.13 1.87 2.02 2.26 2.29 2.15 2.05
REACTOME_ASPARTATE_AND_ASPARAGINE_METABOLISM 1.75 2.02 2.43 2.3 2.2 2.42 2.61 2.38 2.58 2.43 2.41 2.26 2.46 2.36 2.55 2.58 2.26 1.99 2.16 2.32 2.05 2.34 2.53 2.55 2.51 2.4
REACTOME_DIGESTION_AND_ABSORPTION 1.61 1.69 1.63 1.67 1.84 1.85 1.65 1.39 1.69 1.85 1.59 1.64 1.8 1.83 1.54 1.6 1.65 1.7 1.74 1.69 1.57 1.7 1.72 1.74 1.8 1.82
REACTOME_ASSEMBLY_OF_ACTIVE_LPL_AND_LIPC_LIPASE_COMPLEXES 1.79 1.88 1.94 1.71 2.17 2.24 2.07 2.09 2.01 2.19 1.95 2.08 2.18 2.16 2.05 2.03 1.89 1.71 2.02 2.13 1.96 2.04 2.13 2.28 2.12 2.06
REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY 2.29 2.39 2.59 2.45 2.65 2.71 2.58 2.5 2.7 2.6 2.4 2.58 2.72 2.72 2.54 2.54 2.47 2.25 2.5 2.71 2.52 2.6 2.74 2.81 2.66 2.52
REACTOME_PLASMA_LIPOPROTEIN_REMODELING 1.7 1.89 2.01 1.87 2.05 2.16 2.03 2.01 1.99 2.08 1.85 2.03 2.17 2.12 2.01 2.04 1.87 1.79 1.98 2.14 2.02 2.11 2.07 2.23 2.14 2.12
REACTOME_CHYLOMICRON_REMODELING 2.11 2.31 2.43 2.06 2.37 2.44 2.36 2.38 2.26 2.21 2.39 2.4 2.56 2.55 2.43 2.59 2.27 2.16 2.43 2.52 2.47 2.67 2.35 2.56 2.3 2.33
REACTOME_LDL_CLEARANCE 2.19 2.28 2.32 2.15 2.4 2.51 2.46 2.45 2.54 2.48 2.23 2.37 2.48 2.41 2.47 2.39 2.19 2.3 2.47 2.58 2.26 2.39 2.5 2.67 2.51 2.42
REACTOME_PLASMA_LIPOPROTEIN_CLEARANCE 2.21 2.29 2.32 2.15 2.45 2.49 2.38 2.43 2.52 2.4 2.18 2.37 2.46 2.47 2.41 2.39 2.27 2.25 2.44 2.52 2.32 2.39 2.46 2.62 2.51 2.43
REACTOME_HDL_REMODELING 1.72 1.95 2.22 2.12 1.97 2.14 2.06 1.92 2.05 2.05 1.73 2.12 2.29 2.22 2.06 2.24 2.03 1.87 2.09 2.3 2.26 2.32 2.08 2.29 2.27 2.29
REACTOME_GLUTAMATE_AND_GLUTAMINE_METABOLISM 2.13 2.04 2.31 2.22 2.21 2.35 2.12 1.99 2.24 2.29 2.25 2.09 2.25 2.32 2.27 2.05 2.2 1.93 2.15 2.22 2.14 2.14 2.17 2.21 2.35 2.22
REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_CDC42 2.44 2.51 2.19 2.13 2.51 2.43 2.49 2.5 2.48 2.42 2.38 2.28 2.51 2.48 2.61 2.5 2.44 2.53 2.54 2.51 2.33 2.49 2.49 2.53 2.46 2.36
REACTOME_FATTY_ACID_METABOLISM 1.69 1.81 2.04 1.89 2.09 2.1 2 1.97 2.04 2.06 1.93 1.96 2.08 2.09 1.96 2 1.97 1.83 1.96 2.03 1.86 2.01 2.07 2.1 2.07 2.02
REACTOME_METABOLISM_OF_COFACTORS 1.89 1.87 2.13 1.94 2.17 2.09 2.19 2.09 2.07 2.12 2.13 2 2.13 2.12 2.24 2.24 2.18 1.95 2.01 1.94 2.1 2.17 2.19 2.13 2.19 2.13
REACTOME_TRIGLYCERIDE_METABOLISM 1.91 2.05 2.49 2.43 2.34 2.47 2.42 2.33 2.44 2.46 2.23 2.27 2.44 2.45 2.42 2.39 2.18 2.08 2.21 2.3 2.05 2.24 2.47 2.47 2.29 2.11
REACTOME_RHOA_GTPASE_CYCLE 1.71 1.76 1.84 1.73 2.02 2 1.94 1.87 1.94 1.95 1.81 1.97 1.98 1.94 1.88 1.83 1.84 1.71 1.85 1.92 1.79 1.88 1.99 2.05 1.94 1.84
REACTOME_GLYCOGEN_METABOLISM 2.22 2.25 2.41 2.24 2.35 2.33 2.31 2.39 2.34 2.33 2.41 2.31 2.32 2.36 2.43 2.36 2.37 2.31 2.28 2.29 2.41 2.48 2.48 2.46 2.36 2.29
REACTOME_INTERLEUKIN_15_SIGNALING 2.08 2.01 2.09 2.02 2.47 2.52 2.47 2.43 2.46 2.43 2.21 2.42 2.52 2.47 2.34 2.32 2.37 2.17 2.32 2.36 2.06 2.24 2.49 2.48 2.31 2.25
REACTOME_INTERLEUKIN_35_SIGNALLING 2.5 2.56 2.58 2.42 2.86 2.79 2.71 2.58 2.79 2.69 2.55 2.67 2.81 2.76 2.53 2.69 2.68 2.55 2.62 2.68 2.61 2.63 2.85 2.83 2.79 2.68
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2 1.93 1.88 1.97 1.87 2.1 2.18 2.11 1.96 2.02 2.04 1.91 1.99 2.06 2.13 2.09 2.08 1.86 1.87 2.04 2.07 1.96 1.95 2.14 2.16 2.02 1.94
REACTOME_LOSS_OF_FUNCTION_OF_MECP2_IN_RETT_SYNDROME 1.56 1.51 1.58 1.42 1.74 1.76 1.63 1.56 1.64 1.61 1.68 1.6 1.68 1.71 1.49 1.79 1.39 1.38 1.66 1.59 1.48 1.55 1.7 1.75 1.72 1.58
REACTOME_SIGNALING_BY_NTRK2_TRKB 2.16 2.06 1.89 1.93 2.34 2.35 2.15 1.95 2.31 2.18 2.05 2.2 2.22 2.19 1.94 2.09 1.97 1.83 2.32 2.19 1.95 2.09 2.17 2.26 2.08 2
REACTOME_SIGNALING_BY_ERYTHROPOIETIN 1.75 1.76 1.71 1.65 1.99 2.05 1.97 1.84 2.04 2.02 1.82 1.99 2 2.05 1.92 1.92 1.84 1.8 2.01 1.96 1.63 1.81 2.08 2.09 1.89 1.75
REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS 1.98 2.04 2.12 1.99 2.22 2.28 2.19 2.14 2.19 2.19 2.07 2.17 2.22 2.21 2.16 2.15 2.03 2 2.16 2.24 2.02 2.12 2.24 2.31 2.16 2.08
REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS 1.97 2.03 2.15 2.06 2.24 2.26 2.2 2.17 2.2 2.23 2.1 2.18 2.2 2.21 2.21 2.21 2.08 2.04 2.15 2.24 2.06 2.13 2.27 2.34 2.22 2.16
REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES 2.05 2.11 2.25 2.14 2.28 2.35 2.29 2.23 2.28 2.3 2.16 2.23 2.31 2.31 2.24 2.25 2.15 2.09 2.21 2.3 2.09 2.22 2.3 2.4 2.27 2.19
REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS 1.91 1.98 2.08 2.02 2.15 2.18 2.07 2.01 2.1 2.12 2.02 2.09 2.08 2.18 2.05 2.07 2.04 1.95 2.07 2.11 1.93 2.05 2.15 2.21 2.08 2.04
REACTOME_RAB_REGULATION_OF_TRAFFICKING 1.93 1.97 2.04 1.99 2.07 2.09 2.07 2.04 2.07 2.05 1.97 1.97 2.06 2.09 2 2.01 2.04 1.98 2 2.09 1.99 2.02 2.07 2.07 2.04 1.95
REACTOME_INTERLEUKIN_37_SIGNALING 1.64 1.63 1.86 1.65 1.97 1.98 1.91 1.74 1.97 2 1.81 1.87 2.02 1.99 1.94 1.86 1.73 1.61 1.78 1.81 1.63 1.81 2.04 2.08 1.91 1.79
REACTOME_EXTRA_NUCLEAR_ESTROGEN_SIGNALING 2.27 2.31 2.4 2.28 2.5 2.52 2.49 2.46 2.47 2.48 2.43 2.42 2.48 2.48 2.5 2.5 2.39 2.35 2.42 2.49 2.31 2.44 2.54 2.58 2.47 2.39
REACTOME_ER_QUALITY_CONTROL_COMPARTMENT_ERQC 2.15 2.15 2.24 2.13 2.15 2.15 2.23 2.23 2.18 2.22 2.23 2.25 2.24 2.23 2.2 2.29 2.27 2.27 2.17 2.19 2.4 2.34 2.2 2.19 2.16 2.23
REACTOME_CALNEXIN_CALRETICULIN_CYCLE 2.21 2.2 2.29 2.12 2.18 2.16 2.28 2.25 2.24 2.26 2.28 2.28 2.25 2.25 2.24 2.34 2.35 2.32 2.2 2.22 2.44 2.37 2.25 2.21 2.23 2.27
REACTOME_REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS 2.09 2.09 2.33 2.2 2.25 2.27 2.29 2.24 2.27 2.28 2.16 2.22 2.25 2.25 2.22 2.24 2.2 2.12 2.14 2.3 2.2 2.3 2.32 2.34 2.29 2.2
REACTOME_SIGNALING_BY_NOTCH3 1.99 1.99 2.1 2.07 2.19 2.19 2.13 2.12 2.13 2.12 2.04 2.12 2.09 2.05 2.04 2.03 2.08 2.07 2.07 2.08 1.96 2.09 2.13 2.2 2.09 2.02
REACTOME_RHO_GTPASE_CYCLE 1.83 1.86 1.99 1.89 2.08 2.09 2.03 1.96 2.02 2.03 1.91 2 2.05 2.04 1.98 1.96 1.92 1.84 1.96 2 1.85 1.95 2.06 2.11 2.02 1.93
REACTOME_RHOB_GTPASE_CYCLE 1.69 1.72 1.79 1.67 2.03 2.01 1.89 1.83 1.93 1.98 1.81 2 2.01 1.95 1.87 1.82 1.86 1.73 1.81 1.9 1.79 1.91 1.97 2.02 1.95 1.87
REACTOME_RHOC_GTPASE_CYCLE 1.7 1.76 1.84 1.74 2.01 1.98 1.87 1.81 1.94 1.92 1.85 1.98 1.96 1.92 1.84 1.78 1.87 1.71 1.83 1.9 1.79 1.92 2.02 1.97 1.94 1.84
REACTOME_CDC42_GTPASE_CYCLE 1.73 1.75 1.8 1.67 2.05 2.06 1.93 1.88 1.93 1.97 1.78 1.99 2.01 1.98 1.91 1.88 1.89 1.77 1.89 1.9 1.74 1.86 1.99 2.07 1.93 1.89
REACTOME_RAC1_GTPASE_CYCLE 1.84 1.87 1.89 1.82 2.13 2.16 2.04 1.96 2.03 2.06 1.87 2.05 2.08 2.08 1.98 1.97 1.93 1.86 2.01 2.03 1.8 1.94 2.09 2.14 2.02 1.96
REACTOME_RAC2_GTPASE_CYCLE 1.84 1.85 1.92 1.85 2.12 2.14 2.02 1.98 2.02 2.1 1.86 1.99 2.05 2.03 1.97 1.93 1.91 1.81 2.01 1.98 1.77 1.91 2.11 2.14 1.99 1.9
REACTOME_RHOD_GTPASE_CYCLE 1.74 1.73 1.8 1.69 2.04 2.03 1.93 1.83 1.94 1.96 1.8 1.96 1.98 1.97 1.88 1.8 1.89 1.75 1.94 1.94 1.73 1.85 2.03 2.02 1.9 1.76
REACTOME_RHOQ_GTPASE_CYCLE 1.76 1.8 1.91 1.86 2.06 2.08 1.96 1.91 1.95 2.02 1.82 1.98 2.01 2.01 1.99 1.89 2 1.85 1.89 1.95 1.81 1.95 2.06 2.08 2.03 1.94
REACTOME_RHOH_GTPASE_CYCLE 1.83 1.86 1.98 1.91 1.98 2.03 1.89 1.79 1.9 1.88 1.86 1.8 1.9 1.92 1.83 1.78 1.8 1.78 1.86 1.87 1.67 1.78 1.93 2 1.94 1.77
REACTOME_RHOG_GTPASE_CYCLE 1.74 1.76 1.76 1.7 2.03 2.01 1.89 1.82 1.89 1.92 1.71 1.86 1.94 1.94 1.85 1.73 1.79 1.68 1.82 1.89 1.66 1.77 1.96 1.96 1.88 1.77
REACTOME_RHOJ_GTPASE_CYCLE 1.78 1.85 1.9 1.8 2.1 2.15 2 1.95 1.97 2.04 1.88 2.02 2.09 2.08 1.99 1.96 1.99 1.92 2.01 2.03 1.8 1.97 2.08 2.12 2.01 1.98
REACTOME_RHOBTB2_GTPASE_CYCLE 1.75 1.63 1.87 1.74 1.61 1.54 1.71 1.74 1.66 1.63 1.68 1.53 1.61 1.66 1.7 1.74 1.57 1.71 1.49 1.63 1.83 1.77 1.66 1.57 1.75 1.72
REACTOME_RHOU_GTPASE_CYCLE 1.73 1.81 1.85 1.71 2.01 2.01 1.98 2.01 1.95 2.02 1.82 1.95 1.97 1.96 1.97 1.91 1.73 1.75 1.84 1.87 1.75 1.89 2.04 2.09 1.93 1.83
REACTOME_RHOBTB1_GTPASE_CYCLE 1.26 1.32 1.81 1.72 1.39 1.46 1.53 1.48 1.53 1.52 1.61 1.38 1.49 1.54 1.45 1.53 1.39 1.27 1.35 1.46 1.39 1.43 1.43 1.49 1.51 1.4
REACTOME_RAC3_GTPASE_CYCLE 1.86 1.93 1.97 1.87 2.19 2.23 2.09 2.03 2.1 2.12 1.91 2.06 2.13 2.12 2.05 2.04 2.01 1.87 2.07 2.07 1.85 2.01 2.18 2.22 2.09 2.01
REACTOME_RHOV_GTPASE_CYCLE 1.76 1.78 1.86 1.69 1.98 1.98 1.94 1.98 1.92 1.99 1.79 1.94 1.92 1.92 1.91 1.87 1.77 1.73 1.83 1.86 1.79 1.93 2.03 2.05 1.88 1.78
REACTOME_NOTCH3_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS 2.52 2.56 2.69 2.57 2.73 2.76 2.69 2.71 2.72 2.68 2.61 2.69 2.6 2.57 2.52 2.56 2.63 2.6 2.57 2.64 2.54 2.65 2.7 2.78 2.59 2.52
REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION 1.4 1.35 1.45 1.54 1.61 1.56 1.52 1.46 1.49 1.52 1.38 1.5 1.54 1.5 1.54 1.45 1.46 1.5 1.53 1.44 1.31 1.46 1.49 1.57 1.55 1.49
REACTOME_SIGNALING_BY_NOTCH4 1.76 1.76 1.91 1.81 1.87 1.89 1.85 1.8 1.89 1.81 1.77 1.82 1.83 1.74 1.83 1.78 1.72 1.72 1.82 1.9 1.87 1.89 1.91 1.96 1.77 1.73
REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION 1.27 1.13 1.21 1.09 1.35 1.34 1.24 1.21 1.36 1.26 1.11 1.41 1.3 1.27 1.22 1.14 1.28 1.4 1.35 1.31 1.3 1.26 1.56 1.4 1.27 1.2
REACTOME_NOTCH4_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS 2.08 2.19 2.21 2.13 2.47 2.49 2.18 2.23 2.4 2.43 2.31 2.2 2.25 2.14 2.2 2.04 2.09 1.74 2.23 2.36 1.84 2.04 2.32 2.52 2.03 1.87
REACTOME_TICAM1_DEPENDENT_ACTIVATION_OF_IRF3_IRF7 2.94 2.99 3.06 2.87 3 2.97 2.97 3.03 2.83 2.94 2.9 3.01 2.9 2.91 2.91 3.02 3.05 3.14 2.96 2.94 3.08 3.12 2.95 3.07 2.92 2.98
REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION 1.74 1.78 1.95 1.93 1.98 1.97 1.93 1.92 1.91 1.92 1.87 1.93 1.92 1.9 1.91 1.94 1.84 1.79 1.84 1.95 1.79 1.87 1.92 2.03 1.93 1.89
REACTOME_BIOSYNTHESIS_OF_SPECIALIZED_PRORESOLVING_MEDIATORS_SPMS 1.69 1.9 2.27 2.23 1.98 2.1 2.11 2.06 1.95 1.99 1.86 1.91 1.95 2.04 2.05 2.04 1.84 1.79 1.94 2.11 1.98 2.12 2.05 2.17 2.08 2.07
REACTOME_INTERLEUKIN_2_SIGNALING 1.75 1.76 1.92 1.92 1.9 2.05 1.99 1.91 1.88 2.02 1.87 1.91 1.98 2.13 1.87 2.01 1.81 1.89 2 1.87 1.78 1.84 2.04 2.07 1.95 1.94
REACTOME_INTERLEUKIN_12_SIGNALING 2.46 2.54 2.63 2.47 2.71 2.78 2.71 2.61 2.71 2.67 2.56 2.53 2.75 2.73 2.63 2.71 2.56 2.46 2.61 2.73 2.54 2.65 2.66 2.74 2.65 2.6
REACTOME_INTERLEUKIN_1_SIGNALING 1.97 2 2.29 2.15 2.2 2.28 2.29 2.22 2.24 2.21 2.19 2.15 2.24 2.19 2.25 2.21 2.04 2.03 2.09 2.2 2.13 2.26 2.28 2.32 2.14 2.07
REACTOME_INTERLEUKIN_27_SIGNALING 2.3 2.32 2.32 2.06 2.6 2.4 2.4 2.28 2.53 2.37 2.37 2.34 2.39 2.39 2.16 2.38 2.45 2.36 2.39 2.33 2.29 2.3 2.45 2.49 2.33 2.23
REACTOME_INTERLEUKIN_21_SIGNALING 1.88 2.08 2.06 1.97 2.28 2.31 2.14 2.1 2.22 2.29 2.01 2.24 2.39 2.37 2.07 2.21 2.14 1.85 2.18 2.12 1.91 2.09 2.34 2.4 2.17 2.06
REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY 1.59 1.65 1.71 1.61 1.71 1.77 1.65 1.65 1.67 1.68 1.66 1.72 1.71 1.7 1.63 1.68 1.51 1.59 1.68 1.7 1.7 1.58 1.7 1.77 1.53 1.49
REACTOME_MECP2_REGULATES_NEURONAL_RECEPTORS_AND_CHANNELS 1.7 1.74 1.74 1.62 1.78 1.98 1.9 1.78 1.8 1.82 1.71 1.71 1.82 1.86 2.11 1.96 1.52 1.6 1.84 1.8 1.68 1.76 2 1.79 1.82 1.74
REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING 1.93 2.06 2.03 1.97 2.35 2.36 2.19 2.2 2.24 2.26 2.02 2.22 2.26 2.27 2.21 2.21 2.1 2.08 2.23 2.29 2.09 2.13 2.27 2.37 2.27 2.27
REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOINOSITIDE_3_KINASE_PI3K 2.04 2.13 1.94 1.94 2.4 2.42 2.32 2.15 2.49 2.46 2.16 2.41 2.36 2.38 2.26 2.24 2.15 2.02 2.33 2.39 1.79 2.06 2.47 2.49 2.27 2.02
REACTOME_ERYTHROPOIETIN_ACTIVATES_RAS 1.37 1.36 1.46 1.35 1.61 1.64 1.76 1.66 1.57 1.68 1.5 1.52 1.58 1.6 1.67 1.64 1.45 1.64 1.72 1.61 1.48 1.65 1.68 1.72 1.63 1.45
REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_FRS2_AND_FRS3 2.17 2.07 2.21 2.17 2.5 2.41 2.36 2.25 2.47 2.34 2.35 2.42 2.48 2.48 2.27 2.34 2.23 2.05 2.38 2.33 2.37 2.39 2.39 2.43 2.43 2.29
REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX 1.89 1.99 1.95 1.88 2.22 2.26 2.08 2.02 2.13 2.11 1.89 2.13 2.15 2.16 2.09 2.09 2.04 2.02 2.14 2.2 2.1 2.07 2.18 2.27 2.17 2.15
REACTOME_NGF_STIMULATED_TRANSCRIPTION 1.86 1.88 1.77 1.72 2 1.95 1.83 1.94 1.84 1.88 1.79 1.96 1.96 1.99 1.87 1.84 1.92 1.81 1.89 2.02 1.74 1.73 1.81 1.9 1.9 1.92
REACTOME_PEROXISOMAL_PROTEIN_IMPORT 1.95 2.01 2.11 2.02 2.15 2.17 2.09 2.07 2.13 2.16 2.08 2.07 2.14 2.11 2.13 2.1 2.08 2.02 2.08 2.12 2.12 2.12 2.13 2.19 2.17 2.14
REACTOME_BLOOD_GROUP_SYSTEMS_BIOSYNTHESIS 1.73 1.75 2.22 2.03 2.1 2.12 2 2.08 1.93 2.05 2.05 1.98 2.01 2.09 2.08 2.16 2.03 1.98 2.14 2.02 1.97 2.09 2.19 2.13 1.97 1.96
REACTOME_SIGNALING_BY_NTRK3_TRKC 1.71 1.67 1.69 1.43 2.07 2.1 1.94 1.76 2.08 1.98 1.91 1.84 2.03 1.98 1.74 1.87 1.83 1.62 2.02 1.89 1.69 1.89 1.89 2.04 1.8 1.72
REACTOME_RHOF_GTPASE_CYCLE 2.24 2.25 2.26 2.15 2.51 2.56 2.47 2.35 2.45 2.43 2.28 2.4 2.49 2.47 2.4 2.33 2.32 2.22 2.44 2.43 2.14 2.3 2.48 2.52 2.34 2.2
REACTOME_INTERFERON_ALPHA_BETA_SIGNALING 1.67 1.77 1.96 1.84 1.99 2.05 2 1.89 1.99 2.12 2.07 1.97 2.13 2.1 1.98 1.97 1.85 1.74 1.89 2.04 1.91 2.1 2.08 2.14 2.14 2.04
REACTOME_MEIOTIC_RECOMBINATION 1.41 1.44 1.8 1.75 1.87 1.92 1.73 1.48 1.71 1.81 1.57 1.61 1.7 1.73 1.64 1.65 1.41 1.29 1.55 1.61 1.39 1.62 1.86 1.86 1.7 1.56
REACTOME_INTERLEUKIN_RECEPTOR_SHC_SIGNALING 1.87 1.94 2.07 2.02 2.27 2.41 2.28 2.25 2.31 2.27 2.12 2.23 2.36 2.38 2.2 2.22 2.11 2.02 2.24 2.26 1.92 2.15 2.34 2.39 2.18 2.12
REACTOME_REGULATION_OF_SIGNALING_BY_CBL 2.41 2.5 2.44 2.46 2.49 2.51 2.6 2.55 2.46 2.54 2.55 2.61 2.47 2.54 2.48 2.55 2.55 2.52 2.57 2.53 2.52 2.59 2.59 2.63 2.52 2.5
REACTOME_REGULATION_OF_IFNA_SIGNALING 1.71 1.91 1.97 1.77 2.2 2.25 1.98 1.97 2.1 2.29 2.06 2.06 2.17 2.16 2.14 2.05 1.98 1.7 1.95 2.02 1.86 2.15 2.21 2.25 2.17 2.03
REACTOME_INTERFERON_SIGNALING 2.02 2.04 2.27 2.19 2.24 2.33 2.26 2.16 2.23 2.31 2.2 2.2 2.29 2.31 2.26 2.28 2.08 2.02 2.17 2.25 2.14 2.26 2.36 2.41 2.27 2.18
REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS 1.37 1.42 1.61 1.57 1.76 1.81 1.62 1.63 1.7 1.75 1.51 1.53 1.79 1.81 1.69 1.74 1.47 1.42 1.59 1.64 1.4 1.66 1.78 1.85 1.72 1.69
REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT 2.19 2.23 2.23 2.08 2.22 2.21 2.12 2.1 2.27 2.22 2.1 2.21 2.14 2.12 2.16 2.22 2.27 2.29 2.26 2.19 2.2 2.11 2.16 2.21 2.19 2.19
REACTOME_IRON_UPTAKE_AND_TRANSPORT 2.58 2.68 2.76 2.65 2.74 2.86 2.74 2.77 2.73 2.81 2.66 2.67 2.83 2.76 2.75 2.7 2.53 2.53 2.75 2.82 2.57 2.71 2.79 2.93 2.83 2.72
REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING 2.7 2.8 3.01 2.78 2.82 2.97 2.97 2.94 2.87 2.94 2.76 2.77 2.92 2.82 2.89 2.86 2.7 2.65 2.76 2.93 2.71 2.85 2.88 3.03 2.97 2.81
REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY 1.5 1.56 1.38 1.56 1.6 1.66 1.7 1.81 1.65 1.67 1.43 1.59 1.68 1.67 1.69 1.56 1.61 1.61 1.64 1.7 1.57 1.67 1.68 1.76 1.73 1.63
REACTOME_NONSENSE_MEDIATED_DECAY_NMD 2.18 2.14 2.31 2.16 2.28 2.27 2.28 2.22 2.24 2.29 2.19 2.25 2.24 2.27 2.18 2.22 2.3 2.17 2.14 2.3 2.17 2.28 2.31 2.31 2.28 2.19
REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION 1.74 1.81 1.79 1.74 1.98 2.04 1.92 1.89 1.94 2.01 1.8 1.81 1.96 2.01 1.95 1.86 1.74 1.69 1.93 1.91 1.67 1.89 2.03 2.07 1.99 1.83
REACTOME_TRAF6_MEDIATED_NF_KB_ACTIVATION 2.06 1.92 2.14 2.17 2.39 2.36 2.34 2.29 2.26 2.24 2.13 2.19 2.29 2.24 2.14 2.05 2.26 2.06 2.04 2.22 2.12 2.19 2.19 2.27 2.18 2.12
REACTOME_NF_KB_ACTIVATION_THROUGH_FADD_RIP_1_PATHWAY_MEDIATED_BY_CASPASE_8_AND_10 0.99 1 0.96 0.95 1.11 1.12 1.12 1.27 1.05 1.1 0.98 1.07 1.22 1.18 1.11 0.89 1.13 1.08 1.1 1.07 1.05 1.06 1.04 1.18 1.28 1.33
REACTOME_NEGATIVE_REGULATORS_OF_DDX58_IFIH1_SIGNALING 2.12 2.16 2.39 2.43 2.24 2.29 2.3 2.32 2.28 2.3 2.31 2.18 2.26 2.29 2.38 2.36 2.27 2.27 2.18 2.28 2.34 2.39 2.37 2.41 2.33 2.28
REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES 2.4 2.44 2.63 2.46 2.69 2.68 2.66 2.63 2.6 2.64 2.53 2.6 2.64 2.72 2.64 2.73 2.47 2.49 2.62 2.71 2.5 2.68 2.62 2.77 2.6 2.55
REACTOME_ACTIVATION_OF_IRF3_IRF7_MEDIATED_BY_TBK1_IKK_EPSILON 2.46 2.58 2.44 2.41 2.58 2.5 2.56 2.54 2.55 2.71 2.65 2.67 2.59 2.57 2.53 2.51 2.63 2.66 2.63 2.56 2.73 2.57 2.61 2.61 2.42 2.48
REACTOME_IRAK1_RECRUITS_IKK_COMPLEX 2.85 2.79 2.9 2.85 2.8 2.74 2.72 2.91 2.6 2.73 2.94 2.75 2.83 2.81 2.9 3.05 2.91 2.97 2.77 2.67 3.02 3.04 2.76 2.87 2.84 2.89
REACTOME_IKK_COMPLEX_RECRUITMENT_MEDIATED_BY_RIP1 2.49 2.53 2.6 2.55 2.65 2.54 2.59 2.64 2.56 2.62 2.71 2.59 2.59 2.58 2.67 2.61 2.64 2.55 2.56 2.61 2.69 2.63 2.61 2.61 2.53 2.57
REACTOME_TRAF6_MEDIATED_INDUCTION_OF_TAK1_COMPLEX_WITHIN_TLR4_COMPLEX 2.57 2.66 2.76 2.7 2.74 2.73 2.7 2.67 2.74 2.86 2.87 2.88 2.76 2.74 2.71 2.69 2.75 2.69 2.75 2.71 2.83 2.75 2.77 2.74 2.57 2.62
REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION 2.02 2.07 2.13 2.07 2.15 2.25 2.16 2.15 2.18 2.19 2.08 2.15 2.15 2.19 2.18 2.16 2.03 2 2.15 2.22 2 2.08 2.21 2.29 2.14 2.07
REACTOME_CLASS_I_PEROXISOMAL_MEMBRANE_PROTEIN_IMPORT 1.28 1.26 1.5 1.4 1.11 1.28 1.29 1.33 1.27 1.37 1.39 1.15 1.25 1.29 1.35 1.38 1.19 1.25 1.4 1.26 1.2 1.31 1.29 1.31 1.33 1.44
REACTOME_NEGATIVE_REGULATION_OF_NOTCH4_SIGNALING 1.92 1.93 2.01 1.89 1.99 2.03 2.01 1.96 1.99 1.91 1.88 1.96 2.01 1.9 1.98 1.97 1.86 1.89 1.99 2.09 2.11 2.14 2.01 2.11 1.94 1.92
REACTOME_FLT3_SIGNALING 2.24 2.33 2.51 2.32 2.54 2.55 2.45 2.44 2.44 2.55 2.46 2.55 2.51 2.57 2.47 2.51 2.52 2.39 2.42 2.43 2.39 2.49 2.57 2.57 2.41 2.38
REACTOME_PROTEIN_LOCALIZATION 1.85 1.91 1.99 1.9 2.02 2.05 2.02 1.95 2.03 2.03 1.95 1.93 2.01 2 1.99 1.97 1.92 1.87 1.98 2.01 1.91 1.92 2.05 2.07 2 1.95
REACTOME_INSERTION_OF_TAIL_ANCHORED_PROTEINS_INTO_THE_ENDOPLASMIC_RETICULUM_MEMBRANE 2.19 2.31 1.97 2 2.32 2.36 2.24 2.2 2.23 2.23 2.22 2.22 2.28 2.26 2.23 2.15 2.32 2.22 2.31 2.31 2.06 2.07 2.31 2.3 2.14 2.12
REACTOME_HCMV_INFECTION 1.84 1.92 2.03 1.94 1.96 2.05 2 1.94 2.04 2.07 1.88 2.01 1.95 1.97 2 1.98 1.93 1.9 1.94 2.03 1.88 1.86 2.02 2.12 2.01 1.9
REACTOME_HCMV_EARLY_EVENTS 1.87 1.94 2.1 2.04 2.03 2.13 2.09 2.05 2.09 2.16 1.97 2.08 2.02 2.07 2.09 2.05 1.96 1.92 1.96 2.11 1.94 1.96 2.11 2.22 2.08 1.96
REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS 2.39 2.49 2.49 2.32 2.61 2.73 2.55 2.54 2.54 2.61 2.43 2.6 2.56 2.58 2.48 2.51 2.3 2.48 2.55 2.63 2.39 2.39 2.6 2.74 2.54 2.32
REACTOME_HCMV_LATE_EVENTS 1.61 1.68 1.73 1.65 1.66 1.72 1.71 1.6 1.72 1.69 1.48 1.65 1.64 1.67 1.65 1.64 1.63 1.68 1.67 1.72 1.56 1.54 1.69 1.74 1.68 1.6
REACTOME_AUTOPHAGY 2.12 2.19 2.32 2.24 2.27 2.28 2.28 2.28 2.27 2.3 2.18 2.24 2.24 2.21 2.29 2.26 2.26 2.18 2.19 2.28 2.21 2.21 2.31 2.33 2.32 2.24
REACTOME_CHAPERONE_MEDIATED_AUTOPHAGY 3.19 3.13 3.53 3.35 3.18 3.18 3.37 3.45 3.19 3.23 3.2 3.1 3.19 3.13 3.38 3.31 3.37 3.28 3.03 3.29 3.38 3.33 3.32 3.29 3.36 3.29
REACTOME_FOXO_MEDIATED_TRANSCRIPTION 1.85 1.91 1.99 2 2.13 2.2 2.08 2.13 2.02 2.08 1.99 2.08 2.1 2.09 2.12 2.04 2.04 1.95 2.05 2.16 1.92 2.05 2.1 2.23 2.19 2.09
REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS 2.5 2.47 2.38 2.4 2.37 2.51 2.39 2.26 2.5 2.48 2.39 2.21 2.29 2.34 2.46 2.38 2.48 2.34 2.35 2.33 2.31 2.31 2.48 2.55 2.44 2.18
REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES 1.51 1.56 1.38 1.59 1.73 1.93 1.79 1.92 1.74 1.74 1.48 1.78 1.82 1.82 1.84 1.81 1.77 1.66 1.84 1.98 1.64 1.83 1.69 1.93 1.93 1.73
REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_OXIDATIVE_STRESS_METABOLIC_AND_NEURONAL_GENES 1.27 1.51 1.68 1.51 1.82 1.77 1.67 1.78 1.67 1.69 1.69 1.77 1.73 1.72 1.79 1.72 1.71 1.52 1.71 1.74 1.55 1.67 1.81 1.96 1.88 1.8
REACTOME_LATE_ENDOSOMAL_MICROAUTOPHAGY 2.74 2.75 3.05 2.89 2.74 2.77 2.81 2.83 2.81 2.81 2.78 2.74 2.71 2.67 2.88 2.86 2.97 2.81 2.77 2.84 2.83 2.81 2.89 2.82 2.91 2.84
REACTOME_POSTMITOTIC_NUCLEAR_PORE_COMPLEX_NPC_REFORMATION 1.59 1.73 1.84 1.75 1.76 1.92 1.89 1.82 1.73 1.87 1.52 1.77 1.82 1.88 1.83 1.74 1.64 1.72 1.66 1.79 1.65 1.79 1.84 1.97 1.81 1.73
REACTOME_TRANSCRIPTIONAL_REGULATION_OF_GRANULOPOIESIS 1.48 1.5 1.75 1.81 1.66 1.76 1.7 1.53 1.61 1.72 1.56 1.81 1.66 1.67 1.61 1.6 1.62 1.62 1.56 1.75 1.56 1.53 1.81 1.85 1.68 1.57
REACTOME_NEGATIVE_REGULATION_OF_NMDA_RECEPTOR_MEDIATED_NEURONAL_TRANSMISSION 1.93 1.89 2.04 1.77 2.12 2.22 1.94 1.9 1.94 1.96 2.01 2 2.04 2.04 1.85 2.02 1.75 2.04 2.06 2.1 1.91 2 2 2.13 1.95 1.89
REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_CYCLE_GENES 1.38 1.52 1.76 1.92 1.8 1.85 1.8 1.85 1.69 1.76 1.61 1.79 1.8 1.8 1.92 1.74 1.73 1.65 1.68 1.96 1.58 1.73 1.85 1.89 1.81 1.74
REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS 2.28 2.43 2.57 2.49 2.44 2.64 2.53 2.56 2.52 2.65 2.43 2.6 2.52 2.5 2.55 2.53 2.33 2.34 2.47 2.57 2.41 2.32 2.55 2.71 2.6 2.37
REACTOME_EGR2_AND_SOX10_MEDIATED_INITIATION_OF_SCHWANN_CELL_MYELINATION 1.98 1.97 2.09 1.92 2.16 2.2 2.07 2.08 2.11 2.1 1.98 2.08 2.12 2.11 1.95 1.91 2.15 2.08 1.97 2.11 1.95 1.93 2.03 2.08 2.05 1.96
REACTOME_LONG_TERM_POTENTIATION 1.91 1.88 1.94 1.7 2.15 2.18 1.92 1.9 1.89 1.93 1.96 1.94 2 2 1.93 1.98 1.81 2.08 2.02 2.07 1.89 1.97 1.98 2.07 1.9 1.84
REACTOME_RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY 2.26 2.21 2.45 2.35 2.28 2.26 2.31 2.32 2.29 2.36 2.32 2.32 2.25 2.3 2.29 2.35 2.41 2.32 2.19 2.31 2.31 2.4 2.38 2.38 2.39 2.35
REACTOME_CONSTITUTIVE_SIGNALING_BY_OVEREXPRESSED_ERBB2 1.75 1.61 1.68 1.63 1.89 1.75 1.86 1.91 1.71 1.67 1.81 1.63 1.68 1.61 1.71 1.73 1.71 1.57 1.89 1.6 1.8 1.84 1.57 1.56 1.67 1.62
REACTOME_REGULATION_OF_GLYCOLYSIS_BY_FRUCTOSE_2_6_BISPHOSPHATE_METABOLISM 2.36 2.47 2.68 2.56 2.62 2.65 2.56 2.55 2.64 2.64 2.57 2.6 2.64 2.64 2.61 2.55 2.4 2.41 2.53 2.73 2.28 2.54 2.7 2.6 2.54 2.51
REACTOME_ESTROGEN_DEPENDENT_NUCLEAR_EVENTS_DOWNSTREAM_OF_ESR_MEMBRANE_SIGNALING 2.21 2.31 2.62 2.49 2.46 2.63 2.59 2.52 2.54 2.61 2.56 2.55 2.55 2.58 2.56 2.57 2.45 2.35 2.3 2.51 2.39 2.56 2.68 2.69 2.62 2.47
REACTOME_INFECTION_WITH_MYCOBACTERIUM_TUBERCULOSIS 2.74 2.79 3 2.87 2.84 3 2.95 2.86 2.9 3 2.87 3 3.01 2.94 2.91 2.86 2.89 2.91 2.84 2.99 2.9 2.96 3.03 3.07 2.88 2.81
REACTOME_SUPPRESSION_OF_PHAGOSOMAL_MATURATION 2.72 2.67 2.87 2.79 2.87 2.82 2.66 2.76 2.78 2.84 2.9 2.87 2.85 2.75 2.75 2.86 2.84 2.84 2.73 2.82 2.95 2.87 2.77 2.86 2.73 2.75
REACTOME_RESPONSE_OF_MTB_TO_PHAGOCYTOSIS 2.75 2.74 2.88 2.77 2.78 2.84 2.7 2.68 2.76 2.81 2.81 2.81 2.81 2.76 2.77 2.76 2.75 2.83 2.73 2.84 2.82 2.77 2.82 2.89 2.76 2.67
REACTOME_AMINO_ACIDS_REGULATE_MTORC1 1.94 2.06 2.19 2.12 2.03 2.14 2.1 2.09 2.02 2.11 1.99 1.98 2.09 2.06 2.09 2.09 1.92 1.94 2.04 2.08 1.89 2.07 2.07 2.15 2.12 2.04
REACTOME_DISEASES_OF_PROGRAMMED_CELL_DEATH 2.21 2.27 2.31 2.17 2.33 2.44 2.39 2.35 2.26 2.31 2.23 2.24 2.3 2.34 2.32 2.3 2.28 2.2 2.35 2.41 2.24 2.32 2.32 2.42 2.38 2.3
REACTOME_AGGREPHAGY 2.66 2.79 3.05 2.91 2.81 2.89 2.87 2.95 2.87 2.94 2.88 2.92 2.82 2.83 2.94 2.94 2.83 2.71 2.77 2.9 2.9 2.82 2.9 3.07 2.97 2.81
REACTOME_RAS_PROCESSING 2.51 2.52 2.46 2.46 2.63 2.63 2.6 2.59 2.5 2.54 2.6 2.52 2.51 2.47 2.46 2.56 2.57 2.55 2.52 2.48 2.68 2.68 2.6 2.45 2.61 2.61
REACTOME_RESPONSE_OF_EIF2AK1_HRI_TO_HEME_DEFICIENCY 1.66 1.67 1.63 1.77 1.83 1.99 1.83 1.72 1.88 1.87 1.77 1.88 1.89 1.83 1.72 1.78 1.68 1.67 1.83 1.69 1.54 1.9 1.94 2.02 1.76 1.78
REACTOME_DEFECTS_OF_CONTACT_ACTIVATION_SYSTEM_CAS_AND_KALLIKREIN_KININ_SYSTEM_KKS 1.26 1.42 2.01 1.98 1.58 1.72 1.69 1.49 1.52 1.74 1.53 1.51 1.55 1.62 1.44 1.54 1.72 1.51 1.53 1.71 1.64 1.66 1.72 1.74 1.99 1.88
REACTOME_LEISHMANIA_INFECTION 2.17 2.21 2.25 2.09 2.42 2.48 2.4 2.32 2.39 2.4 2.23 2.34 2.45 2.46 2.39 2.38 2.22 2.17 2.38 2.44 2.15 2.32 2.42 2.51 2.4 2.35
REACTOME_SENSORY_PROCESSING_OF_SOUND 2.45 2.47 2.51 2.33 2.66 2.76 2.63 2.63 2.59 2.64 2.45 2.59 2.7 2.69 2.65 2.67 2.44 2.42 2.63 2.74 2.42 2.59 2.7 2.79 2.66 2.6
REACTOME_ABERRANT_REGULATION_OF_MITOTIC_G1_S_TRANSITION_IN_CANCER_DUE_TO_RB1_DEFECTS 1.5 1.46 2.06 2.15 1.89 1.94 1.75 1.69 1.85 1.89 1.74 1.75 1.86 1.88 1.84 1.82 1.75 1.74 1.65 1.91 1.75 1.86 1.93 1.89 1.82 1.68
REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION 1.91 1.98 2.11 1.92 2.19 2.24 2.21 2.16 2.21 2.21 2.06 2.15 2.29 2.3 2.26 2.24 2.02 2 2.19 2.3 1.95 2.15 2.23 2.34 2.22 2.17
REACTOME_PURINERGIC_SIGNALING_IN_LEISHMANIASIS_INFECTION 2.4 2.33 2.25 2.1 2.58 2.62 2.5 2.53 2.48 2.52 2.22 2.47 2.51 2.48 2.44 2.4 2.46 2.37 2.42 2.52 2.32 2.4 2.48 2.57 2.61 2.58
REACTOME_SENSORY_PROCESSING_OF_SOUND_BY_OUTER_HAIR_CELLS_OF_THE_COCHLEA 2.33 2.34 2.4 2.16 2.58 2.63 2.57 2.52 2.56 2.59 2.38 2.52 2.6 2.56 2.56 2.62 2.38 2.21 2.42 2.54 2.4 2.54 2.7 2.75 2.6 2.53
REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION 1.88 1.94 2.05 1.87 2.16 2.22 2.16 2.1 2.15 2.16 2.02 2.12 2.24 2.25 2.19 2.19 1.99 1.96 2.17 2.24 1.94 2.12 2.19 2.3 2.18 2.15
REACTOME_SELECTIVE_AUTOPHAGY 2.24 2.3 2.49 2.39 2.39 2.46 2.44 2.43 2.38 2.45 2.35 2.38 2.43 2.4 2.43 2.4 2.34 2.29 2.35 2.39 2.38 2.36 2.44 2.51 2.44 2.34
REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS 2.1 2.23 2.19 2.03 2.32 2.42 2.38 2.2 2.39 2.35 2.21 2.41 2.43 2.51 2.3 2.3 2.15 2.17 2.49 2.44 2.08 2.16 2.4 2.51 2.29 2.23
REACTOME_PARASITE_INFECTION 2.49 2.54 2.41 2.42 2.58 2.66 2.63 2.45 2.57 2.55 2.44 2.51 2.57 2.61 2.52 2.48 2.41 2.35 2.65 2.61 2.31 2.44 2.57 2.63 2.48 2.42
REACTOME_KILLING_MECHANISMS 1.4 1.34 1.31 1.37 1.53 1.51 1.52 1.6 1.45 1.56 1.18 1.65 1.43 1.43 1.41 1.51 1.47 1.28 1.5 1.42 1.42 1.49 1.53 1.57 1.4 1.44
REACTOME_SIGNALING_BY_ERBB2_ECD_MUTANTS 1.92 1.85 1.94 1.85 2.17 2.13 2.18 2.12 2.13 2.12 1.98 2.02 2.06 2.05 2 2.06 1.99 1.82 2.07 1.94 1.84 2.06 2.04 1.97 1.96 1.88
REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III 2.43 2.62 2.68 2.6 2.52 2.67 2.62 2.62 2.72 2.7 2.52 2.72 2.62 2.6 2.65 2.68 2.5 2.56 2.6 2.73 2.56 2.35 2.64 2.83 2.75 2.5
REACTOME_SIGNALING_BY_KIT_IN_DISEASE 1.55 1.49 1.47 1.4 1.74 1.76 1.8 1.64 1.7 1.7 1.6 1.71 1.72 1.72 1.7 1.66 1.67 1.55 1.74 1.65 1.43 1.55 1.73 1.69 1.67 1.62
REACTOME_INHIBITION_OF_DNA_RECOMBINATION_AT_TELOMERE 1.48 1.59 1.65 1.74 1.59 1.44 1.59 1.52 1.61 1.61 1.73 1.57 1.62 1.63 1.64 1.68 1.61 1.45 1.6 1.61 1.55 1.49 1.57 1.68 1.57 1.57
REACTOME_SIGNALING_BY_PDGFR_IN_DISEASE 1.52 1.55 1.6 1.55 1.71 1.72 1.65 1.58 1.72 1.72 1.72 1.71 1.75 1.78 1.58 1.63 1.56 1.5 1.77 1.58 1.32 1.54 1.63 1.63 1.56 1.43
REACTOME_SIGNALING_BY_PDGFRA_TRANSMEMBRANE_JUXTAMEMBRANE_AND_KINASE_DOMAIN_MUTANTS 1.24 1.13 0.87 0.9 1.34 1.23 1.22 1.17 1.07 1.09 1.21 1.11 1.01 1.07 0.97 0.97 1.19 1.05 1.34 1.04 1.12 1.17 0.94 0.86 1.06 1.03
REACTOME_SIGNALING_BY_CSF3_G_CSF 2.15 2.21 2.27 2.16 2.3 2.32 2.38 2.44 2.29 2.42 2.31 2.46 2.39 2.36 2.42 2.36 2.43 2.25 2.35 2.41 2.41 2.46 2.43 2.49 2.36 2.34
REACTOME_NERVOUS_SYSTEM_DEVELOPMENT 2.07 2.13 2.21 2.11 2.27 2.33 2.28 2.23 2.24 2.26 2.14 2.23 2.27 2.26 2.23 2.23 2.15 2.11 2.21 2.29 2.12 2.2 2.28 2.35 2.26 2.17
REACTOME_DISEASES_OF_MITOTIC_CELL_CYCLE 1.61 1.57 1.78 1.93 1.86 1.87 1.67 1.61 1.69 1.82 1.64 1.69 1.77 1.76 1.59 1.63 1.73 1.6 1.77 1.75 1.6 1.61 1.73 1.7 1.67 1.67
REACTOME_DISEASES_OF_DNA_REPAIR 1.29 1.35 1.78 1.45 1.59 1.59 1.41 1.23 1.41 1.51 1.63 1.49 1.55 1.56 1.42 1.57 1.1 1.17 1.43 1.38 1.1 1.43 1.63 1.69 1.47 1.39
REACTOME_SARS_COV_1_INFECTION 2.22 2.34 2.35 2.24 2.46 2.44 2.39 2.33 2.46 2.37 2.27 2.39 2.39 2.36 2.36 2.34 2.27 2.28 2.37 2.41 2.39 2.33 2.4 2.51 2.42 2.3
REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS 1.98 1.99 2.16 2.12 2.15 2.17 2.19 2.21 2.18 2.15 2.11 2.11 2.14 2.18 2.22 2.23 2.13 2.15 2.13 2.19 2.1 2.22 2.19 2.23 2.18 2.1
REACTOME_TRANSLATION_OF_REPLICASE_AND_ASSEMBLY_OF_THE_REPLICATION_TRANSCRIPTION_COMPLEX 2.06 2.23 2.3 2.3 2.28 2.26 2.16 2.24 2.45 2.31 2.16 2.35 2.31 2.31 2.26 2.38 2.35 2.35 2.44 2.39 2.34 2.21 2.25 2.35 2.35 2.28
REACTOME_SARS_COV_INFECTIONS 2.03 2.07 2.17 2.1 2.2 2.21 2.2 2.18 2.22 2.17 2.11 2.14 2.16 2.18 2.2 2.2 2.11 2.12 2.15 2.2 2.13 2.18 2.2 2.26 2.19 2.11
REACTOME_FLT3_SIGNALING_IN_DISEASE 2.4 2.42 2.44 2.24 2.58 2.61 2.61 2.57 2.57 2.57 2.46 2.63 2.55 2.54 2.58 2.53 2.5 2.43 2.55 2.5 2.45 2.48 2.55 2.62 2.43 2.45
REACTOME_MATURATION_OF_NUCLEOPROTEIN 1.81 2.05 1.67 1.52 2.08 2.15 2.09 1.8 2.05 1.95 1.53 1.87 2.07 2.07 1.99 1.73 1.59 1.65 1.98 2.1 1.54 1.68 1.9 2.15 1.89 1.5
REACTOME_TRANSLATION_OF_SARS_COV_1_STRUCTURAL_PROTEINS 2.32 2.43 2.34 2.23 2.5 2.46 2.46 2.4 2.45 2.36 2.32 2.45 2.41 2.41 2.4 2.34 2.32 2.36 2.37 2.44 2.48 2.42 2.4 2.55 2.44 2.33
REACTOME_ABERRANT_REGULATION_OF_MITOTIC_EXIT_IN_CANCER_DUE_TO_RB1_DEFECTS 1.75 1.65 1.45 1.6 1.91 1.93 1.67 1.6 1.62 1.83 1.48 1.66 1.73 1.68 1.34 1.45 1.66 1.44 1.84 1.64 1.4 1.36 1.63 1.57 1.58 1.67
REACTOME_TRANSCRIPTIONAL_REGULATION_OF_TESTIS_DIFFERENTIATION 1.81 1.97 1.82 2.09 1.98 2.06 1.86 1.91 1.79 1.85 1.95 1.92 2.01 1.99 1.85 1.88 2.06 2.02 1.96 2.11 2 2.07 1.92 2.02 2.01 1.98
REACTOME_SARS_COV_2_INFECTION 2.12 2.2 2.24 2.12 2.32 2.31 2.26 2.2 2.32 2.24 2.17 2.22 2.24 2.23 2.23 2.22 2.13 2.12 2.23 2.26 2.21 2.18 2.28 2.35 2.26 2.15
REACTOME_MATURATION_OF_SARS_COV_2_SPIKE_PROTEIN 1.89 1.89 1.9 1.72 2.01 1.99 1.99 1.9 2.02 1.89 1.91 1.87 1.86 1.9 1.84 1.88 1.84 1.76 1.88 1.9 1.85 1.8 1.97 1.95 1.93 1.85
REACTOME_TRANSLATION_OF_SARS_COV_2_STRUCTURAL_PROTEINS 2.15 2.22 2.21 2.08 2.29 2.28 2.28 2.22 2.27 2.2 2.17 2.2 2.2 2.22 2.21 2.18 2.11 2.11 2.18 2.24 2.22 2.19 2.25 2.32 2.22 2.13
REACTOME_RND3_GTPASE_CYCLE 1.85 1.88 2.01 1.8 2.23 2.23 2.14 2.06 2.16 2.19 2.02 2.13 2.18 2.15 2.12 2.01 2.01 1.81 1.95 2.07 1.87 2.12 2.22 2.16 2.11 1.98
REACTOME_RND2_GTPASE_CYCLE 1.71 1.81 1.95 1.8 2.11 2.09 2.03 1.95 2.06 2.09 1.94 2.02 2.07 2.03 2.01 1.94 1.94 1.68 1.84 1.98 1.78 2 2.13 2.05 1.99 1.89
REACTOME_RND1_GTPASE_CYCLE 2.02 1.97 2.13 2.02 2.29 2.29 2.21 2.05 2.3 2.28 2.08 2.13 2.2 2.16 2.14 2.09 1.99 1.82 2.05 2.13 1.82 2.09 2.35 2.28 2.09 1.96
REACTOME_STAT5_ACTIVATION_DOWNSTREAM_OF_FLT3_ITD_MUTANTS 1.73 1.86 1.78 1.42 2.21 2.27 2.33 2.29 2.27 2.26 1.78 2.13 2.26 2.15 2.29 2 2.2 1.91 2.02 2.17 1.86 1.93 2.18 2.29 2.05 2.06
REACTOME_SIGNALING_BY_FLT3_FUSION_PROTEINS 1.98 1.95 1.91 1.82 2.21 2.25 2.28 2.16 2.24 2.19 2.01 2.28 2.19 2.15 2.19 2.09 2.1 2.03 2.2 2.17 1.92 1.99 2.15 2.2 1.95 1.98
REACTOME_SIGNALING_BY_FLT3_ITD_AND_TKD_MUTANTS 1.81 1.79 1.74 1.41 2.22 2.26 2.23 2.1 2.24 2.18 1.86 2.1 2.19 2.15 2.17 2.03 2.03 1.85 2.09 2.06 1.74 1.88 2.12 2.16 1.89 1.89
REACTOME_INACTIVATION_OF_CSF3_G_CSF_SIGNALING 2.36 2.43 2.51 2.4 2.49 2.52 2.57 2.6 2.47 2.63 2.54 2.67 2.58 2.57 2.6 2.59 2.61 2.47 2.55 2.6 2.61 2.65 2.65 2.68 2.57 2.53
REACTOME_RHOBTB3_ATPASE_CYCLE 1.58 1.73 1.8 1.77 1.98 2.02 1.8 1.7 2.04 1.83 1.83 1.77 1.94 2.08 1.72 1.86 1.86 1.81 1.66 1.79 1.84 2 1.87 1.96 1.85 1.78
REACTOME_NEGATIVE_REGULATION_OF_FLT3 2.86 2.97 3.11 2.87 3.07 3.03 2.94 2.96 2.88 3.08 3.07 3.13 2.98 3.02 2.91 3.05 3 2.95 2.96 2.95 2.98 2.99 3.02 3.06 2.94 2.96
REACTOME_RHOBTB_GTPASE_CYCLE 1.67 1.63 1.96 1.83 1.62 1.63 1.77 1.79 1.71 1.72 1.79 1.6 1.7 1.75 1.76 1.82 1.65 1.69 1.58 1.68 1.8 1.76 1.64 1.68 1.79 1.74
REACTOME_CYTOPROTECTION_BY_HMOX1 1.86 1.89 2.08 1.98 1.99 2.03 1.96 2.02 1.99 1.95 1.99 1.92 1.99 1.92 2 2.03 1.94 1.9 1.95 2.06 2 2.11 2.03 2.01 2.01 2
REACTOME_REGULATION_OF_HMOX1_EXPRESSION_AND_ACTIVITY 1.83 1.82 1.91 1.82 1.92 1.96 1.92 1.9 1.92 1.86 1.85 1.86 1.94 1.85 1.92 1.91 1.81 1.85 1.92 1.99 1.98 2.02 1.92 1.96 1.89 1.87
REACTOME_HEME_SIGNALING 1.58 1.6 1.86 1.83 1.81 1.85 1.81 1.71 1.8 1.86 1.8 1.73 1.78 1.82 1.82 1.79 1.77 1.72 1.82 1.84 1.52 1.7 1.94 1.76 1.79 1.7
REACTOME_SENSORY_PERCEPTION 1.84 1.87 2.01 1.86 2.08 2.16 2.06 2.01 2.04 2.07 1.94 2 2.11 2.1 2.07 2.08 1.9 1.84 2.03 2.09 1.92 2.05 2.1 2.16 2.06 2
REACTOME_CELLULAR_RESPONSE_TO_STARVATION 2.17 2.18 2.38 2.27 2.23 2.27 2.28 2.27 2.23 2.32 2.21 2.24 2.24 2.26 2.25 2.28 2.25 2.19 2.18 2.28 2.16 2.31 2.3 2.33 2.33 2.25
REACTOME_CELLULAR_RESPONSE_TO_CHEMICAL_STRESS 1.96 2.02 2.22 2.12 2.13 2.17 2.12 2.17 2.15 2.11 2.1 2.07 2.13 2.1 2.15 2.2 2.05 2 2.09 2.17 2.14 2.24 2.18 2.19 2.19 2.17
REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 1.99 2.04 2.17 2.07 2.25 2.28 2.2 2.12 2.2 2.22 2.09 2.15 2.21 2.22 2.16 2.14 2.08 2 2.11 2.18 2 2.1 2.25 2.29 2.19 2.08
REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING 2.92 2.86 3.02 2.88 2.97 2.98 2.99 3.15 2.81 3.05 3.03 3 2.97 2.9 3.11 3.11 3.04 3.09 3.06 3.05 3.08 3.19 3.09 3.16 3 3.03
REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI 1.92 1.95 2.1 1.94 2.23 2.29 2.02 2.15 2.13 2.14 1.95 2.06 2.09 2.15 2.2 2.14 1.87 1.87 2.2 2.21 1.78 1.97 2.16 2.33 1.98 1.94
REACTOME_N_GLYCAN_ANTENNAE_ELONGATION 1.94 2.04 1.95 1.7 2.08 2.13 2 2.09 2.07 2.05 1.83 1.85 1.97 2.1 2.1 2.05 1.63 1.84 2.18 2.11 1.55 1.71 2.08 2.16 1.92 1.64
REACTOME_REACTIONS_SPECIFIC_TO_THE_COMPLEX_N_GLYCAN_SYNTHESIS_PATHWAY 2.02 1.98 2.36 2.31 2.58 2.56 2.13 2.33 2.32 2.36 2.23 2.4 2.34 2.28 2.38 2.32 2.3 1.95 2.34 2.43 2.13 2.37 2.38 2.57 2.13 2.33
REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS 1.25 1.29 1.59 1.48 1.67 1.69 1.49 1.55 1.62 1.66 1.39 1.43 1.72 1.73 1.64 1.66 1.53 1.35 1.35 1.49 1.38 1.68 1.59 1.72 1.77 1.76
REACTOME_AMYLOID_FIBER_FORMATION 2.72 2.8 2.93 2.81 3.04 3.1 2.98 2.99 2.97 2.97 2.86 3.01 3 3.01 2.99 2.9 2.84 2.7 2.87 3.01 2.84 2.94 3.01 3.15 2.99 2.85
REACTOME_GABA_RECEPTOR_ACTIVATION 2.47 2.53 2.54 2.27 2.65 2.75 2.68 2.58 2.63 2.58 2.56 2.52 2.68 2.69 2.63 2.61 2.42 2.5 2.63 2.73 2.45 2.61 2.68 2.72 2.58 2.46
REACTOME_GABA_B_RECEPTOR_ACTIVATION 2.44 2.48 2.38 2.07 2.63 2.65 2.57 2.59 2.52 2.49 2.51 2.51 2.63 2.61 2.56 2.54 2.41 2.51 2.57 2.71 2.46 2.56 2.58 2.62 2.53 2.48
REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING 2.06 2.13 2.05 1.86 2.23 2.3 2.12 2.08 2.13 2.28 2.13 2.26 2.24 2.24 2.14 2.11 2.15 2.01 2.18 2.26 2.12 2.12 2.32 2.38 2.27 2.11
REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION 1.74 1.77 1.93 1.84 1.95 2.02 1.92 1.85 1.93 1.94 1.88 1.84 1.93 1.93 1.91 1.88 1.76 1.7 1.87 1.91 1.72 1.84 1.96 2.02 1.89 1.82
REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION 1.78 1.83 2 1.91 2.02 2.08 2.02 1.93 2.01 2.02 1.96 1.93 2.02 2.02 1.98 1.94 1.84 1.76 1.92 1.99 1.79 1.92 2.06 2.11 1.96 1.9
REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC 1.93 1.99 2.27 2.07 2.07 2.09 2.25 2.18 2.29 2.13 2.14 2.08 2.21 2.18 2.15 2.13 2.03 2.16 1.96 2.14 2.16 2.23 2.29 2.34 2.29 2.19
REACTOME_KINESINS 2.42 2.5 2.56 2.45 2.73 2.78 2.73 2.63 2.69 2.8 2.58 2.7 2.73 2.73 2.76 2.65 2.54 2.49 2.58 2.66 2.44 2.51 2.71 2.8 2.71 2.54
REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION 2.3 2.37 2.46 2.37 2.59 2.64 2.51 2.44 2.53 2.61 2.44 2.48 2.55 2.58 2.56 2.53 2.39 2.3 2.49 2.54 2.24 2.4 2.62 2.65 2.57 2.44
REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS 1.98 2.11 2.11 2.13 2.31 2.4 2.31 2.14 2.27 2.35 2.11 2.33 2.36 2.4 2.19 2.25 2.15 2.18 2.42 2.33 2.06 2.17 2.32 2.4 2.23 2.15
REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR 1.99 2.08 2.22 2.13 2.2 2.27 2.24 2.17 2.23 2.2 2.12 2.16 2.25 2.21 2.19 2.21 2.04 2.07 2.22 2.26 2.12 2.21 2.25 2.32 2.16 2.11
REACTOME_ION_CHANNEL_TRANSPORT 2.41 2.49 2.68 2.47 2.66 2.74 2.67 2.67 2.63 2.67 2.54 2.62 2.71 2.72 2.66 2.69 2.53 2.49 2.61 2.73 2.5 2.69 2.71 2.81 2.69 2.6
